<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">World J. Gastroenterol</journal-id><journal-id journal-id-type="publisher-id">WJG</journal-id><journal-title-group><journal-title>World Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="ppub">1007-9327</issn><issn pub-type="epub">2219-2840</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5473118</article-id><article-id pub-id-type="other">jWJG.v23.i22.pg3978</article-id><article-id pub-id-type="doi">10.3748/wjg.v23.i22.3978</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Aarti</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Kiran Lata</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Annapurna</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yadav</surname><given-names>Alka</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Ashok</given-names></name></contrib><aff>Aarti Sharma, Annapurna Gupta, Alka Yadav, Ashok Kumar, Department of Surgical Gastroenterology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, India</aff><aff>Kiran Lata Sharma, Department of Biochemistry and Medical Genetics, John Buhler Research Centre, University of Manitoba, Winnipeg MB R3E 3P4, Canada</aff></contrib-group><author-notes><fn><p>Author contributions: Sharma A, Sharma KL and Kumar A have written the manuscript; Sharma A, Sharma KL and Gupta A has contributed in literature search; Sharma A, Sharma KL, Gupta A and Yadav A have contributed in designing tables as well as referencing; Kumar A is senior Corresponding author; Sharma KL is co-corresponding author; all the authors have approved the final version of the manuscript.</p><p>Correspondence to: Dr. Ashok Kumar, Professor, Department of Surgical Gastroenterology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, India. <email>akgupta@sgpgi.ac.in</email></p><p>Telephone: +91-522-2494423 Fax: +91-522-2668017</p></fn></author-notes><pub-date pub-type="ppub"><day>14</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>14</day><month>6</month><year>2017</year></pub-date><volume>23</volume><issue>22</issue><fpage>3978</fpage><lpage>3998</lpage><history><date date-type="received"><day>24</day><month>12</month><year>2016</year></date><date date-type="rev-recd"><day>1</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>1</day><month>6</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9;The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><abstract><p>Gallbladder cancer is a malignancy of biliary tract which is infrequent in developed countries but common in some specific geographical regions of developing countries. Late diagnosis and deprived prognosis are major problems for treatment of gallbladder carcinoma. The dramatic associations of this orphan cancer with various genetic and environmental factors are responsible for its poorly defined pathogenesis. An understanding to the relationship between epidemiology, molecular genetics and pathogenesis of gallbladder cancer can add new insights to its undetermined pathophysiology. Present review article provides a recent update regarding epidemiology, pathogenesis, and molecular genetics of gallbladder cancer. We systematically reviewed published literature on gallbladder cancer from online search engine PubMed (http://www.ncbi.nlm.nih.gov/pubmed). Various keywords used for retrieval of articles were Gallbladder, cancer Epidemiology, molecular genetics and bullion operators like AND, OR, NOT. Cross references were manually searched from various online search engines (http://www.ncbi.nlm.nih.gov/pubmed,https://scholar.google.co.in/, http://www.medline.com/home.jsp). Most of the articles published from 1982 to 2015 in peer reviewed journals have been included in this review.</p></abstract><kwd-group><kwd>Gallbladder cancer</kwd><kwd>Epidemiology</kwd><kwd>Molecular genetics</kwd><kwd>Pathogenesis</kwd></kwd-group></article-meta></front><body><p><bold>Core tip:</bold> The Gallbladder cancer is a fatal malignancy which displays considerable differences in certain ethnicities and geographic regions. Indo-Gangetic plains of India, Mapuche Indians in Chile and South America are most affected regions with this cancer. Because of this cancer is largely unstudied as compare to other cancers Present review provides a comprehensive summery of the studies conducted regarding its Epidemiology, Pathogenesis and molecular genetics. This will be helpful for the researchers to understand the current scenario of research work and how much success we have gained till now. Based on which future research work can be planned in appropriate directions.</p><sec><title>INTRODUCTION</title><p>Gallbladder cancer (GBC) is a rare biliary tract malignancy in most western countries, but is much widespread in some other regions of the world. Moreover, this carcinoma is infrequent in developed countries but more common in some developing countries, characterized by its lack of symptoms at initial stage leading to difficulties in treatment.</p><p>The extensive variation in geography, ethnicity, and cultural differences in the incidence of gallbladder cancer suggests the role of key genetic and environmental factors associated with the development and progression of the disease[<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>]. The lack of a serosal layer of gallbladder adjacent to the liver thus enabling hepatic invasion and metastatic progression is one of the major cause of its miserable prognosis[<xref rid="B3" ref-type="bibr">3</xref>]. The present review provides a recent update of studies regarding epidemiology, pathogenesis and molecular genetics of gallbladder cancer as available in literature.</p></sec><sec><title>EPIDIMIOLOGY OF GALLLBLADDER CANCER</title><p>Gallbladder cancer shows an unusual geographic distribution worldwide with substantial geographic variation. Data from Mapuche Indians from Valdivia, Chile, South America shows the rate of gallbladder cancer as: 12.3/100000 for males and 27.3/100000 for females[<xref rid="B3" ref-type="bibr">3</xref>]. The native people is these countries exceed for gallbladder cancer mortality rates from cervical (8.0/100000), breast (8.7/100000), pancreatic (7.4/100000), and ovarian cancers (7.3/100000)[<xref rid="B3" ref-type="bibr">3</xref>]. American Indians in New Mexico, USA, have also very high average annual rate of GBC (8.9/100000)[<xref rid="B4" ref-type="bibr">4</xref>], [Surveillance, Epidemiology End-Results Program (SEER) The Four Most Common Cancers for Different Ethnic Populations 2013. Bethesda, MD: National Cancer Institute; 2013].</p><p>Although the worldwide occurrence of gallbladder cancer is less than 2/100000 individuals, but this has been recorded with extensive variance[<xref rid="B5" ref-type="bibr">5</xref>]. The residents of Indo-Gangetic belt particularly females of northern India (21.5/100000) and south Karachi Pakistan (13.8/100000) have been reported as one of the highest affected regions[<xref rid="B4" ref-type="bibr">4</xref>]. Gallbladder cancer is also found in high frequency in Eastern Europe include Poland (14/100000 in Poland), Czech Republic, and Slovakia and Asia whereas south Americans of Indian descent (3.7 to 9.1 per 100000), Israel (5/100000) and Japan (7/100000) have shown intermediate prevalence of gallbladder cancer[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B6" ref-type="bibr">6</xref>]. The residents of Andean-area, North American Indians and Mexican-Americans are specially predisposed of GBC[<xref rid="B6" ref-type="bibr">6</xref>]. The majority of the world has decreasing mortality trends in gallbladder cancer but GBC frequency is constantly rising in Shanghai, China which is substantial cause of mortality[<xref rid="B7" ref-type="bibr">7</xref>]. Although Gallbladder cancer is more common in females still in some countries like Korea, Iceland and Costa Rica, higher mortality rate has been reported for males as compare to females[<xref rid="B8" ref-type="bibr">8</xref>]. The data from National Cancer Institute; SEER Program (<uri xlink:type="simple" xlink:href="http://seer.cancer.gov/">http://seer.cancer.gov/</uri>) has revealed only little turn down in incidence over the past few decades.</p></sec><sec><title>ETIOLOGICAL FACTORS FOR GBC PATHOGENESIS</title><p>The development of gallbladder cancer has been linked to various genetic and environmental factors. Chronic infection of gallbladder or/and environmental exposure to specific chemicals, heavy metals, and even many dietary factors, have been found to be associated with GBC formation. The dramatic association of GBC with female gender and certain geographical regions (mostly developing countries) has been proposed to be influenced by various female hormones, cholesterol cycling and salmonella infections in existing literature[<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>]. Worldwide GBC affects females 2-3 times more commonly than males, but bias varies greatly in different parts of the world mostly in high prevalent regions of GBC[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B6" ref-type="bibr">6</xref>]. To some extent, the female hormone estrogen causes increased cholesterol super saturation in bile and hence involved in gallstone mediated GBC pathogenesis[<xref rid="B11" ref-type="bibr">11</xref>]. Although the female gender GBC can be linked with the role of female hormones. However an article published previously has questioned the association of hormone receptor expression to tumor differentiation[<xref rid="B12" ref-type="bibr">12</xref>]. So the extent of female hormones contribution in Gallbladder cancer is still not certain and requires more investigation.</p><p>Other well-known GBC associated risk factors such as porcelain gallbladder, Mirizzi&#x02019;s syndrome and bile reflux has also been playing a major role as a predisposing factors of this disease[<xref rid="B9" ref-type="bibr">9</xref>]. Family history of gallstones, tobacco consumption, chemical exposure, residence in Gangetic belt and high concentrations of secondary bile acids, excessive intake of fried foods (reused oil), increases the risk for GBC[<xref rid="B13" ref-type="bibr">13</xref>]. Present data suggest that gallstones are a major risk factor for GBC but their role as a cause for gallbladder cancer is still not certain. A review article by Shrikhande et al[<xref rid="B14" ref-type="bibr">14</xref>] has also supported the fact that the populations reporting high incidence of gallbladder cancer with associated gallstones, prophylactic cholecystectomy should be done only after correlating with the epidemiological profile of the place. Convincing evidence also exists for the presence of gallstones as strongly associated factor for gallbladder cancer etiology[<xref rid="B7" ref-type="bibr">7</xref>]. Most of the etiological factors are summarized in Table <xref ref-type="table" rid="T1">1</xref>[<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B15" ref-type="bibr">15</xref>-<xref rid="B50" ref-type="bibr">50</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Etiological factors for gallbladder cancer pathogenesis</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td rowspan="1" colspan="1"><bold>Major Independent Etiological factors</bold></td><td rowspan="1" colspan="1"><bold>Dependent Etiological factors</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Age[<xref rid="B6" ref-type="bibr">6</xref>]</td><td rowspan="1" colspan="1">Tobacco consumption[<xref rid="B15" ref-type="bibr">15</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex[<xref rid="B6" ref-type="bibr">6</xref>], BMI[<xref rid="B16" ref-type="bibr">16</xref>]</td><td rowspan="1" colspan="1">Mustard oil[<xref rid="B17" ref-type="bibr">17</xref>] Argemone oil (AO) and butter yellow (BY)[<xref rid="B18" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Family history[<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B19" ref-type="bibr">19</xref>]</td><td rowspan="1" colspan="1">Early age at first pregnancy[<xref rid="B20" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Cholelithiasis[<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B22" ref-type="bibr">22</xref>-<xref rid="B24" ref-type="bibr">24</xref>]</td><td rowspan="1" colspan="1">Use of Oral contraceptives[<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic cholecystitis, porcelain gallbladder[<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>]</td><td rowspan="1" colspan="1">Red Chili pepper[<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic infection by <italic>Salmonella</italic> species, <italic>S. paratyphi</italic> or <italic>S. typhican</italic>[<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B31" ref-type="bibr">31</xref>-<xref rid="B34" ref-type="bibr">34</xref>]</td><td rowspan="1" colspan="1">Occupational exposure, Benzene[<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B35" ref-type="bibr">35</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Helocobacter pylori</italic>[<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B37" ref-type="bibr">37</xref>]</td><td rowspan="1" colspan="1">Secondary bile acids[<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B38" ref-type="bibr">38</xref>-<xref rid="B40" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">High parity[<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B26" ref-type="bibr">26</xref>]</td><td rowspan="1" colspan="1">Xanthogranulomatous cholecystitis[<xref rid="B41" ref-type="bibr">41</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Anomalous pancreatobiliary duct junction[<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>]</td><td rowspan="1" colspan="1">Heavy metals[<xref rid="B44" ref-type="bibr">44</xref>,<xref rid="B45" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Porcelain gallbladder[<xref rid="B46" ref-type="bibr">46</xref>]</td><td rowspan="2" colspan="1">Genetic factors[<xref rid="B48" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Gallbladder polyp[<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Obesity[<xref rid="B49" ref-type="bibr">49</xref>]</td><td rowspan="1" colspan="1">Free radical oxidation products[<xref rid="B50" ref-type="bibr">50</xref>]</td></tr></tbody></table></table-wrap><sec><title>Familial and linkage studies</title><p>Swedish family-cancer database and Utah cancer registry has reported the first ever data for familial clustering of GBC[<xref rid="B51" ref-type="bibr">51</xref>]. This study has provided the first data on familial clustering of gallbladder cancer based on medically confirmed records, in which it was estimated that 26% of gallbladder cancers are familial. The significant risk in 3<sup>rd</sup> degree relatives and the disease manifestation in several high risk pedigrees as reported in previous studies gives a strong indication for genetic susceptibility to GBC[<xref rid="B51" ref-type="bibr">51</xref>]. The high risk heritable factors are likely to contribute to a large extent to this cancer further modulated by environmental factors. The nationwide Swedish Family-Cancer Data base from the Swedish Cancer Registry (10.2 million individuals from the year 1961-1998), has reported maternal transmission favoring over paternal in familial gallbladder cancers[<xref rid="B52" ref-type="bibr">52</xref>]. Furthermore, the clustering of gallbladder cancer within families is suggestive of a critical role of genetics in its development[<xref rid="B19" ref-type="bibr">19</xref>]. Carcinoma gallbladder was detected in two siblings from Brazil as reported by Trajber et al[<xref rid="B53" ref-type="bibr">53</xref>]. Role of allele specific mutations in pathogenesis of carcinoma gallbladder has also been reported[<xref rid="B54" ref-type="bibr">54</xref>]. Another report by Pandey et al[<xref rid="B55" ref-type="bibr">55</xref>] has shown higher frequency of carcinoma gallbladder in patients with A+ and AB+ blood groups to which the reason is still unknown.</p></sec></sec><sec><title>GENETIC AND MOLECULAR ALTERATION REPORTED IN GALLBLADDER CARCINOMA</title><p>The present existing information regarding genetic and molecular alterations in GBC is still very much limited. Like other neoplasms, GBC is a multifactorial disorder involving multiple genetic alterations[<xref rid="B56" ref-type="bibr">56</xref>-<xref rid="B58" ref-type="bibr">58</xref>]. Abnormality in tumor suppressor genes, oncogenes, and DNA repair genes, presence of microsatellite instability (MSI) and epigenetic alterations mainly caused by aberrant promoter methylation of gene areas are some of the various well known factors reported till now. The serious of genetic alteration leading to gallbladder cancer formation is still not established clearly. Some of the molecular alterations reported so far are enumerated in Tables <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="table" rid="T3">3</xref> and <xref ref-type="table" rid="T4">4</xref>.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Mutations detected in gallbladder cancer by low throughput methods</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Studied gene</bold></td><td rowspan="1" colspan="1"><bold>Type of study</bold></td><td rowspan="1" colspan="1"><bold>Methods used</bold></td><td rowspan="1" colspan="1"><bold>Studied population</bold></td><td rowspan="1" colspan="1"><bold>Ref</bold>.</td></tr></thead><tbody align="center"><tr><td rowspan="4" align="left" colspan="1"><italic>KRAS</italic></td><td rowspan="1" colspan="1">Mutation at codon-12 (8%)</td><td rowspan="1" colspan="1">PCR-RFLP</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[64]</td></tr><tr><td rowspan="1" colspan="1">Mutation at codon-12 (29%-30%)</td><td rowspan="1" colspan="1">PCR-RFLP</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[76,77]</td></tr><tr><td rowspan="1" colspan="1">Mutation at codon-12 (0%-59%)</td><td rowspan="1" colspan="1">PCR-RFLP, Direct sequencing</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[60,78,79]</td></tr><tr><td rowspan="1" colspan="1">Mutation at codon-12 (50%-80%)</td><td rowspan="1" colspan="1">ELMA, SAB, PCR-SSCP, Direct sequencing</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[63,80]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>INK4A (p16)</italic></td><td rowspan="1" colspan="1">Mutation, deletion</td><td rowspan="1" colspan="1">PCR-RFLP, direct sequencing, IHC</td><td rowspan="1" colspan="1">Japan, Chile</td><td rowspan="1" colspan="1">[54,79,81,82]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>D310 mtDNA</italic></td><td rowspan="1" colspan="1">Mutation (Displacement loop)</td><td rowspan="1" colspan="1">PCR-based assay, direct sequencing</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[83]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>TP53</italic></td><td rowspan="1" colspan="1">Mutation, overexpression, LOH</td><td rowspan="1" colspan="1">PCR-RFLP, direct sequencing, IHC</td><td rowspan="1" colspan="1">Greece, Japan, Chile</td><td rowspan="1" colspan="1">[84-86]</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Mutations studies in gallbladder cancer by high throughput methods</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Platform</bold></td><td rowspan="1" colspan="1"><bold>Number of samples</bold></td><td rowspan="1" colspan="1"><bold>Study population</bold></td><td rowspan="1" colspan="1"><bold>Research planned</bold></td><td rowspan="1" colspan="1"><bold>Key findings</bold></td><td rowspan="1" colspan="1"><bold>Ref</bold>.</td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Sequenom Mass ARRAY technology</td><td rowspan="1" colspan="1">49 FFPE</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">390 mutations in 30 genes</td><td rowspan="1" colspan="1"><italic>PIK3CA</italic> (4%), <italic>KRAS</italic> (2%), <italic>CTNNB1</italic> (4%), <italic>TP53</italic> (18%)</td><td rowspan="1" colspan="1">[95]</td></tr><tr><td rowspan="2" align="left" colspan="1">Mass spectroscopy-based</td><td rowspan="2" colspan="1">57 FFPE</td><td rowspan="4" colspan="1">MD Anderson Centre</td><td rowspan="2" colspan="1">159 mutations in 33 genes</td><td rowspan="1" colspan="1">14 hotspot mutations in 9 cases including (<italic>KRAS, NRAS, PIK3CA, IDH1, ALK, MET</italic>)</td><td rowspan="2" colspan="1">[94]</td></tr><tr><td rowspan="1" colspan="1">26 mutations in 15cases</td></tr><tr><td rowspan="2" align="left" colspan="1">Next-generation sequencing (NGS)</td><td rowspan="2" colspan="1">15 FFPE</td><td rowspan="2" colspan="1">NGS of 182 cancer-related genes</td><td rowspan="1" colspan="1">(<italic>P53, STK11, RICTOR,TSC2, FGF3-TACC</italic> fusion, <italic>FGF10</italic> amplification)</td><td rowspan="2" colspan="1">[94]</td></tr><tr><td rowspan="1" colspan="1">Preponderance of mutations involving the PI3 kinase pathway</td></tr><tr><td rowspan="3" align="left" colspan="1">Whole Exome and transcriptome Sequencing</td><td rowspan="3" colspan="1">29 Fresh Frozen</td><td rowspan="3" colspan="1">Japan</td><td rowspan="3" colspan="1">64 non silent mutations signatures</td><td rowspan="1" colspan="1"><italic>EGFR, ERBB3, PTEN, ARID2, MLL2</italic>,</td><td rowspan="3" colspan="1">[96]</td></tr><tr><td rowspan="1" colspan="1"><italic>MLL3, APOBEC, TERT</italic></td></tr><tr><td rowspan="1" colspan="1"><italic>APOBEC</italic>-associated mutation signature were observed in GBC</td></tr><tr><td rowspan="3" align="left" colspan="1">Exome sequencing and targeted gene sequencing</td><td rowspan="3" colspan="1">57 Fresh Frozen</td><td rowspan="3" colspan="1">China</td><td rowspan="3" colspan="1">Whole exome sequencing</td><td rowspan="1" colspan="1"><italic>TP53</italic> (47.1%), <italic>KRAS</italic> (7.8%) and</td><td rowspan="3" colspan="1">[93]</td></tr><tr><td rowspan="1" colspan="1"><italic>ERBB3</italic> (11.8%)</td></tr><tr><td rowspan="1" colspan="1">ERBB pathway genes mostly mutated</td></tr></tbody></table><table-wrap-foot><fn><p>FFPE: Fresh frozen paraffin embedded.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Summary of global gene expression studies in gallbladder cancer</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Biological sample used</bold></td><td rowspan="1" colspan="1"><bold>Platform/studies key findings</bold></td><td rowspan="1" colspan="1"><bold>Ref</bold>.</td></tr></thead><tbody align="center"><tr><td rowspan="3" align="left" colspan="1">17 gallbladder tissue specimens (6 advanced GBC , 6 early GBC cancers and 5 normal control</td><td rowspan="1" colspan="1">Oligonucleotide Microarray platform</td><td rowspan="3" colspan="1">[97]</td></tr><tr><td rowspan="1" colspan="1">Unregulated genes: 2270</td></tr><tr><td rowspan="1" colspan="1">Downregulated genes: 2412</td></tr><tr><td rowspan="3" align="left" colspan="1">5-Normal biliary epithelial scrapings, 11- surgically resected biliary carcinomas, 9-biliary cancer cell lines</td><td rowspan="1" colspan="1">Oligonucleotide Microarray platform</td><td rowspan="3" colspan="1">[98]</td></tr><tr><td rowspan="1" colspan="1">Unregulated genes : 282 genes</td></tr><tr><td rowspan="1" colspan="1">Downregulated genes: 513</td></tr><tr><td align="left" rowspan="1" colspan="1">37 biliary tract carcinomas</td><td rowspan="1" colspan="1">cDNA array platform</td><td rowspan="2" colspan="1">[99]</td></tr><tr><td align="left" rowspan="1" colspan="1">(15 bile duct, 11 gallbladder, 11 of ampulla of Vater)</td><td rowspan="1" colspan="1">118 genes were identified with a prognostic value</td></tr><tr><td rowspan="2" align="left" colspan="1">12 advanced gallbladder carcinoma tissue 3 samples of normal control gallbladder epithelium</td><td rowspan="1" colspan="1">Oligonucleotide Array platform</td><td rowspan="1" colspan="1">[100]</td></tr><tr><td rowspan="1" colspan="1">Upregulated: (TOPO II-alpha, cyclin B2, CDC28, ubiquitin-conjugating enzyme E2C), and one metabolism-related: (gamma-glutamyl hydrolase)</td><td rowspan="2" colspan="1">[101]</td></tr><tr><td align="left" rowspan="1" colspan="1">34 biliary tract cancers including</td><td rowspan="1" colspan="1">Oligonucleotide Array platform</td></tr><tr><td align="left" rowspan="1" colspan="1">13 intrahepatic (IHC), 12extrahepatic (EHC), 9 (GBC)</td><td rowspan="1" colspan="1">1281 genes with deregulated expression pattern</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec><title>GENETIC ALTERATIONS IN GBC</title><sec><title>KRAS</title><p>KRAS act as initial key player in numerous signal transduction mechanisms and associated pathways. Many pathogenic mutations have been reported in <italic>KRAS onco</italic>gene in Gallbladder cancer tissue[<xref rid="B58" ref-type="bibr">58</xref>-<xref rid="B63" ref-type="bibr">63</xref>]. K<italic>RAS</italic> gene mutations identified in GBC mostly affects codons 12, 13 and 61. In north India <italic>KRAS</italic> codon 13 mutation is more common (about one third) than codon 12 and 61[<xref rid="B64" ref-type="bibr">64</xref>]. However many other studies have not detected any mutations in this gene[<xref rid="B65" ref-type="bibr">65</xref>,<xref rid="B66" ref-type="bibr">66</xref>]. Any activating point mutations in <italic>KRAS</italic> oncogene can give rise to abnormal growth signals which is one of the hallmarks of cancer. The previous reports have co-related a condition called anomalous arrangement of the pancreatico-biliary duct with presence of gallbladder cancer as patients harboring this condition have a higher frequency of <italic>KRAS</italic> gene mutation as compare to normal condition[<xref rid="B65" ref-type="bibr">65</xref>,<xref rid="B67" ref-type="bibr">67</xref>,<xref rid="B68" ref-type="bibr">68</xref>]. However mutation of <italic>KRAS</italic> gene has never been detected in GBC having adenoma carcinoma sequence of development[<xref rid="B69" ref-type="bibr">69</xref>] (Table <xref ref-type="table" rid="T2">2</xref>).</p></sec><sec><title>TP53</title><p>TP53 is a well-known tumor suppressor gene and has various mechanisms of anticancer function and plays significant role in maintenance of genome integrity, apoptosis, genomic stability, and inhibition of angiogenesis etc. Loss of <italic>TP53</italic> function allows deregulated survival of genetically impaired abnormal cells which can lead to neoplastic conversion of later on[<xref rid="B70" ref-type="bibr">70</xref>]. <italic>TP53</italic> mutations are relatively more common in later stages of the disease[<xref rid="B63" ref-type="bibr">63</xref>,<xref rid="B66" ref-type="bibr">66</xref>,<xref rid="B71" ref-type="bibr">71</xref>-<xref rid="B73" ref-type="bibr">73</xref>]. Most of the <italic>TP53</italic> mutations associated with GBC are missense mutations that produce a non-functional protein with an increased half-life. The existing literature has reported mutations of the <italic>TP53</italic> gene in between approximately 27% to 70% of gallbladder carcinomas[<xref rid="B74" ref-type="bibr">74</xref>]. Many codons of the <italic>TP53</italic> codons are affected by pathogenic mutations of this gene. Functional molecular studies have discovered that mutations in exons 5 and 8 of <italic>TP53</italic> gene causes deregulation of this gene[<xref rid="B75" ref-type="bibr">75</xref>]. Details are shown in various existing literature is shown in Table <xref ref-type="table" rid="T2">2</xref>[<xref rid="B54" ref-type="bibr">54</xref>,<xref rid="B60" ref-type="bibr">60</xref>,<xref rid="B63" ref-type="bibr">63</xref>,<xref rid="B64" ref-type="bibr">64</xref>,<xref rid="B76" ref-type="bibr">76</xref>-<xref rid="B86" ref-type="bibr">86</xref>].</p></sec><sec><title>C-ERB-B2</title><p>The oncogene <italic>c-erb-B2</italic> is a homologue for epidermal growth receptor, encoding a protein with tyrosine kinase activity. The immunohistochemical expression of c-erb-B2 has been found positive between 10%-46% of gallbladder cases. However its expression has been found to be absent in dysplasia or adenomas as shown by previous reports[<xref rid="B87" ref-type="bibr">87</xref>,<xref rid="B88" ref-type="bibr">88</xref>]. Animal model studies in transgenic mice have shown that <italic>erbB2</italic> overexpression in the basal layer of the biliary tract epithelium led to the development of GBC in all (100%) of mice. Moreover, the expression of HER2&#x02044;neu was positively observed in 28% of GBCs which was directly correlated with advanced stage of cancer[<xref rid="B89" ref-type="bibr">89</xref>]. Therefore, it can be hypothesized that some oncogene is associated with in Gallbladder cancer progression. In a study from India, C-erbB2 was frequently expressed in well differentiated and stage II to stage IV in about 9.4% of GBC cases[<xref rid="B90" ref-type="bibr">90</xref>]. A recent report showed HER2/neu overexpression occurred in 14% of the advanced gallbladder cancer cases, and this subgroup was expected to be benefited from HER2/neu pathway inhibitors[<xref rid="B91" ref-type="bibr">91</xref>]. Therapeutic targeting of <italic>EGFR/HER2</italic> pathways boosts the anti-proliferative effect of gemcitabine in biliary tract and gallbladder carcinomas as shown by a previous study[<xref rid="B92" ref-type="bibr">92</xref>]. Based on facts it can be concluded that <italic>C-ERB-B2</italic> expression can become a marker for a poor prognosis.</p></sec></sec><sec><title>HIGH THROUGHPUT MUTATION STUDIES IN GBC</title><p>High throughput research has made large scale repetition of experiments feasible as it automates the experiments thus it has now become possible to study how all 21000 genes potentially contribute to cell function or disease. But in case of gallbladder cancer there are very limited high throughput studies. One of the pioneer studies published in nature genetics using high throughput approach by Chinese population has found recurrent mutations in ErbB pathway[<xref rid="B93" ref-type="bibr">93</xref>]. Javle et al[<xref rid="B94" ref-type="bibr">94</xref>] has found 26 missense mutations with more common <italic>TP53</italic> and <italic>PIK3CA</italic> mutations in GBC tumor using NGS technology. Mutation profiling of gallbladder cancer tissue in Indian population has found <italic>PIK3CA</italic> and <italic>KRAS</italic> mutations as most common among this ethnicity[<xref rid="B95" ref-type="bibr">95</xref>]. The variability in the results is an indicator of intra-tumoral heterogeneity of cancer, which describes the observation of different tumor cells showing distinct morphological and molecular profiles including variable gene expression but ultimately leading to a common phenotype. The high throughput mutation studies in GBC are presented in Table <xref ref-type="table" rid="T3">3</xref>[<xref rid="B93" ref-type="bibr">93</xref>-<xref rid="B96" ref-type="bibr">96</xref>].</p></sec><sec><title>GENE EXPRESSION STUDIES IN GBC</title><p>In order to identify potential biomarkers for GBC progression, many studies have been performed to find out the differential gene expression profiles between normal and tumor cells. Existing data various greatly, despite of same grade and stage of the included study subjects. Table <xref ref-type="table" rid="T4">4</xref>[<xref rid="B97" ref-type="bibr">97</xref>-<xref rid="B101" ref-type="bibr">101</xref>] and Table <xref ref-type="table" rid="T5">5</xref>[<xref rid="B54" ref-type="bibr">54</xref>,<xref rid="B66" ref-type="bibr">66</xref>,<xref rid="B75" ref-type="bibr">75</xref>,<xref rid="B84" ref-type="bibr">84</xref>,<xref rid="B86" ref-type="bibr">86</xref>,<xref rid="B90" ref-type="bibr">90</xref>,<xref rid="B102" ref-type="bibr">102</xref>-<xref rid="B180" ref-type="bibr">180</xref>] are summarizing global and single gene expression studies reported in GBC respectively.</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Summary of single gene expression studied reported in gallbladder cancer</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Studied single genes</bold></td><td rowspan="1" colspan="1"><bold>Expression pattern</bold></td><td rowspan="1" colspan="1"><bold>Studied population</bold></td><td rowspan="1" colspan="1"><bold>Ref</bold>.</td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1"><italic>TP53</italic></td><td rowspan="1" colspan="1">Expression (20%-70%)</td><td rowspan="1" colspan="1">India, Slovenia, Greece, Taiwan, Japan, Chile</td><td rowspan="1" colspan="1">[75,84-86,102-106]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>p16</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">South Korea</td><td rowspan="1" colspan="1">[107]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>FHIT</italic></td><td rowspan="1" colspan="1">Expression loss (45%-75%)</td><td rowspan="1" colspan="1">Japan, Chile</td><td rowspan="1" colspan="1">[108,109]</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>ERBB2</italic></td><td rowspan="1" colspan="1">Overexpression (25%-64%)</td><td rowspan="1" colspan="1">India, Japan, China, South Korea</td><td rowspan="1" colspan="1">[66,103,110,111]</td></tr><tr><td rowspan="1" colspan="1">Expressed in 9.4%cases of well differentiated and stage II to stage IV tumors</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[90]</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>RB</italic></td><td rowspan="1" colspan="1">20% cases allelic loss</td><td rowspan="2" colspan="1">Japan</td><td rowspan="2" colspan="1">[54,112]</td></tr><tr><td rowspan="1" colspan="1">4%-14%- loss of expression</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CDKN1A</italic></td><td rowspan="1" colspan="1">Reduced expression 49% cases</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[113]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Cyclin D1, Cyclin E</italic></td><td rowspan="1" colspan="1">Overexpression (41%-49%)</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[114,115]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>COX2</italic></td><td rowspan="1" colspan="1">Over-expressed</td><td rowspan="1" colspan="1">Slovenia, Japan, Chile</td><td rowspan="1" colspan="1">[104,116,117]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>BCL2</italic></td><td rowspan="1" colspan="1">Over-expressed</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[118]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CKIT</italic></td><td rowspan="1" colspan="1">Expression 45%</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[119]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SOX-4</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[120]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Chemokine (C-X-C motif) ligand 12</italic></td><td rowspan="1" colspan="1">Increased expression</td><td rowspan="1" colspan="1">South Korea</td><td rowspan="1" colspan="1">[121]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CXCR4, CXCR7</italic></td><td rowspan="1" colspan="1">Increased expression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[122]</td></tr><tr><td rowspan="3" align="left" colspan="1"><italic>hedgehog pathway components (Shh, Ptch1 and Gli1)</italic></td><td rowspan="1" colspan="1"><italic>Shh</italic>: 81.7% of cases expressed</td><td rowspan="3" colspan="1">China</td><td rowspan="3" colspan="1">[123]</td></tr><tr><td rowspan="1" colspan="1"><italic>Ptch1</italic>: 75.3% of cases</td></tr><tr><td rowspan="1" colspan="1"><italic>Gli1</italic>: 70.0% of cases</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CD56, CD99</italic></td><td rowspan="1" colspan="1">Altered expression</td><td rowspan="1" colspan="1">South Korea</td><td rowspan="1" colspan="1">[124]</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>CD97, CD55</italic></td><td rowspan="1" colspan="1"><italic>CD97</italic>: 69.6% of cases expressed</td><td rowspan="2" colspan="1">China</td><td rowspan="2" colspan="1">[125]</td></tr><tr><td rowspan="1" colspan="1"><italic>CD55</italic>: 65.2% of cases</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>HMGA2 and CD9</italic></td><td rowspan="1" colspan="1"><italic>HMGA2</italic> positive expression</td><td rowspan="2" colspan="1">China</td><td rowspan="2" colspan="1">[126]</td></tr><tr><td rowspan="1" colspan="1"><italic>CD9</italic> negative expression</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>cholecystokinin type-A</italic></td><td rowspan="1" colspan="1">44.1% of cases expressed</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[127]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>vascular endothelial growth factor-A</italic></td><td rowspan="1" colspan="1">53.6% of cases expressed</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[128]</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>VEGF-C, VEGF-D</italic></td><td rowspan="1" colspan="1"><italic>VEGF-C</italic>: 64.0% of cases</td><td rowspan="2" colspan="1">China</td><td rowspan="2" colspan="1">[129]</td></tr><tr><td rowspan="1" colspan="1"><italic>VEGF-D</italic>: 62.0% of cases</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Tumor endothelial marker 8 protein</italic></td><td rowspan="1" colspan="1">Increased expression</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[130]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>L1 cell adhesion molecule</italic></td><td rowspan="1" colspan="1">Increased expression</td><td rowspan="1" colspan="1">South Korea</td><td rowspan="1" colspan="1">[131]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Tissue factor pathway inhibitor-2</italic></td><td rowspan="1" colspan="1">Down-regulated</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[132]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>HIF-1</italic>&#x003b1;</td><td rowspan="1" colspan="1">Increased expression</td><td rowspan="2" colspan="1">China</td><td rowspan="2" colspan="1">[133]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>VHL</italic></td><td rowspan="1" colspan="1">Reduces expression</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ERCC1(excision repair cross-complementing 1)</italic></td><td rowspan="1" colspan="1">High expression in best differentiated tumors</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[134]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>NF-E2-related factor 2 (Nrf2)</italic></td><td rowspan="1" colspan="1">Increased expression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[135]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CD34 , CA15-3</italic></td><td rowspan="1" colspan="1">Highly expressed in stroma and in epithelium</td><td rowspan="1" colspan="1">Italy</td><td rowspan="1" colspan="1">[136]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ADAM-17</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[137]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Cdx2</italic></td><td rowspan="1" colspan="1">Aberrant expression</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[138]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>TLR4</italic></td><td rowspan="1" colspan="1">Expressed in glandular and luminal epithelium</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[139]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MiRNA</italic></td><td rowspan="1" colspan="1">Loss of Dicer and Drosha expression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[140]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Inducible Nitric Oxide Synthase iNOS</italic></td><td rowspan="1" colspan="1">Expressed</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[141]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Prostate stem cell antigen (PSCA)</italic></td><td rowspan="1" colspan="1">Down-regulated</td><td rowspan="1" colspan="1">Japan, China</td><td rowspan="1" colspan="1">[142]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>OCT-4</italic></td><td rowspan="1" colspan="1">Down-regulated</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[143]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>hTERT/Telomerase</italic></td><td rowspan="1" colspan="1">Expressed in 56.66% cases</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[144]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Aquaporins (AQPs)</italic></td><td rowspan="1" colspan="1">Positive expression</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[145]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Ornithine decarboxylase (ODC) and glutamate decarboxylase 65 (GAD65)</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[146]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Alpha-methylacyl coenzyme A (racemase) AMACR</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">Taiwan</td><td rowspan="1" colspan="1">[147]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Sonic Hh (Shh)</italic></td><td rowspan="1" colspan="1">Elevated expression</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[148]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>TGF-&#x003b2; induced miR-182</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[149]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SLP-2</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[150]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>TMPRSS4</italic></td><td rowspan="1" colspan="1">Higher expression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[151]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>zinc finger X-chromosomal protein</italic></td><td rowspan="1" colspan="1">Suppressed</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[152]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>multidrug resistance-associated protein 2 (MRP2)</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">South Korea</td><td rowspan="1" colspan="1">[153]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>HuR</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">Taiwan</td><td rowspan="1" colspan="1">[154]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>miR-155</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[155]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>LAPTM4B-35</italic></td><td rowspan="1" colspan="1">Overexpressed(76%)</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[156]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>p27, P21</italic></td><td rowspan="1" colspan="1"><italic>p21</italic> (75% cases) and <italic>p27</italic> (25% cases)</td><td rowspan="1" colspan="1">Jordan</td><td rowspan="1" colspan="1">[157]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Thymidylate synthase (TS)</italic></td><td rowspan="1" colspan="1">Low expression</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[158]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CD146</italic></td><td rowspan="1" colspan="1">Elevated expression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[159]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>AEG-1</italic></td><td rowspan="1" colspan="1">Highly expressed (63.4%)</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[160]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CCKAR</italic></td><td rowspan="1" colspan="1">Expression increased (76.6%)</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[127]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Nemo-like kinase (NLK)</italic></td><td rowspan="1" colspan="1">Overexpression of <italic>NLK</italic></td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[161]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>C-erbB2</italic></td><td rowspan="1" colspan="1">Overexpression (9.4%)</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[90]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Phospho-mTOR expression</italic></td><td rowspan="1" colspan="1">Positive expression (64.1%)</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[162]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>human telomerase reverse transcriptase (hTERT)</italic></td><td rowspan="1" colspan="1">Expression increased</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[163]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Phosphoglycerate kinase 1 (PGK1)</italic></td><td rowspan="1" colspan="1">Decreased expression (54.7%)</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[164]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Notch 1 and Notch 3</italic></td><td rowspan="1" colspan="1">Positive expression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[165]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CCK-A</italic></td><td rowspan="1" colspan="1">Decreased expression</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[166]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>3-phosphoinositide-dependent protein kinase 1 (PDK1)</italic></td><td rowspan="1" colspan="1">Positively expressed</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[167]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Zinc finger X-chromosomal protein (ZFX)</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[151]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>miR-138</italic></td><td rowspan="1" colspan="1">Over expression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[168]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>HSP gp96</italic></td><td rowspan="1" colspan="1">Expression (90.7%)</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[169]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Long non-coding RNA-LET</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[170]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Survivin</italic></td><td rowspan="1" colspan="1">higher expression (2.9- fold)</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[171]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Long non-coding RNA CCAT1</italic></td><td rowspan="1" colspan="1">Overexpressed</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[172]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>TEM8</italic></td><td rowspan="1" colspan="1">Expression increased</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[130]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Fhit,MIh1, P53</italic></td><td rowspan="1" colspan="1">Reduced expression of Fhit and Mlh1 protein and Overexpression of P53</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[108]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>NDRG2, CD24</italic></td><td rowspan="1" colspan="1">NDRG2 down-regulation, CD24 up-regulation</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[173]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>IL-6</italic></td><td rowspan="1" colspan="1">Overexpressed</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[174]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SLP-2</italic></td><td rowspan="1" colspan="1">Overexpression</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[150]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>BCL6, p19(ARF)</italic></td><td rowspan="1" colspan="1"><italic>BCL6</italic> overexpression , p19 (ARF) Low Expression</td><td rowspan="1" colspan="1">Taiwan</td><td rowspan="1" colspan="1">[175]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>VEGF-A</italic></td><td rowspan="1" colspan="1">High expression of <italic>VEGF-A</italic></td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[176]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MALAT1</italic></td><td rowspan="1" colspan="1">Upregulation of MALAT1</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[177]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>miR-182</italic></td><td rowspan="1" colspan="1">Upregulation of miR-182</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[149]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>miR-155</italic></td><td rowspan="1" colspan="1">High expression level of miR-155</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[155]</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>p53, S100A4, p27, p16, RB, Smad4, FHIT, E-cadherin and PML</italic></td><td rowspan="1" colspan="1"><italic>p53</italic> and <italic>S100A4</italic> overexpressed,</td><td rowspan="2" colspan="1">South Korea</td><td rowspan="2" colspan="1">[178]</td></tr><tr><td rowspan="1" colspan="1">Loss of p27, p16, RB, Smad4, <italic>FHIT</italic>, E-cadherin and <italic>PML</italic> expression</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>PEG10, TSG101</italic></td><td rowspan="1" colspan="1"><italic>PEG10</italic> and <italic>TSG101</italic> overexpressed</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[179]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CK7, CK20</italic></td><td rowspan="1" colspan="1"><italic>CK7</italic> (69.05%), <italic>CK20</italic> (28.57%) expressed</td><td rowspan="1" colspan="1">Greece</td><td rowspan="1" colspan="1">[180]</td></tr></tbody></table></table-wrap></sec><sec><title>LOSS OF HETEROZYGOSITY AND MICROSATALLIE INSTABILITY</title><p>Loss of heterozygosity (LOH) is a common genetic alteration in cancer genome. The events like heterozygous deletion of one of the two alleles, or duplication of a maternal or paternal chromosome or chromosomal region and concurrent loss of the other allele gives rise to LOH. The studies focused to detect loss of heterozygosity (LOH) in GBCs have shown frequent heterozygous allelic loss which spans in 18 different chromosomal regions[<xref rid="B57" ref-type="bibr">57</xref>]. Cytogenetic locations involved in frequent loss of heterozygosity <italic>i.e</italic>., 3p, 8p, 9p, and 22q regions have also been identified in GBC from different populations; which have also been reported in several other cancers like Retinoblastoma, melanoma, Squamous cell carcinoma of larynx[<xref rid="B181" ref-type="bibr">181</xref>-<xref rid="B183" ref-type="bibr">183</xref>]. In particular, gallbladder tumor shows numerous site of allelic loss in the short arm of chromosome 3, which harbors several known or putative tumor suppressor genes[<xref rid="B109" ref-type="bibr">109</xref>,<xref rid="B181" ref-type="bibr">181</xref>]. High degree of microsatellite instability (MSI) in 10% of GBC cases was observed as reported in research article published by Goldin et al[<xref rid="B184" ref-type="bibr">184</xref>]. A different pattern of allelic loss has also been detected in Japanese population. In this report the allelotype analysis of gallbladder carcinoma revealed an interesting associated with anomalous junction of pancreatico-biliary duct[<xref rid="B68" ref-type="bibr">68</xref>]. Table <xref ref-type="table" rid="T6">6</xref>[<xref rid="B54" ref-type="bibr">54</xref>,<xref rid="B57" ref-type="bibr">57</xref>,<xref rid="B66" ref-type="bibr">66</xref>,<xref rid="B68" ref-type="bibr">68</xref>,<xref rid="B109" ref-type="bibr">109</xref>,<xref rid="B112" ref-type="bibr">112</xref>,<xref rid="B185" ref-type="bibr">185</xref>-<xref rid="B193" ref-type="bibr">193</xref>] enlists various studies conducted in GBC regarding LOH and MSI.</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Loss of heterozygosity and microsatellite instability studies reported in gallbladder cancer</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Studied reported in respective population</bold></td><td rowspan="1" colspan="1"><bold>LOH/MSI</bold></td><td rowspan="1" colspan="1"><bold>Ref</bold>.</td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Chilean</td><td rowspan="1" colspan="1">LOH reported in : 3p, 6q, 7q, 8p, 9p, 9q, 11q, 12q, 17p, 18q, 19p, 22q, and Xq</td><td rowspan="1" colspan="1">[57]</td></tr><tr><td align="left" rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">LOH reported in : 2p, 4p, 4q, 8q,9q, 10p,14p,14q,16p, 19p, 21p and Xp [Maximum deletion- 2p24, 14q22 and 21q22]</td><td rowspan="1" colspan="1">[68]</td></tr><tr><td align="left" rowspan="1" colspan="1">Chilean, Japan</td><td rowspan="1" colspan="1">p53, 9p.8p, DCC, KRAS, p16, 16q24, 3p,9q, 22q and p161NK4</td><td rowspan="1" colspan="1">[54,66,109,112,185]</td></tr><tr><td align="left" rowspan="1" colspan="1">Greece</td><td rowspan="1" colspan="1">BAT-26</td><td rowspan="1" colspan="1">[186]</td></tr><tr><td align="left" rowspan="1" colspan="1">Chile, Japan</td><td rowspan="1" colspan="1">MSI reported (20%-33%)</td><td rowspan="1" colspan="1">[187,188]</td></tr><tr><td align="left" rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">E-cadherin (CDH1) 2p, 2q, 6q, 7q,17p</td><td rowspan="1" colspan="1">[189]</td></tr><tr><td align="left" rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">Fragile histidine triad (FHIT) MSI-H 17.5% LOH :27.5%</td><td rowspan="1" colspan="1">[190]</td></tr><tr><td align="left" rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">High incidences of LOH at 1p36 (19/36:53%), 9p21 (12/32:38%), 13q14 (20/36: 56%), 16q24 (31/54: 61%), and 17p13 (15/36: 42%)</td><td rowspan="1" colspan="1">[191]</td></tr><tr><td align="left" rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">FHIT gene locus (3p14.2)</td><td rowspan="1" colspan="1">[109]</td></tr><tr><td align="left" rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">LOH at 8 loci, that is 3p12, 3p14.2, 5q21, 9p21, 9q, 13q, 17p13, and 18q for tumor suppressor genes (DUTT1, FHIT, APC, p16, FCMD, RB1, p53, and DCC genes)</td><td rowspan="1" colspan="1">[192]</td></tr><tr><td align="left" rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">genomic instability at 2p, 2q, 6q, 7q, and 17p loci</td><td rowspan="1" colspan="1">[189]</td></tr><tr><td align="left" rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">DUTT1 (3p12), FHIT (3p14.2), BLU, RASSF1A, SEMA3B and hMLH1 (3p21.3)</td><td rowspan="1" colspan="1">[193]</td></tr></tbody></table><table-wrap-foot><fn><p>LOH: Loss of heterozygosity; MSI: Microsatellite instability.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>METHYLATION AND GALLBLADDER CANCER</title><p>Understanding of DNA methylation patterns of gallbladder tumors can prove to be important biomarkers to refine the diagnosis and prognostic information which ultimately helps in appropriate therapeutic selection. Hypermethylation in gene promoter regions is a common epigenetic mechanism for the inactivation of tumor suppressor genes. One of the important research article published previously has found an important link between methylation and survival. In this study methylation of genes <italic>p73, MGMT</italic>, and <italic>DCL1</italic> was significantly associated with survival of gallbladder cancer patients[<xref rid="B194" ref-type="bibr">194</xref>,<xref rid="B195" ref-type="bibr">195</xref>]. The study was conducted in a series of 109 advanced gallbladder cancer cases. However genes like <italic>CDH13</italic> and <italic>FHIT</italic> did not show any significant tendency with respect to gallbladder cancer patient&#x02019;s survival[<xref rid="B194" ref-type="bibr">194</xref>,<xref rid="B195" ref-type="bibr">195</xref>]. Multivariate analysis found <italic>MGMT</italic> gene to be an independent prognostic factor for survival found, representing the important role of epigenetic process in gallbladder carcinogenesis[<xref rid="B195" ref-type="bibr">195</xref>]. The recent report showed that promoter methylation of specific genes like <italic>CDH1, CDKN2A-p16</italic>, <italic>REPRIMO</italic> (tumor suppressor gene family) and <italic>UCHL1</italic> (also known as PGP9.5) have important role in gallbladder carcinogenesis[<xref rid="B196" ref-type="bibr">196</xref>]. Other studies conducted on GBC have shown variable methylation pattern of a number of genes Table <xref ref-type="table" rid="T7">7</xref>[<xref rid="B81" ref-type="bibr">81</xref>,<xref rid="B82" ref-type="bibr">82</xref>,<xref rid="B193" ref-type="bibr">193</xref>-<xref rid="B208" ref-type="bibr">208</xref>].</p><table-wrap id="T7" position="float"><label>Table 7</label><caption><p>Aberrant promoter methylation gene studies summary in gallbladder cancer</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Gene</bold></td><td rowspan="1" colspan="1"><bold>Full name</bold></td><td rowspan="1" colspan="1"><bold>Function</bold></td><td rowspan="1" colspan="1"><bold>Meth Freq</bold></td><td rowspan="1" colspan="1"><bold>Population</bold></td><td rowspan="1" colspan="1"><bold>Ref</bold>.</td></tr></thead><tbody align="center"><tr><td rowspan="2" align="left" colspan="1"><italic>CDH1</italic></td><td rowspan="1" colspan="1">Cadherin 1, type 1,</td><td rowspan="2" colspan="1">Tissue invasion (cell-cell adhesion)</td><td rowspan="2" colspan="1">11%-65%</td><td rowspan="2" colspan="1">Japan, Chile</td><td rowspan="2" colspan="1">[194-200]</td></tr><tr><td rowspan="1" colspan="1">E-cadherin (epithelial)</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>FHIT</italic></td><td rowspan="1" colspan="1">Fragile histidine triad gene</td><td rowspan="1" colspan="1">Regulation of DNA Replication, and apoptosis</td><td rowspan="1" colspan="1">30%-57%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[81,193-195,199]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>APC</italic></td><td rowspan="1" colspan="1">Adenomatous polyposis coli</td><td rowspan="1" colspan="1">Tumor suppressor gene (Cell migration, adhesion and apoptosis)</td><td rowspan="1" colspan="1">26%-35%</td><td rowspan="1" colspan="1">Chile, United States</td><td rowspan="1" colspan="1">[81,194,195,198,199]</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>hMLH1</italic></td><td rowspan="1" colspan="1">Human homologs of</td><td rowspan="2" colspan="1">Mismatch repair</td><td rowspan="2" colspan="1">0%-14%</td><td rowspan="2" colspan="1">Chile, United States</td><td rowspan="2" colspan="1">[81,193-195,199]</td></tr><tr><td rowspan="1" colspan="1">MutL gene of bacteria</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>p16</italic></td><td rowspan="1" colspan="1">Cyclin-dependent kinase</td><td rowspan="2" colspan="1">Cell cycle regulation</td><td rowspan="2" colspan="1">15%-60%</td><td rowspan="2" colspan="1">Chile, United States, Germany</td><td rowspan="2" colspan="1">[81,82,195,197-199,201,202]</td></tr><tr><td rowspan="1" colspan="1">inhibitor 2A</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>p15</italic></td><td rowspan="1" colspan="1">Cyclin-dependent kinase inhibitor 2B</td><td rowspan="1" colspan="1">Cell cycle regulation</td><td rowspan="1" colspan="1">22%-44%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[81,198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>DAPK1</italic></td><td rowspan="1" colspan="1">Death-associated protein kinase 1</td><td rowspan="1" colspan="1">Serine-threonine kinase</td><td rowspan="1" colspan="1">8%-61%</td><td rowspan="1" colspan="1">Japan, Chile</td><td rowspan="1" colspan="1">[81,197,198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>DLC1</italic></td><td rowspan="1" colspan="1">Deleted in liver cancer 1</td><td rowspan="1" colspan="1">GTPase-activating protein</td><td rowspan="1" colspan="1">39%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[81]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>RASSF1</italic></td><td rowspan="1" colspan="1">RAS association domain family protein 1A</td><td rowspan="1" colspan="1">Signal transduction</td><td rowspan="1" colspan="1">0%-36%</td><td rowspan="1" colspan="1">Japan, Chile South Korea</td><td rowspan="1" colspan="1">[81,193,197,198,203]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MGMT</italic></td><td rowspan="1" colspan="1">O-6-methylguanine-DNAmethyltransferase</td><td rowspan="1" colspan="1">Methyltransferase</td><td rowspan="1" colspan="1">13%-30%</td><td rowspan="1" colspan="1">Chile, United States</td><td rowspan="1" colspan="1">[81,195]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CDH13</italic></td><td rowspan="1" colspan="1">CDH13 Cadherin 13, H-cadherin(heart)</td><td rowspan="1" colspan="1">Tissue invasion (cell-cell adhesion)</td><td rowspan="1" colspan="1">44%-70%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[81,198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>TIMP3</italic></td><td rowspan="1" colspan="1">Metallopeptidase inhibitor 3</td><td rowspan="1" colspan="1">Degradation of extracellular matrix</td><td rowspan="1" colspan="1">0%-39%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[81,198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>GSTP1</italic></td><td rowspan="1" colspan="1">Glutathione S-transferase pi 1</td><td rowspan="1" colspan="1">Conjugation of hydrophobic and electrophilic compounds</td><td rowspan="1" colspan="1">13%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>RAR&#x003b2;2</italic></td><td rowspan="1" colspan="1">Retinoic acid receptor, beta</td><td rowspan="1" colspan="1">Encodes retinoic acid receptor beta</td><td rowspan="1" colspan="1">4%-44%</td><td rowspan="1" colspan="1">Chile, United States</td><td rowspan="1" colspan="1">[81,198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>REPRIMO</italic></td><td rowspan="1" colspan="1">TP53 dependent G2 arrest mediator candidate</td><td rowspan="1" colspan="1">Cell cycle regulation (p53 mediator)</td><td rowspan="1" colspan="1">62%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[204]</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>SHP1</italic></td><td rowspan="1" colspan="1">Protein tyrosine phosphatase,</td><td rowspan="1" colspan="1">Regulate cell growth,</td><td rowspan="2" colspan="1">80%</td><td rowspan="2" colspan="1">Chile</td><td rowspan="2" colspan="1">[198]</td></tr><tr><td rowspan="1" colspan="1">non-receptor type 6</td><td rowspan="1" colspan="1">differentiation, mitotic cycle</td></tr><tr><td rowspan="2" align="left" colspan="1"><italic>3-OST-2</italic></td><td rowspan="1" colspan="1">Heparan sulfate (glucosamine)</td><td rowspan="2" colspan="1">Osulfotransferase</td><td rowspan="2" colspan="1">72%</td><td rowspan="2" colspan="1">Chile</td><td rowspan="2" colspan="1">[198]</td></tr><tr><td rowspan="1" colspan="1">3-O-sulfotransferase 2</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>RUNX3</italic></td><td rowspan="1" colspan="1">Runt-related transcription factor 3</td><td rowspan="1" colspan="1">TGF-beta signal pathway</td><td rowspan="1" colspan="1">22%-32%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[197,198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>RIZ1</italic></td><td rowspan="1" colspan="1">PR domain containing 2, with ZNF domain</td><td rowspan="1" colspan="1">Histone/protein methyltransferase</td><td rowspan="1" colspan="1">26%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>HPP1</italic></td><td rowspan="1" colspan="1">Transmembrane protein with EGF-like and two follistatin-like domains 2</td><td rowspan="1" colspan="1">TGF-beta signal pathway</td><td rowspan="1" colspan="1">20%</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">[198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>P73</italic></td><td rowspan="1" colspan="1">Tumor protein p73</td><td rowspan="1" colspan="1">Induction of apoptosis and cell cycle regulation</td><td rowspan="1" colspan="1">14%-28%</td><td rowspan="1" colspan="1">Chile, United States</td><td rowspan="1" colspan="1">[81,198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SOCS-1</italic></td><td rowspan="1" colspan="1">Suppressor of cytokine signaling 1</td><td rowspan="1" colspan="1">JAK-STAT pathway</td><td rowspan="1" colspan="1">12%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>DCR2</italic></td><td rowspan="1" colspan="1">Tumor necrosis factor receptor superfamily, member 10d</td><td rowspan="1" colspan="1">TNF-receptor superfamily</td><td rowspan="1" colspan="1">6%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[198]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SEMA3B</italic></td><td rowspan="1" colspan="1">Sema domain, immunoglobulin domain (Ig), short basic domain, secreted,(semaphorin) 3B</td><td rowspan="1" colspan="1">Induction of apoptosis</td><td rowspan="1" colspan="1">92%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[193]</td></tr><tr><td rowspan="3" align="left" colspan="1"><italic>DUTT1</italic></td><td rowspan="1" colspan="1">Human homolog of</td><td rowspan="3" colspan="1">Cell migration and metastasis</td><td rowspan="3" colspan="1">22%</td><td rowspan="3" colspan="1">Chile</td><td rowspan="3" colspan="1">[193]</td></tr><tr><td rowspan="1" colspan="1">Drosophila Roundabout</td></tr><tr><td rowspan="1" colspan="1">(ROBO1)</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>BLU</italic></td><td rowspan="1" colspan="1">Zinc finger, MYND-type containing 10</td><td rowspan="1" colspan="1">Cell cycle regulation</td><td rowspan="1" colspan="1">26%</td><td rowspan="1" colspan="1">Chile</td><td rowspan="1" colspan="1">[193]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>p14</italic></td><td rowspan="1" colspan="1">Ribonuclease P/MRP 14 kDa subunit</td><td rowspan="1" colspan="1">Cell cycle regulation</td><td rowspan="1" colspan="1">40%</td><td rowspan="1" colspan="1">Germany</td><td rowspan="1" colspan="1">[201]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MASPIN</italic></td><td rowspan="1" colspan="1">Mammary serine protease inhibitor</td><td rowspan="1" colspan="1">Tumor suppressor gene</td><td rowspan="1" colspan="1">70%</td><td rowspan="3" colspan="1">India</td><td rowspan="3" colspan="1">[205]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>THBS1</italic></td><td rowspan="1" colspan="1">Thrombospondin 1</td><td rowspan="1" colspan="1">Platelet aggregation, angiogenesis, and tumorigenesis</td><td rowspan="1" colspan="1">52%</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>HLTF</italic></td><td rowspan="1" colspan="1">Helicase-like transcription factor</td><td rowspan="1" colspan="1">Regulate transcription</td><td rowspan="1" colspan="1">16%</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MYC</italic></td><td rowspan="1" colspan="1">V-Myc Avian Myelocytomatosis Viral Oncogene Homolog transcription factor</td><td rowspan="1" colspan="1">Cell cycle progression, apoptosis and cellular transformation</td><td rowspan="1" colspan="1">80%</td><td rowspan="1" colspan="1">Brazil</td><td rowspan="1" colspan="1">[206]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>APC</italic></td><td rowspan="1" colspan="1">Adenomatous polyposis coli</td><td rowspan="1" colspan="1">Tumor suppressor gene</td><td rowspan="5" colspan="1">71%-95%</td><td rowspan="5" colspan="1">Chile</td><td rowspan="5" colspan="1">[207]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CDKN2A</italic></td><td rowspan="1" colspan="1">Cyclin-dependent kinase inhibitor 2A</td><td rowspan="1" colspan="1">Cell cycle</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ESR1</italic></td><td rowspan="1" colspan="1">Estrogen receptor 1</td><td rowspan="1" colspan="1">Transcription factor</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>PGP9.5</italic></td><td rowspan="1" colspan="1">Protein gene product 9.5</td><td rowspan="1" colspan="1">Neural and/or nerve sheath differentiation</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SSBP2</italic></td><td rowspan="1" colspan="1">Single-stranded DNA-binding protein 2</td><td rowspan="1" colspan="1">Microsatellite instability</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>PGP9.5</italic></td><td rowspan="1" colspan="1">Protein gene product 9.5</td><td rowspan="1" colspan="1">Neural and/or nerve sheath differentiation</td><td rowspan="1" colspan="1">27.2%</td><td rowspan="1" colspan="1">South Korea</td><td rowspan="1" colspan="1">[208]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MLH1, CDKN2A</italic></td><td rowspan="1" colspan="1">MutL homolog 1</td><td rowspan="1" colspan="1">Mismatch repair</td><td rowspan="1" colspan="1">5%</td><td rowspan="5" colspan="1">Chile</td><td rowspan="5" colspan="1">[194]</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cyclin-dependent kinase inhibitor 2A</td><td rowspan="1" colspan="1">Cell cycle</td><td rowspan="1" colspan="1">35%</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>FHIT</italic></td><td rowspan="1" colspan="1">Fragile histidine triad protein</td><td rowspan="1" colspan="1">Purine metabolism</td><td rowspan="1" colspan="1">21%</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>APC</italic></td><td rowspan="1" colspan="1">Adenomatous polyposis coli</td><td rowspan="1" colspan="1">Tumor suppressor genes</td><td rowspan="1" colspan="1">25%</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CDH1</italic></td><td rowspan="1" colspan="1">Cadherin-1</td><td rowspan="1" colspan="1">Cell cycle</td><td rowspan="1" colspan="1">66%</td></tr></tbody></table></table-wrap><p>In addition, with the help of advanced technologies like high resolution allele stratification (allelotyping analysis) investigated very high frequencies of 3p (100%), 8p (100%), 9q (88%), 22q (92%) sites in gallbladder cancer that lead to positional identification of tumor suppressor genes associated with GBC malignancies and pathogenesis[<xref rid="B57" ref-type="bibr">57</xref>,<xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B109" ref-type="bibr">109</xref>,<xref rid="B209" ref-type="bibr">209</xref>]. Moreover, some well-known tumor suppressor genes that are present in chromosomes like 3p, 5q, 8p,13q and 18q can also influence the gallbladder cancer formation[<xref rid="B57" ref-type="bibr">57</xref>,<xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B109" ref-type="bibr">109</xref>,<xref rid="B209" ref-type="bibr">209</xref>].</p><sec><title>Candidate genes for gallbladder cancer susceptibility</title><p>The merely successful mechanism for identifying low or moderate penetrance cancer genes, is the analysis of genes involved in candidate loci. Therefore, these genes are also termed as candidate genes. The candidate gene analysis is done via case-control study, in which allele frequencies in cancer patients and healthy controls are compared and obtained results are analyzed statistically. Candidate modifier genes are selected on the basis of biological plausibility. Most studies are based on genes that encode proteins, thought to be involved in carcinogenesis, such as those involved in apoptosis, cell-cycle control, DNA repair, xenobiotic metabolism, hormonal and inflammatory pathway or other risk factors. Moreover, known genes account for a small proportion of the heritability of gallbladder cancer, and it is likely that many genes with modest effects are yet to be found.</p><p>A study by Wang et al[<xref rid="B210" ref-type="bibr">210</xref>] from china suggested about CCK-induced impaired gallbladder emptying in patients having gallstones. Most of the candidate genes identified so far are related to the classical rate limiting enzymes and proteins of lipid metabolism, steroidogenesis, lipid transport, bile acid synthesis, bile canalicular transport, gallbladder contractility, cell cycle, DNA repair and Inflammatory pathway[<xref rid="B211" ref-type="bibr">211</xref>-<xref rid="B233" ref-type="bibr">233</xref>]. Till now there are very limited studies in GBC which are independently replicated which includes <italic>OGG1</italic><sub>rs1052133</sub>, <italic>TP53</italic><sub>rs1042522</sub>, <italic>GSTM1</italic> null polymorphism and <italic>CYP1A1</italic><sub>rs1048943</sub> polymorphism[<xref rid="B48" ref-type="bibr">48</xref>]. No definitive conclusions can be drawn due to limited number of studies. Hence there is a great need to explore genes related to GBC susceptibility. Table <xref ref-type="table" rid="T8">8</xref>[<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B214" ref-type="bibr">214</xref>-<xref rid="B273" ref-type="bibr">273</xref>] shows an overview of candidate gene studies reported in GBC.</p><table-wrap id="T8" position="float"><label>Table 8</label><caption><p>Candidate gene studies (low susceptibility genes) in gallbladder cancer</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Pathway involved</bold></td><td rowspan="1" colspan="1"><bold>Gene</bold></td><td rowspan="1" colspan="1"><bold>Polymorphism</bold></td><td rowspan="1" colspan="1"><bold>Population</bold></td><td rowspan="1" colspan="1"><bold>Ref</bold>.</td></tr></thead><tbody align="center"><tr><td rowspan="14" align="left" colspan="1">DNA repair pathway genes</td><td rowspan="2" colspan="1"><italic>XPC</italic></td><td rowspan="1" colspan="1">(rs2228000) Ala499Val</td><td rowspan="1" colspan="1">China</td><td rowspan="2" colspan="1">[236]</td></tr><tr><td rowspan="1" colspan="1">(rs2228001) Lys939Gln</td><td rowspan="1" colspan="1">China</td></tr><tr><td rowspan="2" colspan="1"><italic>ERCC2</italic></td><td rowspan="1" colspan="1">(rs1799793) Asp312Asn</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="5" colspan="1">[232]</td></tr><tr><td rowspan="1" colspan="1">(rs13181) Lys751Gln</td><td rowspan="4" colspan="1">North Indian</td></tr><tr><td rowspan="2" colspan="1"><italic>MSH2</italic></td><td rowspan="1" colspan="1">(rs2303426) IVS1+9G&#x0003e;C</td></tr><tr><td rowspan="1" colspan="1">(rs2303425) -118T&#x0003e;C</td></tr><tr><td rowspan="1" colspan="1"><italic>OGG1</italic></td><td rowspan="1" colspan="1">(rs2072668) 748-15C&#x0003e;G</td></tr><tr><td rowspan="1" colspan="1"><italic>TP53</italic></td><td rowspan="1" colspan="1">(rs1042522) Pro72Arg</td><td rowspan="1" colspan="1">Chilean, Hungary, Japanese</td><td rowspan="1" colspan="1">[237-239]</td></tr><tr><td rowspan="2" colspan="1"><italic>XRCC1</italic></td><td rowspan="1" colspan="1">(rs1799782) Arg194Trp</td><td rowspan="2" colspan="1">North Indian Shanghai, China</td><td rowspan="2" colspan="1">[222,231]</td></tr><tr><td rowspan="1" colspan="1">(rs25487) Arg399Gln</td></tr><tr><td rowspan="1" colspan="1"><italic>APEX1</italic></td><td rowspan="1" colspan="1">(rs3136820) Asp148Glu</td><td rowspan="3" colspan="1">Shanghai, China</td><td rowspan="1" colspan="1">[222]</td></tr><tr><td rowspan="2" colspan="1"><italic>RAD23B</italic></td><td rowspan="1" colspan="1">(rs1805335) IVS5-15A&#x0003e;G</td><td rowspan="2" colspan="1">[223]</td></tr><tr><td rowspan="1" colspan="1">(rs1805329) EX7+65C&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1"><italic>FEN1</italic></td><td rowspan="1" colspan="1">FEN1-69G&#x0003e;A and haplotypes</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[240]</td></tr><tr><td rowspan="33" align="left" colspan="1">Hormonal pathway genes</td><td rowspan="1" colspan="1"><italic>CCKAR</italic></td><td rowspan="1" colspan="1">(rs1800857) IVS1-5T&#x0003e;C</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[227]</td></tr><tr><td rowspan="1" colspan="1"><italic>CCK and CCKAR</italic></td><td rowspan="1" colspan="1">(rs2071011G&#x0003e;C, rs915889C/T, rs3822222C/T, rs1800855T/A</td><td rowspan="1" colspan="1">Shanghai, China,</td><td rowspan="1" colspan="1">[241]</td></tr><tr><td rowspan="5" colspan="1"><italic>ESR1</italic></td><td rowspan="1" colspan="1">(rs2234693) IVS1-397T&#x0003e;C</td><td rowspan="5" colspan="1">Shanghai, China, North India</td><td rowspan="7" colspan="1">[241-243]</td></tr><tr><td rowspan="1" colspan="1">(rs3841686) IVS5-34-&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1">(rs2228480) Ex8+229G&#x0003e;A</td></tr><tr><td rowspan="1" colspan="1">(rs1801132) Ex4-122G&#x0003e;C</td></tr><tr><td rowspan="1" colspan="1">(rs9340799) IVS1-351A&#x0003e;G</td></tr><tr><td rowspan="1" colspan="1"><italic>ESR2</italic></td><td rowspan="1" colspan="1">(rs1256049) Val328Val</td><td rowspan="1" colspan="1">Shanghai, China</td></tr><tr><td rowspan="1" colspan="1"><italic>PGR</italic></td><td rowspan="1" colspan="1">Ins/Del</td><td rowspan="1" colspan="1">North India</td></tr><tr><td rowspan="1" colspan="1"><italic>AR</italic></td><td rowspan="1" colspan="1">(CAG)n</td><td rowspan="1" colspan="1">Shanghai, China</td><td rowspan="1" colspan="1">[244]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs4633) His62His</td><td rowspan="4" colspan="1">Shanghai, China</td><td rowspan="4" colspan="1">[224]</td></tr><tr><td rowspan="1" colspan="1"><italic>COMT</italic></td><td rowspan="1" colspan="1">(rs4818) Leu136Leu</td></tr><tr><td rowspan="1" colspan="1"><italic>CYP1A1</italic></td><td rowspan="1" colspan="1">(rs2606345) IVS1+606G&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1"><italic>CYP1B1</italic></td><td rowspan="1" colspan="1">(rs10012)Arg48Gly</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs1065778) IVS4-76A&#x0003e;G</td><td rowspan="6" colspan="1">Shanghai, China</td><td rowspan="6" colspan="1">[224]</td></tr><tr><td rowspan="1" colspan="1"><italic>CYP19A1</italic></td><td rowspan="1" colspan="1">(rs700518) Val80Val</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs2304463) IVS7-106T&#x0003e;G</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs700519) Arg264Cys</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs1065779) IVS9-53G&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs4646) Ex11+410G&#x0003e;T</td></tr><tr><td rowspan="2" colspan="1"><italic>HSD3B2</italic></td><td rowspan="1" colspan="1">(rs1819698) Ex4-133C&#x0003e;T</td><td rowspan="6" colspan="1">Shanghai, China</td><td rowspan="6" colspan="1">[224]</td></tr><tr><td rowspan="1" colspan="1">(rs1361530) Ex4-88C&#x0003e;G</td></tr><tr><td rowspan="1" colspan="1"><italic>HSD17B3</italic></td><td rowspan="1" colspan="1">(rs2066479) Gly289Arg</td></tr><tr><td rowspan="1" colspan="1"><italic>HSD17B1</italic></td><td rowspan="1" colspan="1">(rs2830) Ex1-486G&#x0003e;A</td></tr><tr><td rowspan="1" colspan="1"><italic>SHBG</italic></td><td rowspan="1" colspan="1">(rs6259) Ex8+6G&#x0003e;A</td></tr><tr><td rowspan="1" colspan="1"><italic>SRD5A2</italic></td><td rowspan="1" colspan="1">(rs523349) Ex1-17G&#x0003e;C</td></tr><tr><td rowspan="2" colspan="1"><italic>RXR-a</italic></td><td rowspan="1" colspan="1">(rs1536475) IVS6+70A&#x0003e;G</td><td rowspan="4" colspan="1">Shanghai, China</td><td rowspan="4" colspan="1">[245]</td></tr><tr><td rowspan="1" colspan="1">(rs1805343) IVS1-27A&#x0003e;G</td></tr><tr><td rowspan="2" colspan="1"><italic>RXR-b</italic></td><td rowspan="1" colspan="1">(rs2744537) G392T</td></tr><tr><td rowspan="1" colspan="1">(rs2076310) C51T</td></tr><tr><td rowspan="1" colspan="1"><italic>INS</italic></td><td rowspan="1" colspan="1">(rs689) A-6T</td><td rowspan="1" colspan="1">Shanghai, China</td><td rowspan="3" colspan="1">[245]</td></tr><tr><td rowspan="1" colspan="1"><italic>PPARD</italic></td><td rowspan="1" colspan="1">(rs2016520) Ex4+15C&#x0003e;T</td><td rowspan="1" colspan="1">Shanghai, China</td></tr><tr><td rowspan="1" colspan="1"><italic>PPARG</italic></td><td rowspan="1" colspan="1">(rs3856806) His477His</td><td rowspan="1" colspan="1">Shanghai, China</td></tr><tr><td rowspan="15" align="left" colspan="1">Inflammatory pathway genes</td><td rowspan="1" colspan="1"><italic>CR1</italic></td><td rowspan="1" colspan="1">(rs2274567) His1208Arg</td><td rowspan="2" colspan="1">North Indian</td><td rowspan="2" colspan="1">[230]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">( rs12144461) Intron 27, HindIII</td></tr><tr><td rowspan="1" colspan="1"><italic>IL1RN</italic></td><td rowspan="1" colspan="1">86-bp VNTR</td><td rowspan="3" colspan="1">North Indian</td><td rowspan="1" colspan="1">[220]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs689466) -1195G&#x0003e;A</td><td rowspan="2" colspan="1">[233]</td></tr><tr><td rowspan="1" colspan="1"><italic>PTGS2</italic></td><td rowspan="1" colspan="1">(rs20417) -765G&#x0003e;C</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs5275) +8473T&#x0003e;C</td><td rowspan="1" colspan="1">North Indian Shanghai, China</td><td rowspan="1" colspan="1">[233,246]</td></tr><tr><td rowspan="1" colspan="1"><italic>IL1B</italic></td><td rowspan="1" colspan="1">(rs16944) -1060T&#x0003e;C</td><td rowspan="1" colspan="1">Shanghai, China north Indian</td><td rowspan="1" colspan="1">[220,247]</td></tr><tr><td rowspan="2" colspan="1"><italic>IL10</italic></td><td rowspan="1" colspan="1">rs1800871)- 7334T&#x0003e;C</td><td rowspan="1" colspan="1">Shanghai</td><td rowspan="2" colspan="1">[247]</td></tr><tr><td rowspan="1" colspan="1">(rs1800872) -6653A&#x0003e;C</td><td rowspan="1" colspan="1">Shanghai</td></tr><tr><td rowspan="1" colspan="1"><italic>IL-8</italic></td><td rowspan="1" colspan="1">(rs10805066) IL8 -13985C&#x0003e;G</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[248]</td></tr><tr><td rowspan="1" colspan="1"><italic>EGF</italic></td><td rowspan="1" colspan="1">(rs4444903) +61A&#x0003e;G</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[221]</td></tr><tr><td rowspan="1" colspan="1"><italic>TGFb1</italic></td><td rowspan="1" colspan="1">(rs1800469)-509C&#x0003e;T</td><td rowspan="3" colspan="1">Shanghai, north Indian</td><td rowspan="3" colspan="1">[219,221,247]</td></tr><tr><td rowspan="1" colspan="1"><italic>TNF-</italic>&#x003b1;</td><td rowspan="1" colspan="1">(rs1800629) -308G&#x0003e;A</td></tr><tr><td rowspan="1" colspan="1"><italic>IL6</italic></td><td rowspan="1" colspan="1">(rs1800795) 236C&#x0003e;G)</td></tr><tr><td rowspan="1" colspan="1"><italic>IL8</italic></td><td rowspan="1" colspan="1">(rs10805066) -13985C&#x0003e;G</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[248]</td></tr><tr><td rowspan="7" align="left" colspan="1"/><td rowspan="2" colspan="1"><italic>MMP-2</italic></td><td rowspan="1" colspan="1">(rs2285053) -735 C&#x0003e;T</td><td rowspan="7" colspan="1">North Indian</td><td rowspan="7" colspan="1">[249]</td></tr><tr><td rowspan="1" colspan="1">(rs9340799) -1306 C&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1"><italic>MMP-7</italic></td><td rowspan="1" colspan="1">(rs11568818) -181 A&#x0003e;G</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs2250889) P574R</td></tr><tr><td rowspan="1" colspan="1"><italic>MMP9</italic></td><td rowspan="1" colspan="1">(rs 17576) R279Q</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs 17577) R668Q</td></tr><tr><td rowspan="1" colspan="1"><italic>TIMP2</italic></td><td rowspan="1" colspan="1">(rs8179090) -418 G&#x0003e;C</td></tr><tr><td rowspan="33" align="left" colspan="1">Metabolic pathway genes</td><td rowspan="1" colspan="1"><italic>MTHFR</italic></td><td rowspan="1" colspan="1">(rs1801133) Ala222Val</td><td rowspan="1" colspan="1">Indian</td><td rowspan="1" colspan="1">[228]</td></tr><tr><td rowspan="1" colspan="1"><italic>APOB</italic></td><td rowspan="1" colspan="1">(rs17240441) 35_43del9</td><td rowspan="1" colspan="1">Indian</td><td rowspan="1" colspan="1">[217]</td></tr><tr><td rowspan="3" colspan="1"><italic>NAT2</italic></td><td rowspan="1" colspan="1">(rs1799929) NAT2*5A</td><td rowspan="3" colspan="1">Indian</td><td rowspan="3" colspan="1">[216]</td></tr><tr><td rowspan="1" colspan="1">(rs1799930) NAT2*6B</td></tr><tr><td rowspan="1" colspan="1">rs1799931, NAT2*7A</td></tr><tr><td rowspan="1" colspan="1"><italic>GSTT1</italic></td><td rowspan="1" colspan="1">Null polymorphism</td><td rowspan="2" colspan="1">Indian</td><td rowspan="2" colspan="1">[215]</td></tr><tr><td rowspan="1" colspan="1"><italic>GSTP1</italic></td><td rowspan="1" colspan="1">(rs1695) Ile105Val</td></tr><tr><td rowspan="1" colspan="1"><italic>CYP17</italic></td><td rowspan="1" colspan="1">(rs743572) Ex1+27T&#x0003e;C</td><td rowspan="1" colspan="1">Shanghai Indian (265)</td><td rowspan="1" colspan="1">[250,251]</td></tr><tr><td rowspan="1" colspan="1"><italic>GSTM1</italic></td><td rowspan="1" colspan="1">Null polymorphism</td><td rowspan="1" colspan="1">Indian, Chilean Hungary Japanese</td><td rowspan="1" colspan="1">[215,237,238]</td></tr><tr><td rowspan="2" colspan="1"><italic>CYP1A1</italic></td><td rowspan="1" colspan="1">(rs4646903) CYP1A1*2A</td><td rowspan="1" colspan="1">Indian, Chilean Hungary Japanese</td><td rowspan="1" colspan="1">[218,237,239]</td></tr><tr><td rowspan="1" colspan="1">(rs1048943) Ile462Val (*2C)</td><td rowspan="1" colspan="1">China, Chilean, Hungary Japanese</td><td rowspan="1" colspan="1">[224,237-239]</td></tr><tr><td rowspan="1" colspan="1"><italic>Cyp1a1 cyp1b1</italic></td><td rowspan="1" colspan="1">CYP1A1-MspI, CYP1A1-Ile462Val, and CYP1B1-Val432Leu</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">[252]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs5930) EX10+55G&#x0003e;A</td><td rowspan="1" colspan="1">Shanghai</td><td rowspan="5" colspan="1">[253]</td></tr><tr><td rowspan="1" colspan="1"><italic>LDLR</italic></td><td rowspan="1" colspan="1">(rs6413504) IVS17_42A&#x0003e;G</td><td rowspan="4" colspan="1">Shanghai</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(rs14158) EX18+88G&#x0003e;A</td></tr><tr><td rowspan="1" colspan="1"><italic>LPL</italic></td><td rowspan="1" colspan="1">(rs263) IVS5-540C&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1"><italic>ALOX5</italic></td><td rowspan="1" colspan="1">(rs2029253) IVS3+100G&#x0003e;A</td></tr><tr><td rowspan="1" colspan="1"><italic>ApoB</italic></td><td rowspan="1" colspan="1">rs693) Thr2515Thr</td><td rowspan="1" colspan="1">Indian Chilean</td><td rowspan="1" colspan="1">[30,217]</td></tr><tr><td rowspan="1" colspan="1"><italic>ABCG8</italic></td><td rowspan="1" colspan="1">(rs11887534) Asp19His</td><td rowspan="1" colspan="1">North Indian Shanghai China</td><td rowspan="1" colspan="1">[229,254]</td></tr><tr><td rowspan="2" colspan="1"><italic>CETP</italic></td><td rowspan="1" colspan="1">(rs708272) TaqIB</td><td rowspan="1" colspan="1">Chilean Shanghai China</td><td rowspan="1" colspan="1">[30,254]</td></tr><tr><td rowspan="1" colspan="1">(rs1800775) -629C&#x0003e;A</td><td rowspan="1" colspan="1">Shanghai China</td><td rowspan="1" colspan="1">[254]</td></tr><tr><td rowspan="1" colspan="1"><italic>LRPAP1</italic></td><td rowspan="1" colspan="1">(rs11267919)752_177_752_176 I 37</td><td rowspan="1" colspan="1">North Indian Shanghai China</td><td rowspan="1" colspan="1">[214,254]</td></tr><tr><td rowspan="1" colspan="1"><italic>CYP7A1</italic></td><td rowspan="1" colspan="1">(rs3808607) -204 A&#x0003e;C</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="2" colspan="1">[255]</td></tr><tr><td rowspan="1" colspan="1"><italic>CYP7A1</italic></td><td rowspan="1" colspan="1">(rs3824260) -469 T&#x0003e;C</td><td rowspan="1" colspan="1">North Indian</td></tr><tr><td rowspan="1" colspan="1"><italic>CYP17</italic></td><td rowspan="1" colspan="1">(rs743572)A/G</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[250,251]</td></tr><tr><td rowspan="5" colspan="1"><italic>ApoB</italic></td><td rowspan="1" colspan="1">(rs676210) Pro2739Leu</td><td rowspan="5" colspan="1">Shanghai</td><td rowspan="5" colspan="1">[253]</td></tr><tr><td rowspan="1" colspan="1">(rs673548) IVS23-79T&#x0003e;C</td></tr><tr><td rowspan="1" colspan="1">rs520354) IVS6+360C &#x0003e; T</td></tr><tr><td rowspan="1" colspan="1">(rs1367117) Thr98Ile</td></tr><tr><td rowspan="1" colspan="1">(rs440446) IVS1+69C&#x0003e;G</td></tr><tr><td rowspan="2" colspan="1"><italic>CYP2C19</italic></td><td rowspan="1" colspan="1">(rs4244285) CYP2C19*2,</td><td rowspan="2" colspan="1">Japanese</td><td rowspan="2" colspan="1">[256]</td></tr><tr><td rowspan="1" colspan="1">(rs4986893) CYP2C19*3</td></tr><tr><td rowspan="1" colspan="1"><italic>ADRB3</italic></td><td rowspan="1" colspan="1">(rs4994)A/G</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[257]</td></tr><tr><td rowspan="3" align="left" colspan="1">Apoptosis pathway</td><td rowspan="3" colspan="1"><italic>CASP8</italic></td><td rowspan="1" colspan="1">(rs3834129) -652 6N ins/del</td><td rowspan="3" colspan="1">North Indian</td><td rowspan="3" colspan="1">[258]</td></tr><tr><td rowspan="1" colspan="1">(rs1045485) Asp302His</td></tr><tr><td rowspan="1" colspan="1">(rs3769818 A) IVS12-19 G&#x0003e;A</td></tr><tr><td align="left" rowspan="1" colspan="1">Nuclear Receptors</td><td rowspan="1" colspan="1"><italic>Lxr-alpha, Beta</italic></td><td rowspan="1" colspan="1">LXR-&#x003b1; (rs7120118) and LXR-&#x003b2; (rs35463555 and rs2695121)</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[259]</td></tr><tr><td rowspan="7" align="left" colspan="1">Cancer Stem cell gene</td><td rowspan="1" colspan="1"><italic>CD44</italic></td><td rowspan="1" colspan="1">CD44 (rs13347) C&#x0003e;T, CD44 (rs353639)A&#x0003e;C, CD44 (rs187116) G&#x0003e;A, CD44 (rs187115) T&#x0003e;C</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[260]</td></tr><tr><td rowspan="6" colspan="1"><italic>NANOG, ALCAM, EpCAM, SOX-2, OCT-4, NANOG</italic></td><td rowspan="1" colspan="1">NANOG (rs11055786)T&#x0003e;C,</td><td rowspan="6" colspan="1">North Indian</td><td rowspan="6" colspan="1">[261]</td></tr><tr><td rowspan="1" colspan="1">ALCAM (rs1157)G&#x0003e;A</td></tr><tr><td rowspan="1" colspan="1">EpCAM (rs1126497)T&#x0003e;C,</td></tr><tr><td rowspan="1" colspan="1">SOX-2(rs11915160)A&#x0003e;C</td></tr><tr><td rowspan="1" colspan="1">OCT-4 (rs3130932)T&#x0003e;G,</td></tr><tr><td rowspan="1" colspan="1">NANOG (rs11055786)T&#x0003e;C</td></tr><tr><td align="left" rowspan="1" colspan="1">Prostate stem cell antigen</td><td rowspan="1" colspan="1"><italic>PSCA</italic></td><td rowspan="1" colspan="1">(rs2294008) T/C and rs2978974)</td><td rowspan="1" colspan="1">India, Japan</td><td rowspan="1" colspan="1">[262,263]</td></tr><tr><td rowspan="6" align="left" colspan="1">miRNA</td><td rowspan="1" colspan="1"><italic>hsa-miR-146a</italic></td><td rowspan="1" colspan="1">(rs2910164) G&#x0003e;C</td><td rowspan="3" colspan="1">North Indian</td><td rowspan="3" colspan="1">[264]</td></tr><tr><td rowspan="1" colspan="1"><italic>hsa-mir-196a2</italic></td><td rowspan="1" colspan="1">(rs11614913) C&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1"><italic>hsa-mir-499</italic></td><td rowspan="1" colspan="1">(rs3746444)T&#x0003e;C</td></tr><tr><td rowspan="3" colspan="1"><italic>miR-27,miR-570,miR-181</italic></td><td rowspan="1" colspan="1">miR-27a (rs895819)A&#x0003e;G,</td><td rowspan="3" colspan="1">North Indian population</td><td rowspan="3" colspan="1">[265]</td></tr><tr><td rowspan="1" colspan="1">miR-570(rs4143815)G&#x0003e;C,</td></tr><tr><td rowspan="1" colspan="1">miR-181a(rs12537)C&#x0003e;T</td></tr><tr><td rowspan="5" align="left" colspan="1">GWAS-associated genes</td><td rowspan="5" colspan="1"><italic>DCC</italic></td><td rowspan="1" colspan="1">(rs7504990)C&#x0003e;T</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">[234]</td></tr><tr><td rowspan="1" colspan="1">( rs2229080) C&#x0003e;G</td><td rowspan="4" colspan="1">North Indian</td><td rowspan="4" colspan="1">[235]</td></tr><tr><td rowspan="1" colspan="1">(rs4078288) A&#x0003e;G</td></tr><tr><td rowspan="1" colspan="1">(rs7504990) C&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1">(rs714) A&#x0003e;G</td></tr><tr><td rowspan="8" align="left" colspan="1">Wnt signaling pathway</td><td rowspan="8" colspan="1"><italic>SFRP4, DKK2, DKK3, APC, AXIN-2, &#x00392;-CATENIN, GLI-1</italic></td><td rowspan="1" colspan="1">SFRP4 (rs1802073) G&#x0003e;T,</td><td rowspan="8" colspan="1">North Indian</td><td rowspan="8" colspan="1">[266]</td></tr><tr><td rowspan="1" colspan="1">DKK2 (rs17037102) C&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1">DKK3 (rs3206824) C&#x0003e;T,</td></tr><tr><td rowspan="1" colspan="1">APC (rs4595552)A/T</td></tr><tr><td rowspan="1" colspan="1">APC ( rs11954856) G&#x0003e;T,</td></tr><tr><td rowspan="1" colspan="1">AXIN-2 (rs4791171)C&#x0003e;T</td></tr><tr><td rowspan="1" colspan="1">&#x003b2;-CATENIN (rs4135385) A&#x0003e;G,</td></tr><tr><td rowspan="1" colspan="1">GLI-1(rs222826) C&#x0003e;G</td></tr><tr><td rowspan="9" align="left" colspan="1">Other genes</td><td rowspan="1" colspan="1"><italic>KRAS</italic></td><td rowspan="1" colspan="1">codon 25 Gln25His</td><td rowspan="1" colspan="1">Eastern India</td><td rowspan="1" colspan="1">[267]</td></tr><tr><td rowspan="1" colspan="1"><italic>ACE I/D</italic></td><td rowspan="1" colspan="1">(rs4646994) 289 bp del</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[268]</td></tr><tr><td rowspan="1" colspan="1"><italic>DNMT3B</italic></td><td rowspan="1" colspan="1">(rs1569686) -579 G&#x0003e;T</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[269]</td></tr><tr><td rowspan="1" colspan="1"><italic>TLR2</italic></td><td rowspan="1" colspan="1">-196-174del</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[270]</td></tr><tr><td rowspan="1" colspan="1"><italic>TLR4</italic></td><td rowspan="1" colspan="1">(rs4986791) Thr399Ile</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>Adrenergic receptors (ADRA)</italic></td><td rowspan="1" colspan="1">ADRA2A C-1291G, ADR&#x003b2;3 T190C or Trp64Arg, and ADR&#x003b2;1 C1165G or Arg389Gly</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[271]</td></tr><tr><td rowspan="1" colspan="1"><italic>Death Receptors and their ligands (DR4)</italic></td><td rowspan="1" colspan="1">DR4 (rs20575, rs20576 and rs6557634), FAS (rs2234767) FASL (rs763110)</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>PlCE1</italic></td><td rowspan="1" colspan="1">(rs2274223) A&#x0003e;G and. (rs7922612) T&#x0003e;C</td><td rowspan="1" colspan="1">North Indian</td><td rowspan="1" colspan="1">[272]</td></tr><tr><td rowspan="1" colspan="1"><italic>Vitamin D receptor (VDR)</italic></td><td rowspan="1" colspan="1">FokI C&#x0003e;T</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">[273]</td></tr></tbody></table></table-wrap><p>The only one genome-wide association study conducted in gallbladder cancer identified a SNP (rs7504990) in <italic>DCC</italic> gene which was associated with six times gallbladder cancer risk in the Japanese population. It has also been reported that reduced expression of <italic>DCC</italic> gene (deleted in colorectal cancer, 18q21.3) was designated to be associated with the greater aggressiveness of the disease which include increased proliferation, poorly differentiated histology, and metastasis through loss of adhesiveness[<xref rid="B234" ref-type="bibr">234</xref>]. However genome wide association study (GWAS) identified SNPs was replicated in Indian population and the study found no individual association of <italic>DCC</italic><sub>rs7504990</sub> but haplotype analysis of <italic>DCC</italic> gene found the cumulative effect of G<sub>rs2229080</sub>-A<sub>rs4078288</sub>-C<sub>rs7504990</sub> A<sub>rs714</sub> haplotypes in Gallbladder Cancer predisposition[<xref rid="B235" ref-type="bibr">235</xref>].</p></sec><sec><title>Molecular pathogenesis of GBC</title><p>Gallbladder carcinoma develops through a serious of events before converting in to invasive malignancy. Any exposure to carcinogens may convert normal gallbladder epithelium to condition called metaplasia which subsequently forms dysplasia to carcinoma <italic>in situ</italic> (CIS), and finally proceeding to invasive carcinoma in about 15 years[<xref rid="B274" ref-type="bibr">274</xref>,<xref rid="B275" ref-type="bibr">275</xref>]. The multistage pathogenesis of gallbladder carcinoma begins with gallstones giving rise to a condition called chronic cholecystitis, which increases to risk to gallbladder cancer formation. More than 90% of patients with gallbladder carcinoma show dysplasia and CIS[<xref rid="B274" ref-type="bibr">274</xref>,<xref rid="B275" ref-type="bibr">275</xref>]. There is an unusual asymmetric thickening of the gallbladder wall with infiltration to surrounding structures in gallbladder cancer. Maximum cases reported in carcinomas of gallbladder are adenocarcinomas (80%-95%). Adenocarconomas can further be of papillary, tubular, mucinous, or signet cell type. Some other types which are present in very low frequency include: squamous cell carcinoma (16%), undifferentiated or anaplastic carcinoma (2%-7%), and adeno-squamous carcinoma (1%-4%)[<xref rid="B276" ref-type="bibr">276</xref>]. Most of GBCs (60%) are found in the fundus, near about 30% in the body, and 10% in the neck region.</p></sec><sec><title>Tumor markers in GBC</title><p>Till date there is no reliable tumor marker developed which can be employed in diagnosis of gallbladder cancer. The only two markers <italic>i.e</italic>., carcino-embryonic antigen (CEA) and carbohydrate antigen 19-9 are most often elevated in advanced stages with a low specificity. So most often they are not used in stand-alone diagnosis of GBC[<xref rid="B277" ref-type="bibr">277</xref>]. However, there are other tumor markers like CA125, CA199, CEA (carcino-embryonic antigen), cancer antigens (CA) and CA242, which are for diagnosis of different other types of cancer (<italic>e.g</italic>., gastric, liver, pancreatic), have also been researched in diagnosis of gallbladder cancer but the obtained results are highly inconsistent[<xref rid="B278" ref-type="bibr">278</xref>-<xref rid="B280" ref-type="bibr">280</xref>]. In addition some previous reports have shown CA 242, RCAS1 (receptor binding cancer antigen expressed on SiSo cells) CA15-3, Mac-2BP (macrophage galactose-specific lectin-2 binding protein), Fragments of cytokeratin-19 (CYFRA 21-1) are frequently present in blood of cancer patients and shown to be associated with GBC with variable sensitivity and specificity[<xref rid="B277" ref-type="bibr">277</xref>,<xref rid="B281" ref-type="bibr">281</xref>,<xref rid="B282" ref-type="bibr">282</xref>].</p></sec></sec><sec><title>CONCLUSION</title><p>Various lines of evidence suggest role for various environmental risk factors in Gallbladder carcinoma. Despite of many articles regarding genetic predisposition of gallbladder cancer there is no established genetic marker. Also, very limited Genome wide association studies (GWAS) have been conducted in gallbladder cancer till now.</p><p>The evidence-based model of gallbladder carcinogenesis and its dissemination by Barreto et al[<xref rid="B283" ref-type="bibr">283</xref>] serves as a basic platform for elucidation of molecular mechanisms involved in cancer development which based on recent data can be improved by discovery of other signature mutations using high throughput studies. Technological advancement can be helpful more understanding of pathogenic mechanisms underlying neoplastic conversion of gallbladder cancer muscosa. The tumor markers available for diagnosis GBC has also not of very high specificity and not discovered until advanced stage of the disease leading to complexity of the treatment. Exome sequencing of gallbladder cancer tissue has found ERBB pathway as most dysregulated pathway in this disease. Although the studies have been published in highly distinguished journals but they need to be validated before clinical implication. Moreover, limited studies with small sample size are not robust enough to conclude anything. Regardless of improvement in technologies in research field there is no accountable betterment in the prognosis of GBC patients. The future therefore should be engaged towards good quality research focused on early diagnosis and refinement of prognostic information to ultimately improve the management strategies of gallbladder cancer. Present review provides a comprehensive summery of the studies conducted regarding its Epidemiology, Pathogenesis and molecular genetics under a single umbrella. This will be helpful for the researchers to understand the current scenario of research work and how much success we have gained till now. Based on that future research work can be planned in appropriate directions.</p></sec></body><back><fn-group><fn><p>Manuscript source: Invited manuscript</p></fn><fn><p>Specialty type: Gastroenterology and hepatology</p></fn><fn><p>Country of origin: India</p></fn><fn><p>Peer-review report classification</p></fn><fn><p>Grade A (Excellent): 0</p></fn><fn><p>Grade B (Very good): B, B</p></fn><fn><p>Grade C (Good): 0</p></fn><fn><p>Grade D (Fair): D</p></fn><fn><p>Grade E (Poor): 0</p></fn><fn fn-type="COI-statement"><p>Conflict-of-interest statement: We declare that we have no conflict of interest.</p></fn><fn><p>Peer-review started: December 29, 2016</p></fn><fn><p>First decision: January 19, 2017</p></fn><fn><p>Article in press: June 1, 2017</p></fn><fn><p>P- Reviewer: Barreto S, Lee KT, Suzuki H S- Editor: Gong ZM L- Editor: A E- Editor: Wang CH</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Chaturvedi</surname><given-names>A</given-names></name><name><surname>Misra</surname><given-names>NC</given-names></name><name><surname>Sharma</surname><given-names>ID</given-names></name></person-group><article-title>Carcinoma of the gallbladder</article-title><source>Lancet Oncol</source><year>2003</year><volume>4</volume><fpage>167</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">12623362</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andia</surname><given-names>ME</given-names></name><name><surname>Hsing</surname><given-names>AW</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Ferreccio</surname><given-names>C</given-names></name></person-group><article-title>Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study</article-title><source>Int J Cancer</source><year>2008</year><volume>123</volume><fpage>1411</fpage><lpage>1416</lpage><pub-id pub-id-type="pmid">18566990</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hundal</surname><given-names>R</given-names></name><name><surname>Shaffer</surname><given-names>EA</given-names></name></person-group><article-title>Gallbladder cancer: epidemiology and outcome</article-title><source>Clin Epidemiol</source><year>2014</year><volume>6</volume><fpage>99</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">24634588</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randi</surname><given-names>G</given-names></name><name><surname>Franceschi</surname><given-names>S</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name></person-group><article-title>Gallbladder cancer worldwide: geographical distribution and risk factors</article-title><source>Int J Cancer</source><year>2006</year><volume>118</volume><fpage>1591</fpage><lpage>1602</lpage><pub-id pub-id-type="pmid">16397865</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaffer</surname><given-names>EA</given-names></name></person-group><article-title>Gallbladder cancer: the basics</article-title><source>Gastroenterol Hepatol (N Y)</source><year>2008</year><volume>4</volume><fpage>737</fpage><lpage>741</lpage><pub-id pub-id-type="pmid">21960896</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazcano-Ponce</surname><given-names>EC</given-names></name><name><surname>Miquel</surname><given-names>JF</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>N</given-names></name><name><surname>Herrero</surname><given-names>R</given-names></name><name><surname>Ferrecio</surname><given-names>C</given-names></name><name><surname>Wistuba</surname><given-names>II</given-names></name><name><surname>Alonso de Ruiz</surname><given-names>P</given-names></name><name><surname>Aristi Urista</surname><given-names>G</given-names></name><name><surname>Nervi</surname><given-names>F</given-names></name></person-group><article-title>Epidemiology and molecular pathology of gallbladder cancer</article-title><source>CA Cancer J Clin</source><year>2001</year><volume>51</volume><fpage>349</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">11760569</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsing</surname><given-names>AW</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Goldstein</surname><given-names>AM</given-names></name><name><surname>Han</surname><given-names>TQ</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Fraumeni</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China</article-title><source>Int J Cancer</source><year>2007</year><volume>121</volume><fpage>832</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">17450525</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hariharan</surname><given-names>D</given-names></name><name><surname>Saied</surname><given-names>A</given-names></name><name><surname>Kocher</surname><given-names>HM</given-names></name></person-group><article-title>Analysis of mortality rates for gallbladder cancer across the world</article-title><source>HPB (Oxford)</source><year>2008</year><volume>10</volume><fpage>327</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">18982147</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilgrim</surname><given-names>CH</given-names></name><name><surname>Groeschl</surname><given-names>RT</given-names></name><name><surname>Christians</surname><given-names>KK</given-names></name><name><surname>Gamblin</surname><given-names>TC</given-names></name></person-group><article-title>Modern perspectives on factors predisposing to the development of gallbladder cancer</article-title><source>HPB (Oxford)</source><year>2013</year><volume>15</volume><fpage>839</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">23458506</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>P</given-names></name><name><surname>Barreto</surname><given-names>SG</given-names></name><name><surname>Sahoo</surname><given-names>B</given-names></name><name><surname>Chandrani</surname><given-names>P</given-names></name><name><surname>Ramadwar</surname><given-names>MR</given-names></name><name><surname>Shrikhande</surname><given-names>SV</given-names></name><name><surname>Dutt</surname><given-names>A</given-names></name></person-group><article-title>Non-typhoidal Salmonella DNA traces in gallbladder cancer</article-title><source>Infect Agent Cancer</source><year>2016</year><volume>11</volume><fpage>12</fpage><pub-id pub-id-type="pmid">26941832</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everson</surname><given-names>GT</given-names></name><name><surname>McKinley</surname><given-names>C</given-names></name><name><surname>Kern</surname><given-names>F</given-names></name></person-group><article-title>Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism</article-title><source>J Clin Invest</source><year>1991</year><volume>87</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">1845870</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barreto</surname><given-names>SG</given-names></name><name><surname>Haga</surname><given-names>H</given-names></name><name><surname>Shukla</surname><given-names>PJ</given-names></name></person-group><article-title>Hormones and gallbladder cancer in women</article-title><source>Indian J Gastroenterol</source><year>2009</year><volume>28</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">19937419</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>K</given-names></name><name><surname>Sreenivas</surname><given-names>V</given-names></name><name><surname>Velpandian</surname><given-names>T</given-names></name><name><surname>Kapil</surname><given-names>U</given-names></name><name><surname>Garg</surname><given-names>PK</given-names></name></person-group><article-title>Risk factors for gallbladder cancer: a case-control study</article-title><source>Int J Cancer</source><year>2013</year><volume>132</volume><fpage>1660</fpage><lpage>1666</lpage><pub-id pub-id-type="pmid">22890893</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrikhande</surname><given-names>SV</given-names></name><name><surname>Barreto</surname><given-names>SG</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Udwadia</surname><given-names>TE</given-names></name><name><surname>Agarwal</surname><given-names>AK</given-names></name></person-group><article-title>Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause!</article-title><source>Eur J Surg Oncol</source><year>2010</year><volume>36</volume><fpage>514</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">20537839</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>S</given-names></name><name><surname>Hsieh</surname><given-names>CC</given-names></name><name><surname>MacMahon</surname><given-names>B</given-names></name></person-group><article-title>Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral-contraceptive use</article-title><source>Cancer</source><year>1987</year><volume>59</volume><fpage>2112</fpage><lpage>2116</lpage><pub-id pub-id-type="pmid">3567872</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>DY</given-names></name><name><surname>Je</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name></person-group><article-title>Body mass index and biliary tract disease: a systematic review and meta-analysis of prospective studies</article-title><source>Prev Med</source><year>2014</year><volume>65</volume><fpage>13</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">24721739</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>VK</given-names></name><name><surname>Rastogi</surname><given-names>AN</given-names></name><name><surname>Adukia</surname><given-names>TK</given-names></name><name><surname>Raizada</surname><given-names>RB</given-names></name><name><surname>Reddy</surname><given-names>DC</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name></person-group><article-title>Organochlorine pesticides in carcinoma of the gallbladder: a case-control study</article-title><source>Eur J Cancer Prev</source><year>2001</year><volume>10</volume><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">11330456</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>V</given-names></name><name><surname>Mishra</surname><given-names>M</given-names></name><name><surname>Ansari</surname><given-names>KM</given-names></name><name><surname>Chaudhari</surname><given-names>BP</given-names></name><name><surname>Khanna</surname><given-names>R</given-names></name><name><surname>Das</surname><given-names>M</given-names></name></person-group><article-title>Edible oil adulterants, argemone oil and butter yellow, as aetiological factors for gall bladder cancer</article-title><source>Eur J Cancer</source><year>2012</year><volume>48</volume><fpage>2075</fpage><lpage>2085</lpage><pub-id pub-id-type="pmid">22071130</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Holm</surname><given-names>NV</given-names></name><name><surname>Verkasalo</surname><given-names>PK</given-names></name><name><surname>Iliadou</surname><given-names>A</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Skytthe</surname><given-names>A</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name></person-group><article-title>Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">10891514</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moerman</surname><given-names>CJ</given-names></name><name><surname>Berns</surname><given-names>MP</given-names></name><name><surname>Bueno de Mesquita</surname><given-names>HB</given-names></name><name><surname>Runia</surname><given-names>S</given-names></name></person-group><article-title>Reproductive history and cancer of the biliary tract in women</article-title><source>Int J Cancer</source><year>1994</year><volume>57</volume><fpage>146</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">8157350</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavani</surname><given-names>A</given-names></name><name><surname>Negri</surname><given-names>E</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name></person-group><article-title>Menstrual and reproductive factors and biliary tract cancers</article-title><source>Eur J Cancer Prev</source><year>1996</year><volume>5</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">8894561</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diehl</surname><given-names>AK</given-names></name></person-group><article-title>Epidemiology of gallbladder cancer: a synthesis of recent data</article-title><source>J Natl Cancer Inst</source><year>1980</year><volume>65</volume><fpage>1209</fpage><lpage>1214</lpage><pub-id pub-id-type="pmid">6933267</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>W</given-names></name><name><surname>Miyata</surname><given-names>R</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Yamashiro</surname><given-names>M</given-names></name></person-group><article-title>Simultaneous development of gallbladder and bile duct carcinomas with atypical epithelium intervention: a case report</article-title><source>Jpn J Clin Oncol</source><year>1989</year><volume>19</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">2810826</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zatonski</surname><given-names>WA</given-names></name><name><surname>Lowenfels</surname><given-names>AB</given-names></name><name><surname>Boyle</surname><given-names>P</given-names></name><name><surname>Maisonneuve</surname><given-names>P</given-names></name><name><surname>Bueno de Mesquita</surname><given-names>HB</given-names></name><name><surname>Ghadirian</surname><given-names>P</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Przewozniak</surname><given-names>K</given-names></name><name><surname>Baghurst</surname><given-names>P</given-names></name><name><surname>Moerman</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer</article-title><source>J Natl Cancer Inst</source><year>1997</year><volume>89</volume><fpage>1132</fpage><lpage>1138</lpage><pub-id pub-id-type="pmid">9262251</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feigelson</surname><given-names>HS</given-names></name><name><surname>Ross</surname><given-names>RK</given-names></name><name><surname>Yu</surname><given-names>MC</given-names></name><name><surname>Coetzee</surname><given-names>GA</given-names></name><name><surname>Reichardt</surname><given-names>JK</given-names></name><name><surname>Henderson</surname><given-names>BE</given-names></name></person-group><article-title>Genetic susceptibility to cancer from exogenous and endogenous exposures</article-title><source>J Cell Biochem Suppl</source><year>1996</year><volume>25</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">9027593</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhiman</surname><given-names>RK</given-names></name><name><surname>Chawla</surname><given-names>YK</given-names></name></person-group><article-title>Is there a link between oestrogen therapy and gallbladder disease?</article-title><source>Expert Opin Drug Saf</source><year>2006</year><volume>5</volume><fpage>117</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">16370961</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piehler</surname><given-names>JM</given-names></name><name><surname>Crichlow</surname><given-names>RW</given-names></name></person-group><article-title>Primary carcinoma of the gallbladder</article-title><source>Surg Gynecol Obstet</source><year>1978</year><volume>147</volume><fpage>929</fpage><lpage>942</lpage><pub-id pub-id-type="pmid">362580</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephen</surname><given-names>AE</given-names></name><name><surname>Berger</surname><given-names>DL</given-names></name></person-group><article-title>Carcinoma in the porcelain gallbladder: a relationship revisited</article-title><source>Surgery</source><year>2001</year><volume>129</volume><fpage>699</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">11391368</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>I</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Calvo</surname><given-names>A</given-names></name><name><surname>Cavada</surname><given-names>G</given-names></name><name><surname>B&#x000e1;ez</surname><given-names>S</given-names></name><name><surname>Endoh</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Tajima</surname><given-names>K</given-names></name></person-group><article-title>Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population</article-title><source>Int J Cancer</source><year>2002</year><volume>102</volume><fpage>407</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">12402311</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e1;ez</surname><given-names>S</given-names></name><name><surname>Tsuchiya</surname><given-names>Y</given-names></name><name><surname>Calvo</surname><given-names>A</given-names></name><name><surname>Pruyas</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Kiyohara</surname><given-names>C</given-names></name><name><surname>Oyama</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women</article-title><source>World J Gastroenterol</source><year>2010</year><volume>16</volume><fpage>372</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">20082485</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>U</given-names></name><name><surname>Garg</surname><given-names>PK</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Tandon</surname><given-names>RK</given-names></name></person-group><article-title>Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder</article-title><source>Am J Gastroenterol</source><year>2000</year><volume>95</volume><fpage>784</fpage><lpage>787</lpage><pub-id pub-id-type="pmid">10710075</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leong</surname><given-names>RW</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name></person-group><article-title>Review article: Helicobacter species and hepatobiliary diseases</article-title><source>Aliment Pharmacol Ther</source><year>2002</year><volume>16</volume><fpage>1037</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">12030944</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname><given-names>G</given-names></name><name><surname>Gulati</surname><given-names>AK</given-names></name><name><surname>Shukla</surname><given-names>VK</given-names></name></person-group><article-title>Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder</article-title><source>World J Gastroenterol</source><year>2010</year><volume>16</volume><fpage>5395</fpage><lpage>5404</lpage><pub-id pub-id-type="pmid">21086555</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanu</surname><given-names>T</given-names></name><name><surname>Spaapen</surname><given-names>RM</given-names></name><name><surname>Bakker</surname><given-names>JM</given-names></name><name><surname>Pratap</surname><given-names>CB</given-names></name><name><surname>Wu</surname><given-names>LE</given-names></name><name><surname>Hofland</surname><given-names>I</given-names></name><name><surname>Broeks</surname><given-names>A</given-names></name><name><surname>Shukla</surname><given-names>VK</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Janssen</surname><given-names>H</given-names></name><etal/></person-group><article-title>Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma</article-title><source>Cell Host Microbe</source><year>2015</year><volume>17</volume><fpage>763</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">26028364</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>KY</given-names></name><name><surname>Cha</surname><given-names>SW</given-names></name><name><surname>Um</surname><given-names>WH</given-names></name><name><surname>Chun</surname><given-names>CG</given-names></name><name><surname>Jeong</surname><given-names>SW</given-names></name><name><surname>Jang</surname><given-names>JY</given-names></name><name><surname>Cho</surname><given-names>YD</given-names></name></person-group><article-title>Simultaneous occurrence of gallbladder cancer in a laundry couple: association between gallbladder cancer and benzene</article-title><source>Korean J Gastroenterol</source><year>2013</year><volume>61</volume><fpage>107</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">23458990</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>RR</given-names></name><name><surname>Tewari</surname><given-names>M</given-names></name><name><surname>Shukla</surname><given-names>HS</given-names></name></person-group><article-title>Helicobacter pylori and pathogenesis of gallbladder cancer</article-title><source>J Gastroenterol Hepatol</source><year>2011</year><volume>26</volume><fpage>260</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">21261714</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>EH</given-names></name><name><surname>Gerges</surname><given-names>SS</given-names></name><name><surname>El-Atrebi</surname><given-names>KA</given-names></name><name><surname>El-Bassyouni</surname><given-names>HT</given-names></name></person-group><article-title>The role of H. pylori infection in gall bladder cancer: clinicopathological study</article-title><source>Tumour Biol</source><year>2015</year><volume>36</volume><fpage>7093</fpage><lpage>7098</lpage><pub-id pub-id-type="pmid">25877756</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>VK</given-names></name><name><surname>Tiwari</surname><given-names>SC</given-names></name><name><surname>Roy</surname><given-names>SK</given-names></name></person-group><article-title>Biliary bile acids in cholelithiasis and carcinoma of the gall bladder</article-title><source>Eur J Cancer Prev</source><year>1993</year><volume>2</volume><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">8461866</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>T</given-names></name><name><surname>Srivastava</surname><given-names>J</given-names></name><name><surname>DiGiovanni</surname><given-names>J</given-names></name><name><surname>Kiguchi</surname><given-names>K</given-names></name></person-group><article-title>Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer</article-title><source>Mol Carcinog</source><year>2015</year><volume>54</volume><fpage>459</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">24839254</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gowda</surname><given-names>GA</given-names></name></person-group><article-title>Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers</article-title><source>Biomark Med</source><year>2010</year><volume>4</volume><fpage>299</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">20406071</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benbow</surname><given-names>EW</given-names></name></person-group><article-title>Xanthogranulomatous cholecystitis</article-title><source>Br J Surg</source><year>1990</year><volume>77</volume><fpage>255</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">2182176</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>Y</given-names></name><name><surname>Fujii</surname><given-names>H</given-names></name><name><surname>Aoyama</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Sugahara</surname><given-names>K</given-names></name><name><surname>Suda</surname><given-names>K</given-names></name></person-group><article-title>Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens</article-title><source>Am J Surg</source><year>1992</year><volume>163</volume><fpage>239</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">1739180</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Ikoma</surname><given-names>A</given-names></name><name><surname>Hamada</surname><given-names>N</given-names></name><name><surname>Nishida</surname><given-names>S</given-names></name><name><surname>Kadono</surname><given-names>J</given-names></name><name><surname>Taira</surname><given-names>A</given-names></name></person-group><article-title>Biliary tract cancer accompanied by anomalous junction of pancreaticobiliary ductal system in adults</article-title><source>Am J Surg</source><year>1998</year><volume>175</volume><fpage>218</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">9560123</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>M</given-names></name></person-group><article-title>Risk factors for gallbladder cancer: a reappraisal</article-title><source>Eur J Cancer Prev</source><year>2003</year><volume>12</volume><fpage>15</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">12548106</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>M</given-names></name></person-group><article-title>Environmental pollutants in gallbladder carcinogenesis</article-title><source>J Surg Oncol</source><year>2006</year><volume>93</volume><fpage>640</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">16724354</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>Y</given-names></name><name><surname>Mizumoto</surname><given-names>R</given-names></name><name><surname>Isaji</surname><given-names>S</given-names></name><name><surname>Kusuda</surname><given-names>T</given-names></name><name><surname>Matsuda</surname><given-names>S</given-names></name><name><surname>Tabata</surname><given-names>M</given-names></name></person-group><article-title>Radical operations for carcinoma of the gallbladder: present status in Japan</article-title><source>World J Surg</source><year>1991</year><volume>15</volume><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">1853612</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiles</surname><given-names>R</given-names></name><name><surname>Varadpande</surname><given-names>M</given-names></name><name><surname>Muly</surname><given-names>S</given-names></name><name><surname>Webb</surname><given-names>J</given-names></name></person-group><article-title>Growth rate and malignant potential of small gallbladder polyps--systematic review of evidence</article-title><source>Surgeon</source><year>2014</year><volume>12</volume><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">24502936</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis</article-title><source>Mutat Res</source><year>2011</year><volume>728</volume><fpage>67</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">21708280</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>SC</given-names></name><name><surname>Wolk</surname><given-names>A</given-names></name></person-group><article-title>Obesity and the risk of gallbladder cancer: a meta-analysis</article-title><source>Br J Cancer</source><year>2007</year><volume>96</volume><fpage>1457</fpage><lpage>1461</lpage><pub-id pub-id-type="pmid">17375043</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>VK</given-names></name><name><surname>Shukla</surname><given-names>PK</given-names></name><name><surname>Pandey</surname><given-names>M</given-names></name><name><surname>Rao</surname><given-names>BR</given-names></name><name><surname>Roy</surname><given-names>SK</given-names></name></person-group><article-title>Lipid peroxidation product in bile from patients with carcinoma of the gallbladder: a preliminary study</article-title><source>J Surg Oncol</source><year>1994</year><volume>56</volume><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">8057656</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>HH</given-names></name><name><surname>Glasgow</surname><given-names>RE</given-names></name><name><surname>Mulvihill</surname><given-names>SJ</given-names></name><name><surname>Cannon-Albright</surname><given-names>LA</given-names></name></person-group><article-title>Cannon-Albright. Familial risk in gallbladder cancer</article-title><source>J Am Coll Surg</source><year>2007</year><issue>205</issue><fpage>S38</fpage><lpage>S138</lpage><pub-id pub-id-type="pmid">17916517</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemminki</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden</article-title><source>Gut</source><year>2003</year><volume>52</volume><fpage>592</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">12631675</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trajber</surname><given-names>HJ</given-names></name><name><surname>Szego</surname><given-names>T</given-names></name><name><surname>de Camargo</surname><given-names>HS</given-names></name><name><surname>Mester</surname><given-names>M</given-names></name><name><surname>Marujo</surname><given-names>WC</given-names></name><name><surname>Roll</surname><given-names>S</given-names></name></person-group><article-title>Adenocarcinoma of the gallbladder in two siblings</article-title><source>Cancer</source><year>1982</year><volume>50</volume><fpage>1200</fpage><lpage>1203</lpage><pub-id pub-id-type="pmid">7104965</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wistuba</surname><given-names>II</given-names></name><name><surname>Sugio</surname><given-names>K</given-names></name><name><surname>Hung</surname><given-names>J</given-names></name><name><surname>Kishimoto</surname><given-names>Y</given-names></name><name><surname>Virmani</surname><given-names>AK</given-names></name><name><surname>Roa</surname><given-names>I</given-names></name><name><surname>Albores-Saavedra</surname><given-names>J</given-names></name><name><surname>Gazdar</surname><given-names>AF</given-names></name></person-group><article-title>Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile</article-title><source>Cancer Res</source><year>1995</year><volume>55</volume><fpage>2511</fpage><lpage>2515</lpage><pub-id pub-id-type="pmid">7780959</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>M</given-names></name><name><surname>Khatri</surname><given-names>AK</given-names></name><name><surname>Dubey</surname><given-names>SS</given-names></name><name><surname>Gautam</surname><given-names>A</given-names></name><name><surname>Shukla</surname><given-names>VK</given-names></name></person-group><article-title>Erythrocyte membrane fatty acid profile in patients with primary carcinoma of the gallbladder</article-title><source>J Surg Oncol</source><year>1995</year><volume>59</volume><fpage>31</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">7745974</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasatomi</surname><given-names>E</given-names></name><name><surname>Tokunaga</surname><given-names>O</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name></person-group><article-title>Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings</article-title><source>J Hepatobiliary Pancreat Surg</source><year>2000</year><volume>7</volume><fpage>556</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">11180887</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wistuba</surname><given-names>II</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Maitra</surname><given-names>A</given-names></name><name><surname>Alvarez</surname><given-names>H</given-names></name><name><surname>Troncoso</surname><given-names>P</given-names></name><name><surname>Pimentel</surname><given-names>F</given-names></name><name><surname>Gazdar</surname><given-names>AF</given-names></name></person-group><article-title>Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>3795</fpage><lpage>3800</lpage><pub-id pub-id-type="pmid">11325854</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rashid</surname><given-names>A</given-names></name></person-group><article-title>Cellular and molecular biology of biliary tract cancers</article-title><source>Surg Oncol Clin N Am</source><year>2002</year><volume>11</volume><fpage>995</fpage><lpage>1009</lpage><pub-id pub-id-type="pmid">12607585</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>M</given-names></name><name><surname>Hoshi</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name></person-group><article-title>K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis</article-title><source>Cancer</source><year>1994</year><volume>73</volume><fpage>2727</fpage><lpage>2733</lpage><pub-id pub-id-type="pmid">8194013</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajiki</surname><given-names>T</given-names></name><name><surname>Fujimori</surname><given-names>T</given-names></name><name><surname>Onoyama</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Kitazawa</surname><given-names>S</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Saitoh</surname><given-names>Y</given-names></name></person-group><article-title>K-ras gene mutation in gall bladder carcinomas and dysplasia</article-title><source>Gut</source><year>1996</year><volume>38</volume><fpage>426</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">8675098</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoi</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Ajioka</surname><given-names>Y</given-names></name><name><surname>Oohashi</surname><given-names>Y</given-names></name><name><surname>Takel</surname><given-names>K</given-names></name><name><surname>Nishikura</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Horil</surname><given-names>A</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><article-title>APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis</article-title><source>Pathol Int</source><year>1996</year><volume>46</volume><fpage>333</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">8809879</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoi</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Ajioka</surname><given-names>Y</given-names></name><name><surname>Nishikura</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><article-title>Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas</article-title><source>Pathol Int</source><year>1997</year><volume>47</volume><fpage>525</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">9293532</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuhara</surname><given-names>S</given-names></name><name><surname>Kasuya</surname><given-names>K</given-names></name><name><surname>Aoki</surname><given-names>T</given-names></name><name><surname>Yoshimatsu</surname><given-names>A</given-names></name><name><surname>Tsuchida</surname><given-names>A</given-names></name><name><surname>Koyanagi</surname><given-names>Y</given-names></name></person-group><article-title>Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction</article-title><source>J Hepatobiliary Pancreat Surg</source><year>2000</year><volume>7</volume><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">10982614</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>MK</given-names></name><name><surname>Chetri</surname><given-names>K</given-names></name><name><surname>Pandey</surname><given-names>UB</given-names></name><name><surname>Kapoor</surname><given-names>VK</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name></person-group><article-title>Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer</article-title><source>J Gastroenterol Hepatol</source><year>2004</year><volume>19</volume><fpage>916</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">15242496</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wistuba</surname><given-names>II</given-names></name><name><surname>Albores-Saavedra</surname><given-names>J</given-names></name></person-group><article-title>Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma</article-title><source>J Hepatobiliary Pancreat Surg</source><year>1999</year><volume>6</volume><fpage>237</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">10526058</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YT</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Jang</surname><given-names>YH</given-names></name><name><surname>Lee</surname><given-names>WJ</given-names></name><name><surname>Ryu</surname><given-names>JK</given-names></name><name><surname>Park</surname><given-names>YK</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>WH</given-names></name><name><surname>Yoon</surname><given-names>YB</given-names></name><name><surname>Kim</surname><given-names>CY</given-names></name></person-group><article-title>Genetic alterations in gallbladder adenoma, dysplasia and carcinoma</article-title><source>Cancer Lett</source><year>2001</year><volume>169</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">11410326</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanada</surname><given-names>K</given-names></name><name><surname>Tsuchida</surname><given-names>A</given-names></name><name><surname>Kajiyama</surname><given-names>G</given-names></name></person-group><article-title>Cellular kinetics and gene mutations in gallbladder mucosa with an anomalous junction of pancreaticobiliary duct</article-title><source>J Hepatobiliary Pancreat Surg</source><year>1999</year><volume>6</volume><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">10526056</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>K</given-names></name><name><surname>Konno</surname><given-names>M</given-names></name><name><surname>Kanzaki</surname><given-names>A</given-names></name><name><surname>Morikawa</surname><given-names>T</given-names></name><name><surname>Miyashita</surname><given-names>H</given-names></name><name><surname>Fujioka</surname><given-names>T</given-names></name><name><surname>Uchida</surname><given-names>T</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name><name><surname>Takao</surname><given-names>S</given-names></name><name><surname>Aikou</surname><given-names>T</given-names></name><etal/></person-group><article-title>Allelotype analysis of gallbladder carcinoma associated with anomalous junction of pancreaticobiliary duct</article-title><source>Cancer Lett</source><year>2001</year><volume>166</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">11311485</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>N</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Ajioka</surname><given-names>Y</given-names></name><name><surname>Nishikura</surname><given-names>K</given-names></name><name><surname>Date</surname><given-names>K</given-names></name><name><surname>Kijima</surname><given-names>H</given-names></name><name><surname>Shirai</surname><given-names>Y</given-names></name><name><surname>Hatakeyama</surname><given-names>K</given-names></name></person-group><article-title>[Genetic alterations in gallbladder carcinoma: a review]</article-title><source>Nihon Geka Gakkai Zasshi</source><year>1998</year><volume>99</volume><fpage>687</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">9866832</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeifer</surname><given-names>GP</given-names></name></person-group><article-title>Involvement of DNA damage and repair in mutational spectra</article-title><source>Mutat Res</source><year>2000</year><volume>450</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">10838130</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billo</surname><given-names>P</given-names></name><name><surname>Marchegiani</surname><given-names>C</given-names></name><name><surname>Capella</surname><given-names>C</given-names></name><name><surname>Sessa</surname><given-names>F</given-names></name></person-group><article-title>[Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa]</article-title><source>Pathologica</source><year>2000</year><volume>92</volume><fpage>249</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">11029885</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa</surname><given-names>I</given-names></name><name><surname>Melo</surname><given-names>A</given-names></name><name><surname>Roa</surname><given-names>J</given-names></name><name><surname>Araya</surname><given-names>J</given-names></name><name><surname>Villaseca</surname><given-names>M</given-names></name><name><surname>de Aretxabala</surname><given-names>X</given-names></name></person-group><article-title>[P53 gene mutation in gallbladder cancer]</article-title><source>Rev Med Chil</source><year>2000</year><volume>128</volume><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">10962865</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>M</given-names></name><name><surname>Horita</surname><given-names>Y</given-names></name><name><surname>Okuda</surname><given-names>S</given-names></name><name><surname>Okumoto</surname><given-names>S</given-names></name><name><surname>Samizo</surname><given-names>M</given-names></name><name><surname>Wada</surname><given-names>T</given-names></name><name><surname>Kuroda</surname><given-names>Y</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name></person-group><article-title>Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?</article-title><source>Hepatogastroenterology</source><year>2002</year><volume>49</volume><fpage>935</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">12143246</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quan</surname><given-names>ZW</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Merrell</surname><given-names>RC</given-names></name></person-group><article-title>Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer</article-title><source>J Am Coll Surg</source><year>2001</year><volume>193</volume><fpage>380</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">11584965</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>N</given-names></name><name><surname>Hitomi</surname><given-names>J</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Ajioka</surname><given-names>Y</given-names></name><name><surname>Pruyas</surname><given-names>M</given-names></name><name><surname>Serra</surname><given-names>I</given-names></name><name><surname>Shirai</surname><given-names>Y</given-names></name><name><surname>Hatakeyama</surname><given-names>K</given-names></name></person-group><article-title>Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>1998</year><volume>7</volume><fpage>297</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">9568784</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa</surname><given-names>JC</given-names></name><name><surname>Roa</surname><given-names>I</given-names></name><name><surname>de Aretxabala</surname><given-names>X</given-names></name><name><surname>Melo</surname><given-names>A</given-names></name><name><surname>Far&#x000ed;a</surname><given-names>G</given-names></name><name><surname>Tapia</surname><given-names>O</given-names></name></person-group><article-title>[K-ras gene mutation in gallbladder carcinoma]</article-title><source>Rev Med Chil</source><year>2004</year><volume>132</volume><fpage>955</fpage><lpage>960</lpage><pub-id pub-id-type="pmid">15478297</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa</surname><given-names>JC</given-names></name><name><surname>Anabal&#x000f3;n</surname><given-names>L</given-names></name><name><surname>Tapia</surname><given-names>O</given-names></name><name><surname>Melo</surname><given-names>A</given-names></name><name><surname>de Aretxabala</surname><given-names>X</given-names></name><name><surname>Roa</surname><given-names>I</given-names></name></person-group><article-title>[Frequency of K-ras mutation in biliary and pancreatic tumors]</article-title><source>Rev Med Chil</source><year>2005</year><volume>133</volume><fpage>1434</fpage><lpage>1440</lpage><pub-id pub-id-type="pmid">16446870</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tada</surname><given-names>M</given-names></name><name><surname>Yokosuka</surname><given-names>O</given-names></name><name><surname>Omata</surname><given-names>M</given-names></name><name><surname>Ohto</surname><given-names>M</given-names></name><name><surname>Isono</surname><given-names>K</given-names></name></person-group><article-title>Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing</article-title><source>Cancer</source><year>1990</year><volume>66</volume><fpage>930</fpage><lpage>935</lpage><pub-id pub-id-type="pmid">2167148</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Todoroki</surname><given-names>T</given-names></name><name><surname>Ichikawa</surname><given-names>Y</given-names></name><name><surname>Hanai</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Hori</surname><given-names>M</given-names></name><name><surname>Fukao</surname><given-names>K</given-names></name><name><surname>Miwa</surname><given-names>M</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name></person-group><article-title>Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers</article-title><source>Cancer Res</source><year>1995</year><volume>55</volume><fpage>2756</fpage><lpage>2760</lpage><pub-id pub-id-type="pmid">7796400</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanada</surname><given-names>K</given-names></name><name><surname>Tsuchida</surname><given-names>A</given-names></name><name><surname>Iwao</surname><given-names>T</given-names></name><name><surname>Eguchi</surname><given-names>N</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Morinaka</surname><given-names>K</given-names></name><name><surname>Matsubara</surname><given-names>K</given-names></name><name><surname>Kawasaki</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Kajiyama</surname><given-names>G</given-names></name></person-group><article-title>Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct</article-title><source>Am J Gastroenterol</source><year>1999</year><volume>94</volume><fpage>1638</fpage><lpage>1642</lpage><pub-id pub-id-type="pmid">10364037</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>House</surname><given-names>MG</given-names></name><name><surname>Wistuba</surname><given-names>II</given-names></name><name><surname>Argani</surname><given-names>P</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Schulick</surname><given-names>RD</given-names></name><name><surname>Hruban</surname><given-names>RH</given-names></name><name><surname>Herman</surname><given-names>JG</given-names></name><name><surname>Maitra</surname><given-names>A</given-names></name></person-group><article-title>Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer</article-title><source>Ann Surg Oncol</source><year>2003</year><volume>10</volume><fpage>882</fpage><lpage>889</lpage><pub-id pub-id-type="pmid">14527906</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueki</surname><given-names>T</given-names></name><name><surname>Hsing</surname><given-names>AW</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Fraumeni</surname><given-names>JF</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name></person-group><article-title>Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><fpage>1717</fpage><lpage>1725</lpage><pub-id pub-id-type="pmid">15014024</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Baez</surname><given-names>S</given-names></name><name><surname>Pruyas</surname><given-names>M</given-names></name><name><surname>Diaz</surname><given-names>A</given-names></name><name><surname>Calvo</surname><given-names>A</given-names></name><name><surname>Riquelme</surname><given-names>E</given-names></name><name><surname>Wistuba</surname><given-names>II</given-names></name></person-group><article-title>Mitochondrial DNA mutation at the D310 (displacement loop) mononucleotide sequence in the pathogenesis of gallbladder carcinoma</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><fpage>1041</fpage><lpage>1046</lpage><pub-id pub-id-type="pmid">14871983</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saetta</surname><given-names>AA</given-names></name></person-group><article-title>K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer</article-title><source>J Surg Oncol</source><year>2006</year><volume>93</volume><fpage>644</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">16724348</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>K</given-names></name><name><surname>Yokozaki</surname><given-names>H</given-names></name><name><surname>Yasui</surname><given-names>W</given-names></name><name><surname>Kuniyasu</surname><given-names>H</given-names></name><name><surname>Hirata</surname><given-names>M</given-names></name><name><surname>Kajiyama</surname><given-names>G</given-names></name><name><surname>Tahara</surname><given-names>E</given-names></name></person-group><article-title>High frequency of p53 gene mutation in adenocarcinomas of the gallbladder</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>1996</year><volume>5</volume><fpage>461</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">8781743</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanada</surname><given-names>K</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Fujii</surname><given-names>K</given-names></name><name><surname>Tsuchida</surname><given-names>A</given-names></name><name><surname>Ooishi</surname><given-names>H</given-names></name><name><surname>Kajiyama</surname><given-names>G</given-names></name></person-group><article-title>K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct</article-title><source>Cancer</source><year>1996</year><volume>77</volume><fpage>452</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">8630951</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamel</surname><given-names>D</given-names></name><name><surname>P&#x000e4;&#x000e4;kk&#x000f6;</surname><given-names>P</given-names></name><name><surname>Nuorva</surname><given-names>K</given-names></name><name><surname>V&#x000e4;h&#x000e4;kangas</surname><given-names>K</given-names></name><name><surname>Soini</surname><given-names>Y</given-names></name></person-group><article-title>p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder</article-title><source>J Pathol</source><year>1993</year><volume>170</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">8100854</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YW</given-names></name><name><surname>Huh</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>YK</given-names></name><name><surname>Yoon</surname><given-names>TY</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Hong</surname><given-names>SH</given-names></name></person-group><article-title>Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas</article-title><source>Oncol Rep</source><year>2001</year><volume>8</volume><fpage>1127</fpage><lpage>1132</lpage><pub-id pub-id-type="pmid">11496329</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiguchi</surname><given-names>K</given-names></name><name><surname>Carbajal</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Beltr&#x000e1;n</surname><given-names>L</given-names></name><name><surname>Ruffino</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Yoshimi</surname><given-names>N</given-names></name><name><surname>DiGiovanni</surname><given-names>J</given-names></name></person-group><article-title>Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>6971</fpage><lpage>6976</lpage><pub-id pub-id-type="pmid">11585718</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname><given-names>N</given-names></name><name><surname>Kapoor</surname><given-names>VK</given-names></name><name><surname>Krishnani</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>K</given-names></name><name><surname>Baitha</surname><given-names>DK</given-names></name></person-group><article-title>Role of C-erbB2 expression in gallbladder cancer</article-title><source>Indian J Pathol Microbiol</source><year>2012</year><volume>55</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">22499306</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa</surname><given-names>I</given-names></name><name><surname>de Toro</surname><given-names>G</given-names></name><name><surname>Schalper</surname><given-names>K</given-names></name><name><surname>de Aretxabala</surname><given-names>X</given-names></name><name><surname>Churi</surname><given-names>C</given-names></name><name><surname>Javle</surname><given-names>M</given-names></name></person-group><article-title>Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer</article-title><source>Gastrointest Cancer Res</source><year>2014</year><volume>7</volume><fpage>42</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">24799970</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignochino</surname><given-names>Y</given-names></name><name><surname>Sarotto</surname><given-names>I</given-names></name><name><surname>Peraldo-Neia</surname><given-names>C</given-names></name><name><surname>Penachioni</surname><given-names>JY</given-names></name><name><surname>Cavalloni</surname><given-names>G</given-names></name><name><surname>Migliardi</surname><given-names>G</given-names></name><name><surname>Casorzo</surname><given-names>L</given-names></name><name><surname>Chiorino</surname><given-names>G</given-names></name><name><surname>Risio</surname><given-names>M</given-names></name><name><surname>Bardelli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas</article-title><source>BMC Cancer</source><year>2010</year><volume>10</volume><fpage>631</fpage><pub-id pub-id-type="pmid">21087480</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>XA</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway</article-title><source>Nat Genet</source><year>2014</year><volume>46</volume><fpage>872</fpage><lpage>876</lpage><pub-id pub-id-type="pmid">24997986</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javle</surname><given-names>M</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Churi</surname><given-names>C</given-names></name><name><surname>Kar</surname><given-names>S</given-names></name><name><surname>Zuo</surname><given-names>M</given-names></name><name><surname>Eterovic</surname><given-names>AK</given-names></name><name><surname>Nogueras-Gonzalez</surname><given-names>GM</given-names></name><name><surname>Janku</surname><given-names>F</given-names></name><name><surname>Shroff</surname><given-names>RT</given-names></name><name><surname>Aloia</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Molecular characterization of gallbladder cancer using somatic mutation profiling</article-title><source>Hum Pathol</source><year>2014</year><volume>45</volume><fpage>701</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">24508317</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname><given-names>N</given-names></name><name><surname>Corless</surname><given-names>CL</given-names></name><name><surname>Warrick</surname><given-names>A</given-names></name><name><surname>Beadling</surname><given-names>C</given-names></name><name><surname>Nelson</surname><given-names>D</given-names></name><name><surname>Neff</surname><given-names>T</given-names></name><name><surname>Krishnani</surname><given-names>N</given-names></name><name><surname>Kapoor</surname><given-names>VK</given-names></name></person-group><article-title>Mutation profiling in gallbladder cancer in Indian population</article-title><source>Indian J Pathol Microbiol</source><year>2014</year><volume>57</volume><fpage>9</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">24739824</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Totoki</surname><given-names>Y</given-names></name><name><surname>Shirota</surname><given-names>T</given-names></name><name><surname>Elzawahry</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Hama</surname><given-names>N</given-names></name><name><surname>Hosoda</surname><given-names>F</given-names></name><name><surname>Urushidate</surname><given-names>T</given-names></name><name><surname>Ohashi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genomic spectra of biliary tract cancer</article-title><source>Nat Genet</source><year>2015</year><volume>47</volume><fpage>1003</fpage><lpage>1010</lpage><pub-id pub-id-type="pmid">26258846</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>HN</given-names></name><name><surname>Lee</surname><given-names>KT</given-names></name><name><surname>Lee</surname><given-names>JK</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Paik</surname><given-names>SW</given-names></name><name><surname>Rhee</surname><given-names>JC</given-names></name><name><surname>Lowe</surname><given-names>AW</given-names></name></person-group><article-title>Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis</article-title><source>Tumour Biol</source><year>2008</year><volume>29</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">18497548</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansel</surname><given-names>DE</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Hidalgo</surname><given-names>M</given-names></name><name><surname>Thuluvath</surname><given-names>PJ</given-names></name><name><surname>Lillemoe</surname><given-names>KD</given-names></name><name><surname>Schulick</surname><given-names>R</given-names></name><name><surname>Ku</surname><given-names>JL</given-names></name><name><surname>Park</surname><given-names>JG</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name><name><surname>Ashfaq</surname><given-names>R</given-names></name><etal/></person-group><article-title>Identification of novel cellular targets in biliary tract cancers using global gene expression technology</article-title><source>Am J Pathol</source><year>2003</year><volume>163</volume><fpage>217</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">12819026</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakawa</surname><given-names>K</given-names></name><name><surname>Tada</surname><given-names>M</given-names></name><name><surname>Takada</surname><given-names>M</given-names></name><name><surname>Tamoto</surname><given-names>E</given-names></name><name><surname>Shindoh</surname><given-names>G</given-names></name><name><surname>Teramoto</surname><given-names>K</given-names></name><name><surname>Matsunaga</surname><given-names>A</given-names></name><name><surname>Komuro</surname><given-names>K</given-names></name><name><surname>Kanai</surname><given-names>M</given-names></name><name><surname>Kawakami</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data</article-title><source>J Surg Res</source><year>2004</year><volume>122</volume><fpage>184</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">15555617</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Washiro</surname><given-names>M</given-names></name><name><surname>Ohtsuka</surname><given-names>M</given-names></name><name><surname>Kimura</surname><given-names>F</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Yoshidome</surname><given-names>H</given-names></name><name><surname>Sugimoto</surname><given-names>T</given-names></name><name><surname>Seki</surname><given-names>N</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name></person-group><article-title>Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target</article-title><source>J Cancer Res Clin Oncol</source><year>2008</year><volume>134</volume><fpage>793</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">18204862</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>G</given-names></name><name><surname>Socci</surname><given-names>ND</given-names></name><name><surname>Dhall</surname><given-names>D</given-names></name><name><surname>D&#x02019;Angelica</surname><given-names>M</given-names></name><name><surname>DeMatteo</surname><given-names>RP</given-names></name><name><surname>Allen</surname><given-names>PJ</given-names></name><name><surname>Singh</surname><given-names>B</given-names></name><name><surname>Fong</surname><given-names>Y</given-names></name><name><surname>Blumgart</surname><given-names>LH</given-names></name><name><surname>Klimstra</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract</article-title><source>J Exp Clin Cancer Res</source><year>2009</year><volume>28</volume><fpage>62</fpage><pub-id pub-id-type="pmid">19435499</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Chaturvedi</surname><given-names>A</given-names></name><name><surname>Goel</surname><given-names>MM</given-names></name><name><surname>Mehrotra</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>ID</given-names></name><name><surname>Srivastava</surname><given-names>AN</given-names></name><name><surname>Misra</surname><given-names>NC</given-names></name></person-group><article-title>Overexpression of p53 protein in gallbladder carcinoma in North India</article-title><source>Eur J Surg Oncol</source><year>2000</year><volume>26</volume><fpage>164</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">10744937</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaube</surname><given-names>A</given-names></name><name><surname>Tewari</surname><given-names>M</given-names></name><name><surname>Garbyal</surname><given-names>RS</given-names></name><name><surname>Singh</surname><given-names>U</given-names></name><name><surname>Shukla</surname><given-names>HS</given-names></name></person-group><article-title>Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582</article-title><source>BMC Cancer</source><year>2006</year><volume>6</volume><fpage>126</fpage><pub-id pub-id-type="pmid">16686942</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legan</surname><given-names>M</given-names></name><name><surname>Luzar</surname><given-names>B</given-names></name><name><surname>Ferlan-Marolt</surname><given-names>V</given-names></name><name><surname>C&#x000f6;r</surname><given-names>A</given-names></name></person-group><article-title>Cyclooxygenase-2 expression determines neo-angiogenesis in gallbladder carcinomas</article-title><source>Bosn J Basic Med Sci</source><year>2006</year><volume>6</volume><fpage>58</fpage><lpage>63</lpage></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SN</given-names></name><name><surname>Chung</surname><given-names>SC</given-names></name><name><surname>Tsai</surname><given-names>KB</given-names></name><name><surname>Chai</surname><given-names>CY</given-names></name><name><surname>Chang</surname><given-names>WT</given-names></name><name><surname>Kuo</surname><given-names>KK</given-names></name><name><surname>Chen</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>KT</given-names></name></person-group><article-title>Aberrant p53 expression and the development of gallbladder carcinoma and adenoma</article-title><source>Kaohsiung J Med Sci</source><year>2006</year><volume>22</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">16568721</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>M</given-names></name><name><surname>Sakhuja</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Agarwal</surname><given-names>AK</given-names></name></person-group><article-title>p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer</article-title><source>Saudi J Gastroenterol</source><year>2013</year><volume>19</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">23319036</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>HJ</given-names></name><name><surname>Yun</surname><given-names>SS</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name></person-group><article-title>Expression of p16 protein in gallbladder carcinoma and its precancerous conditions</article-title><source>Hepatogastroenterology</source><year>2010</year><volume>57</volume><fpage>18</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">20422865</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koda</surname><given-names>M</given-names></name><name><surname>Yashima</surname><given-names>K</given-names></name><name><surname>Kawaguchi</surname><given-names>K</given-names></name><name><surname>Andachi</surname><given-names>H</given-names></name><name><surname>Hosoda</surname><given-names>A</given-names></name><name><surname>Shiota</surname><given-names>G</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Murawaki</surname><given-names>Y</given-names></name></person-group><article-title>Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma</article-title><source>Cancer Lett</source><year>2003</year><volume>199</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">12969785</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wistuba</surname><given-names>II</given-names></name><name><surname>Ashfaq</surname><given-names>R</given-names></name><name><surname>Maitra</surname><given-names>A</given-names></name><name><surname>Alvarez</surname><given-names>H</given-names></name><name><surname>Riquelme</surname><given-names>E</given-names></name><name><surname>Gazdar</surname><given-names>AF</given-names></name></person-group><article-title>Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma</article-title><source>Am J Pathol</source><year>2002</year><volume>160</volume><fpage>2073</fpage><lpage>2079</lpage><pub-id pub-id-type="pmid">12057912</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Takano</surname><given-names>Y</given-names></name><name><surname>Kakita</surname><given-names>A</given-names></name><name><surname>Okudaira</surname><given-names>M</given-names></name></person-group><article-title>An immunohistochemical and molecular biological study of c-erbB-2 amplification and prognostic relevance in gallbladder cancer</article-title><source>Pathol Res Pract</source><year>1993</year><volume>189</volume><fpage>283</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">8101375</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>NH</given-names></name><name><surname>Huang</surname><given-names>SM</given-names></name><name><surname>Chan</surname><given-names>SH</given-names></name><name><surname>Mo</surname><given-names>LR</given-names></name><name><surname>Hwang</surname><given-names>MH</given-names></name><name><surname>Su</surname><given-names>WC</given-names></name></person-group><article-title>Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract</article-title><source>Anticancer Res</source><year>1995</year><volume>15</volume><fpage>1055</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">7645925</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>YZ</given-names></name><name><surname>Hui</surname><given-names>AM</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Takayama</surname><given-names>T</given-names></name><name><surname>Makuuchi</surname><given-names>M</given-names></name></person-group><article-title>Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas</article-title><source>Clin Cancer Res</source><year>2000</year><volume>6</volume><fpage>4096</fpage><lpage>4100</lpage><pub-id pub-id-type="pmid">11051262</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Hui</surname><given-names>AM</given-names></name><name><surname>Shi</surname><given-names>YZ</given-names></name><name><surname>Takayama</surname><given-names>T</given-names></name><name><surname>Makuuchi</surname><given-names>M</given-names></name></person-group><article-title>Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder</article-title><source>Hum Pathol</source><year>2001</year><volume>32</volume><fpage>771</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">11521218</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eguchi</surname><given-names>N</given-names></name><name><surname>Fujii</surname><given-names>K</given-names></name><name><surname>Tsuchida</surname><given-names>A</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Kajiyama</surname><given-names>G</given-names></name></person-group><article-title>Cyclin E overexpression in human gallbladder carcinomas</article-title><source>Oncol Rep</source><year>1999</year><volume>6</volume><fpage>93</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">9864408</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>AM</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>YZ</given-names></name><name><surname>Takayama</surname><given-names>T</given-names></name><name><surname>Torzilli</surname><given-names>G</given-names></name><name><surname>Makuuchi</surname><given-names>M</given-names></name></person-group><article-title>Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma</article-title><source>Clin Cancer Res</source><year>2000</year><volume>6</volume><fpage>4272</fpage><lpage>4277</lpage><pub-id pub-id-type="pmid">11106243</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Shoda</surname><given-names>J</given-names></name><name><surname>Ueda</surname><given-names>T</given-names></name><name><surname>Kawamoto</surname><given-names>T</given-names></name><name><surname>Todoroki</surname><given-names>T</given-names></name><name><surname>Shimonishi</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>T</given-names></name><name><surname>Sugimoto</surname><given-names>Y</given-names></name><name><surname>Ichikawa</surname><given-names>A</given-names></name><name><surname>Mutoh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression</article-title><source>Clin Cancer Res</source><year>2002</year><volume>8</volume><fpage>1157</fpage><lpage>1167</lpage><pub-id pub-id-type="pmid">11948128</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>T</given-names></name><name><surname>Shoda</surname><given-names>J</given-names></name><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Ueda</surname><given-names>T</given-names></name><name><surname>Furukawa</surname><given-names>M</given-names></name><name><surname>Koike</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>N</given-names></name><name><surname>Todoroki</surname><given-names>T</given-names></name><name><surname>Miwa</surname><given-names>M</given-names></name></person-group><article-title>Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder</article-title><source>Int J Cancer</source><year>2002</year><volume>98</volume><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">11920595</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasatomi</surname><given-names>E</given-names></name><name><surname>Tokunaga</surname><given-names>O</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name></person-group><article-title>Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene</article-title><source>Cancer</source><year>1996</year><volume>78</volume><fpage>2101</fpage><lpage>2110</lpage><pub-id pub-id-type="pmid">8918403</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Shuto</surname><given-names>T</given-names></name><name><surname>Takemura</surname><given-names>S</given-names></name><name><surname>Hai</surname><given-names>S</given-names></name><name><surname>Sakabe</surname><given-names>K</given-names></name><name><surname>Uenishi</surname><given-names>T</given-names></name><name><surname>Hirohashi</surname><given-names>K</given-names></name><name><surname>Kubo</surname><given-names>S</given-names></name></person-group><article-title>Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer</article-title><source>J Hepatobiliary Pancreat Surg</source><year>2006</year><volume>13</volume><fpage>228</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">16708300</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Zang</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>N</given-names></name><name><surname>Dong</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Du</surname><given-names>X</given-names></name></person-group><article-title>Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma</article-title><source>Diagn Pathol</source><year>2012</year><volume>7</volume><fpage>41</fpage><pub-id pub-id-type="pmid">22510499</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>DG</given-names></name><name><surname>Bae</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Liang</surname><given-names>ZL</given-names></name><name><surname>Huang</surname><given-names>SM</given-names></name><name><surname>Suk Oh</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Jo</surname><given-names>DY</given-names></name><etal/></person-group><article-title>Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor</article-title><source>Clin Cancer Res</source><year>2012</year><volume>18</volume><fpage>3270</fpage><lpage>3280</lpage><pub-id pub-id-type="pmid">22553346</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>High expression of CXCR4 and CXCR7 predicts poor survival in gallbladder cancer</article-title><source>J Int Med Res</source><year>2011</year><volume>39</volume><fpage>1253</fpage><lpage>1264</lpage><pub-id pub-id-type="pmid">21986127</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Dong</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zang</surname><given-names>L</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><etal/></person-group><article-title>Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma</article-title><source>Surg Today</source><year>2012</year><volume>42</volume><fpage>770</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">22407314</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>YL</given-names></name><name><surname>Xuan</surname><given-names>YH</given-names></name><name><surname>Shin</surname><given-names>YK</given-names></name><name><surname>Chae</surname><given-names>SW</given-names></name><name><surname>Kook</surname><given-names>MC</given-names></name><name><surname>Sung</surname><given-names>RH</given-names></name><name><surname>Youn</surname><given-names>SJ</given-names></name><name><surname>Choi</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name></person-group><article-title>An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions</article-title><source>J Histochem Cytochem</source><year>2004</year><volume>52</volume><fpage>591</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">15100237</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Lei</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Gu</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma</article-title><source>J Biomed Biotechnol</source><year>2012</year><volume>2012</volume><fpage>587672</fpage><pub-id pub-id-type="pmid">22547928</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Q</given-names></name><name><surname>Xiong</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Lv</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name></person-group><article-title>Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder</article-title><source>World J Surg Oncol</source><year>2012</year><volume>10</volume><fpage>92</fpage><pub-id pub-id-type="pmid">22613496</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Tewari</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>TB</given-names></name><name><surname>Shukla</surname><given-names>HS</given-names></name></person-group><article-title>Expression profile of cholecystokinin type-A receptor in gallbladder cancer and gallstone disease</article-title><source>Hepatobiliary Pancreat Dis Int</source><year>2011</year><volume>10</volume><fpage>408</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">21813391</pub-id></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>XN</given-names></name><name><surname>Cao</surname><given-names>WG</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Gu</surname><given-names>BX</given-names></name><name><surname>Yang</surname><given-names>QC</given-names></name><name><surname>Hu</surname><given-names>JB</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name></person-group><article-title>Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma</article-title><source>Tumour Biol</source><year>2011</year><volume>32</volume><fpage>1183</fpage><lpage>1190</lpage><pub-id pub-id-type="pmid">21853312</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name><name><surname>She</surname><given-names>FF</given-names></name><name><surname>Tang</surname><given-names>NH</given-names></name><name><surname>Li</surname><given-names>XJ</given-names></name><name><surname>Wang</surname><given-names>XX</given-names></name></person-group><article-title>[Expressions of VEGF-C and VEGF-D and their correlation with lymphangiogenesis and angiogenesis in gallbladder carcinoma]</article-title><source>Zhonghua Zhong Liu Za Zhi</source><year>2010</year><volume>32</volume><fpage>190</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">20450586</pub-id></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurya</surname><given-names>SK</given-names></name><name><surname>Tewari</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Thakur</surname><given-names>MK</given-names></name><name><surname>Shukla</surname><given-names>HS</given-names></name></person-group><article-title>Expression pattern of tumor endothelial marker 8 protein in gallbladder carcinomas</article-title><source>Asian Pac J Cancer Prev</source><year>2011</year><volume>12</volume><fpage>507</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">21545221</pub-id></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Jo</surname><given-names>YS</given-names></name><name><surname>Huang</surname><given-names>SM</given-names></name><name><surname>Liang</surname><given-names>ZL</given-names></name><name><surname>Min</surname><given-names>JK</given-names></name><name><surname>Hong</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name></person-group><article-title>L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma</article-title><source>Hum Pathol</source><year>2011</year><volume>42</volume><fpage>1476</fpage><lpage>1483</lpage><pub-id pub-id-type="pmid">21496863</pub-id></element-citation></ref><ref id="B132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>YY</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Weng</surname><given-names>MZ</given-names></name><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Quan</surname><given-names>ZW</given-names></name></person-group><article-title>[The role of tissue factor pathway inhibitor-2 gene in gallbladder cancer]</article-title><source>Zhonghua Wai Ke Za Zhi</source><year>2012</year><volume>50</volume><fpage>1099</fpage><lpage>1103</lpage><pub-id pub-id-type="pmid">23336488</pub-id></element-citation></ref><ref id="B133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Xiong</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name></person-group><article-title>Expression of VHL and HIF-1&#x003b1; and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder</article-title><source>Appl Immunohistochem Mol Morphol</source><year>2011</year><volume>19</volume><fpage>534</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">21415706</pub-id></element-citation></ref><ref id="B134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa</surname><given-names>I</given-names></name><name><surname>de Aretxabala</surname><given-names>X</given-names></name><name><surname>Lantadilla</surname><given-names>S</given-names></name><name><surname>Munoz</surname><given-names>S</given-names></name></person-group><article-title>ERCC1 (excision repair cross-complementing 1) expression in pT2 gallbladder cancer is a prognostic factor</article-title><source>Histol Histopathol</source><year>2011</year><volume>26</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">21117025</pub-id></element-citation></ref><ref id="B135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival</article-title><source>J Surg Res</source><year>2010</year><volume>164</volume><fpage>e99</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">20828733</pub-id></element-citation></ref><ref id="B136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artico</surname><given-names>M</given-names></name><name><surname>Bronzetti</surname><given-names>E</given-names></name><name><surname>Alicino</surname><given-names>V</given-names></name><name><surname>Ionta</surname><given-names>B</given-names></name><name><surname>Bosco</surname><given-names>S</given-names></name><name><surname>Grande</surname><given-names>C</given-names></name><name><surname>Bruno</surname><given-names>M</given-names></name><name><surname>Tranquilli Leali</surname><given-names>FM</given-names></name><name><surname>Ionta</surname><given-names>G</given-names></name><name><surname>Fumagalli</surname><given-names>L</given-names></name></person-group><article-title>Human gallbladder carcinoma: Role of neurotrophins, MIB-1, CD34 and CA15-3</article-title><source>Eur J Histochem</source><year>2010</year><volume>54</volume><fpage>e10</fpage><pub-id pub-id-type="pmid">20353905</pub-id></element-citation></ref><ref id="B137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Liao</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name></person-group><article-title>ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients</article-title><source>Med Oncol</source><year>2011</year><volume>28</volume><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">20300969</pub-id></element-citation></ref><ref id="B138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wani</surname><given-names>Y</given-names></name><name><surname>Notohara</surname><given-names>K</given-names></name><name><surname>Fujisawa</surname><given-names>M</given-names></name></person-group><article-title>Aberrant expression of an &#x0201c;intestinal marker&#x0201d; Cdx2 in pyloric gland adenoma of the gallbladder</article-title><source>Virchows Arch</source><year>2008</year><volume>453</volume><fpage>521</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">18843504</pub-id></element-citation></ref><ref id="B139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huan</surname><given-names>P</given-names></name><name><surname>Maosheng</surname><given-names>T</given-names></name><name><surname>Zhiqian</surname><given-names>H</given-names></name><name><surname>Long</surname><given-names>C</given-names></name><name><surname>Xiaojun</surname><given-names>Y</given-names></name></person-group><article-title>TLR4 expression in normal gallbladder, chronic cholecystitis and gallbladder carcinoma</article-title><source>Hepatogastroenterology</source><year>2012</year><volume>59</volume><fpage>42</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">22251522</pub-id></element-citation></ref><ref id="B140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>GS</given-names></name><name><surname>Yang</surname><given-names>ZL</given-names></name><name><surname>Liu</surname><given-names>DC</given-names></name></person-group><article-title>Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances</article-title><source>Pathol Res Pract</source><year>2012</year><volume>208</volume><fpage>392</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">22658478</pub-id></element-citation></ref><ref id="B141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>JW</given-names></name><name><surname>Ren</surname><given-names>TR</given-names></name><name><surname>Zhu</surname><given-names>YF</given-names></name><name><surname>Han</surname><given-names>YJ</given-names></name><name><surname>K&#x000fc;hnel</surname><given-names>W</given-names></name></person-group><article-title>Correlated expression of inducible nitric oxide synthase and P53, Bax in benign and malignant diseased gallbladder</article-title><source>Ann Anat</source><year>2003</year><volume>185</volume><fpage>549</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">14704000</pub-id></element-citation></ref><ref id="B142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Hiraoka</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Woo</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>WJ</given-names></name><name><surname>Choi</surname><given-names>IJ</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Yanagihara</surname><given-names>K</given-names></name><name><surname>Kanai</surname><given-names>Y</given-names></name><name><surname>Ohnami</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis</article-title><source>Genes Chromosomes Cancer</source><year>2012</year><volume>51</volume><fpage>30</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">21936014</pub-id></element-citation></ref><ref id="B143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name></person-group><article-title>PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma</article-title><source>Biomed Res Int</source><year>2013</year><volume>2013</volume><fpage>648420</fpage><pub-id pub-id-type="pmid">23984394</pub-id></element-citation></ref><ref id="B144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>VK</given-names></name><name><surname>Chauhan</surname><given-names>VS</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name></person-group><article-title>Telomerase activation--one step on the road to carcinoma of the gall bladder</article-title><source>Anticancer Res</source><year>2006</year><volume>26</volume><fpage>4761</fpage><lpage>4766</lpage><pub-id pub-id-type="pmid">17214337</pub-id></element-citation></ref><ref id="B145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname><given-names>S</given-names></name><name><surname>Shimada</surname><given-names>Y</given-names></name><name><surname>Nagata</surname><given-names>T</given-names></name><name><surname>Moriyama</surname><given-names>M</given-names></name><name><surname>Omura</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Hori</surname><given-names>R</given-names></name><name><surname>Yoshioka</surname><given-names>I</given-names></name><name><surname>Okumura</surname><given-names>T</given-names></name><name><surname>Sawada</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prognostic significance of aquaporins in human biliary tract carcinoma</article-title><source>Oncol Rep</source><year>2012</year><volume>27</volume><fpage>1741</fpage><lpage>1747</lpage><pub-id pub-id-type="pmid">22470085</pub-id></element-citation></ref><ref id="B146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name></person-group><article-title>Ornithine decarboxylase and glutamate decarboxylase 65 as prognostic markers of gallbladder malignancy: a clinicopathological study in benign and malignant lesions of the gallbladder</article-title><source>Mol Med Rep</source><year>2013</year><volume>7</volume><fpage>413</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">23152127</pub-id></element-citation></ref><ref id="B147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>LC</given-names></name><name><surname>Chen</surname><given-names>LT</given-names></name><name><surname>Tsai</surname><given-names>YJ</given-names></name><name><surname>Lin</surname><given-names>CM</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Tian</surname><given-names>YF</given-names></name><name><surname>Sheu</surname><given-names>MJ</given-names></name><name><surname>Uen</surname><given-names>YH</given-names></name><name><surname>Shiue</surname><given-names>YL</given-names></name><name><surname>Wang</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator</article-title><source>J Clin Pathol</source><year>2012</year><volume>65</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">22267983</pub-id></element-citation></ref><ref id="B148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>S</given-names></name><name><surname>Onishi</surname><given-names>H</given-names></name><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Nagamatsu</surname><given-names>I</given-names></name><name><surname>Imaizumi</surname><given-names>A</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name><name><surname>Oda</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Katano</surname><given-names>M</given-names></name></person-group><article-title>Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer</article-title><source>Cancer Sci</source><year>2014</year><volume>105</volume><fpage>272</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">24438533</pub-id></element-citation></ref><ref id="B149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Kan</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>N</given-names></name><name><surname>Yi</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name></person-group><article-title>TGF-&#x003b2; upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1</article-title><source>Mol Biosyst</source><year>2014</year><volume>10</volume><fpage>679</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">24445397</pub-id></element-citation></ref><ref id="B150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>WX</given-names></name><name><surname>Lin</surname><given-names>QF</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>SP</given-names></name><name><surname>Mao</surname><given-names>WD</given-names></name><name><surname>Ma</surname><given-names>G</given-names></name><name><surname>Qi</surname><given-names>WD</given-names></name></person-group><article-title>Clinicopathological significance of SLP-2 overexpression in human gallbladder cancer</article-title><source>Tumour Biol</source><year>2014</year><volume>35</volume><fpage>419</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">23918306</pub-id></element-citation></ref><ref id="B151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Zinc finger X-chromosomal protein (ZFX) is a significant prognostic indicator and promotes cellular malignant potential in gallbladder cancer</article-title><source>Cancer Biol Ther</source><year>2015</year><volume>16</volume><fpage>1462</fpage><lpage>1470</lpage><pub-id pub-id-type="pmid">26230915</pub-id></element-citation></ref><ref id="B152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Weng</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Bao</surname><given-names>R</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Mu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Regulation of cell proliferation and migration in gallbladder cancer by zinc finger X-chromosomal protein</article-title><source>Gene</source><year>2013</year><volume>528</volume><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">23860324</pub-id></element-citation></ref><ref id="B153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>NC</given-names></name><name><surname>Chae</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Park</surname><given-names>WS</given-names></name><name><surname>Park</surname><given-names>YK</given-names></name><name><surname>Kim</surname><given-names>YW</given-names></name></person-group><article-title>Expression of multidrug resistance-associated protein 2 in human gallbladder carcinoma</article-title><source>Biomed Res Int</source><year>2013</year><volume>2013</volume><fpage>527534</fpage><pub-id pub-id-type="pmid">23841074</pub-id></element-citation></ref><ref id="B154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>DP</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Tian</surname><given-names>YF</given-names></name><name><surname>Chen</surname><given-names>LT</given-names></name><name><surname>Lin</surname><given-names>LC</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Hsing</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>HH</given-names></name><name><surname>Shiue</surname><given-names>YL</given-names></name><name><surname>Huang</surname><given-names>HY</given-names></name><etal/></person-group><article-title>Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression</article-title><source>Tumour Biol</source><year>2013</year><volume>34</volume><fpage>3059</fpage><lpage>3069</lpage><pub-id pub-id-type="pmid">23722602</pub-id></element-citation></ref><ref id="B155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kono</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Ohtsuka</surname><given-names>T</given-names></name><name><surname>Nagayoshi</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Takahata</surname><given-names>S</given-names></name><name><surname>Aishima</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name></person-group><article-title>High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma</article-title><source>Oncol Rep</source><year>2013</year><volume>30</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">23660842</pub-id></element-citation></ref><ref id="B156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>XD</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>QC</given-names></name><name><surname>Qu</surname><given-names>Q</given-names></name><name><surname>Rui</surname><given-names>JA</given-names></name><name><surname>Zhao</surname><given-names>YP</given-names></name></person-group><article-title>Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma</article-title><source>Eur J Cancer</source><year>2007</year><volume>43</volume><fpage>809</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">17276673</pub-id></element-citation></ref><ref id="B157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsheyab</surname><given-names>FM</given-names></name><name><surname>Ziadeh</surname><given-names>MT</given-names></name><name><surname>Bani-Hani</surname><given-names>KE</given-names></name></person-group><article-title>Expression of p21 and p27 in gallbladder cancer</article-title><source>Saudi Med J</source><year>2007</year><volume>28</volume><fpage>683</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">17457432</pub-id></element-citation></ref><ref id="B158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwahashi</surname><given-names>S</given-names></name><name><surname>Shimada</surname><given-names>M</given-names></name><name><surname>Utsunomiya</surname><given-names>T</given-names></name><name><surname>Morine</surname><given-names>Y</given-names></name><name><surname>Imura</surname><given-names>S</given-names></name><name><surname>Ikemoto</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Hanaoka</surname><given-names>J</given-names></name></person-group><article-title>Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in gallbladder carcinoma</article-title><source>Surg Today</source><year>2012</year><volume>42</volume><fpage>565</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">22270332</pub-id></element-citation></ref><ref id="B159"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>ZL</given-names></name><name><surname>Liu</surname><given-names>JQ</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Miao</surname><given-names>XY</given-names></name></person-group><article-title>Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma</article-title><source>Tumour Biol</source><year>2012</year><volume>33</volume><fpage>173</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">22076922</pub-id></element-citation></ref><ref id="B160"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>YZ</given-names></name><name><surname>Xi</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>XS</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>JT</given-names></name></person-group><article-title>Astrocyte elevated gene-1 overexpression in human primary gallbladder carcinomas: an unfavorable and independent prognostic factor</article-title><source>Oncol Rep</source><year>2011</year><volume>26</volume><fpage>1133</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">21750868</pub-id></element-citation></ref><ref id="B161"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Weng</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Mu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer</article-title><source>Tumour Biol</source><year>2013</year><volume>34</volume><fpage>3995</fpage><lpage>4000</lpage><pub-id pub-id-type="pmid">23857283</pub-id></element-citation></ref><ref id="B162"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leal</surname><given-names>P</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>P</given-names></name><name><surname>Sandoval</surname><given-names>A</given-names></name><name><surname>Letelier</surname><given-names>P</given-names></name><name><surname>Brebi</surname><given-names>P</given-names></name><name><surname>Ili</surname><given-names>C</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>H</given-names></name><name><surname>Tapia</surname><given-names>O</given-names></name><name><surname>Roa</surname><given-names>JC</given-names></name></person-group><article-title>Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma</article-title><source>Arch Pathol Lab Med</source><year>2013</year><volume>137</volume><fpage>552</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">23544944</pub-id></element-citation></ref><ref id="B163"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deblakshmi</surname><given-names>RK</given-names></name><name><surname>Deka</surname><given-names>M</given-names></name><name><surname>Saikia</surname><given-names>AK</given-names></name><name><surname>Sharma</surname><given-names>BK</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Das</surname><given-names>NN</given-names></name><name><surname>Bose</surname><given-names>S</given-names></name></person-group><article-title>Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma</article-title><source>Asian Pac J Cancer Prev</source><year>2015</year><volume>16</volume><fpage>2923</fpage><lpage>2928</lpage><pub-id pub-id-type="pmid">25854384</pub-id></element-citation></ref><ref id="B164"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer</article-title><source>Medicine (Baltimore)</source><year>2015</year><volume>94</volume><fpage>e2244</fpage><pub-id pub-id-type="pmid">26656369</pub-id></element-citation></ref><ref id="B165"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>ZL</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zou</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>G</given-names></name><etal/></person-group><article-title>The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance</article-title><source>Pathol Oncol Res</source><year>2016</year><volume>22</volume><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">26634853</pub-id></element-citation></ref><ref id="B166"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faridi</surname><given-names>MS</given-names></name><name><surname>Jaiswal</surname><given-names>MS</given-names></name><name><surname>Goel</surname><given-names>SK</given-names></name></person-group><article-title>Expression of CCK Receptors in Carcinoma Gallbladder and Cholelithiasis: A Pilot Study</article-title><source>J Clin Diagn Res</source><year>2015</year><volume>9</volume><fpage>PC04</fpage><lpage>PC07</lpage></element-citation></ref><ref id="B167"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lian</surname><given-names>S</given-names></name><name><surname>Shao</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name></person-group><article-title>PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>29076</fpage><lpage>29086</lpage><pub-id pub-id-type="pmid">26318166</pub-id></element-citation></ref><ref id="B168"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Weng</surname><given-names>M</given-names></name><name><surname>Quan</surname><given-names>Z</given-names></name></person-group><article-title>MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0126499</fpage><pub-id pub-id-type="pmid">25962180</pub-id></element-citation></ref><ref id="B169"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name></person-group><article-title>Expression of heat-shock protein gp96 in gallbladder cancer and its prognostic clinical significance</article-title><source>Int J Clin Exp Pathol</source><year>2015</year><volume>8</volume><fpage>1946</fpage><lpage>1953</lpage><pub-id pub-id-type="pmid">25973087</pub-id></element-citation></ref><ref id="B170"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>MZ</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Weng</surname><given-names>MZ</given-names></name><name><surname>Zhang</surname><given-names>MD</given-names></name><name><surname>Qin</surname><given-names>YY</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>WJ</given-names></name><name><surname>Quan</surname><given-names>ZW</given-names></name></person-group><article-title>Long non-coding RNA-LET is a positive prognostic factor and exhibits tumor-suppressive activity in gallbladder cancer</article-title><source>Mol Carcinog</source><year>2015</year><volume>54</volume><fpage>1397</fpage><lpage>1406</lpage><pub-id pub-id-type="pmid">25213660</pub-id></element-citation></ref><ref id="B171"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nigam</surname><given-names>J</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>Kazmi</surname><given-names>HR</given-names></name><name><surname>Parmar</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name></person-group><article-title>Prognostic significance of survivin in resected gallbladder cancer</article-title><source>J Surg Res</source><year>2015</year><volume>194</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">25472573</pub-id></element-citation></ref><ref id="B172"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>MZ</given-names></name><name><surname>Chu</surname><given-names>BF</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Weng</surname><given-names>MZ</given-names></name><name><surname>Qin</surname><given-names>YY</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Quan</surname><given-names>ZW</given-names></name></person-group><article-title>Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>e1583</fpage><pub-id pub-id-type="pmid">25569100</pub-id></element-citation></ref><ref id="B173"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>SP</given-names></name><name><surname>Zhang</surname><given-names>SB</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Hao</surname><given-names>YQ</given-names></name><name><surname>Liao</surname><given-names>MM</given-names></name><name><surname>Zhang</surname><given-names>YD</given-names></name><name><surname>Li</surname><given-names>ZH</given-names></name></person-group><article-title>NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma</article-title><source>Med Oncol</source><year>2012</year><volume>29</volume><fpage>1879</fpage><lpage>1885</lpage><pub-id pub-id-type="pmid">22135002</pub-id></element-citation></ref><ref id="B174"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Weng</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>F</given-names></name><name><surname>Quan</surname><given-names>Z</given-names></name></person-group><article-title>Expression of interleukin-6 is associated with epithelial-mesenchymal transition and survival rates in gallbladder cancer</article-title><source>Mol Med Rep</source><year>2015</year><volume>11</volume><fpage>3539</fpage><lpage>3546</lpage><pub-id pub-id-type="pmid">25573292</pub-id></element-citation></ref><ref id="B175"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>PI</given-names></name><name><surname>Li</surname><given-names>CF</given-names></name><name><surname>Chen</surname><given-names>LT</given-names></name><name><surname>Sun</surname><given-names>DP</given-names></name><name><surname>Chen</surname><given-names>TJ</given-names></name><name><surname>Hsing</surname><given-names>CH</given-names></name><name><surname>Hsu</surname><given-names>HP</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name></person-group><article-title>BCL6 overexpression is associated with decreased p19 ARF expression and confers an independent prognosticator in gallbladder carcinoma</article-title><source>Tumour Biol</source><year>2014</year><volume>35</volume><fpage>1417</fpage><lpage>1426</lpage><pub-id pub-id-type="pmid">24114011</pub-id></element-citation></ref><ref id="B176"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letelier</surname><given-names>P</given-names></name><name><surname>Garcia</surname><given-names>P</given-names></name><name><surname>Leal</surname><given-names>P</given-names></name><name><surname>Ili</surname><given-names>C</given-names></name><name><surname>Buchegger</surname><given-names>K</given-names></name><name><surname>Riquelme</surname><given-names>I</given-names></name><name><surname>Sandoval</surname><given-names>A</given-names></name><name><surname>Tapia</surname><given-names>O</given-names></name><name><surname>Roa</surname><given-names>JC</given-names></name></person-group><article-title>Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma</article-title><source>Appl Immunohistochem Mol Morphol</source><year>2014</year><volume>22</volume><fpage>530</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">24185122</pub-id></element-citation></ref><ref id="B177"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>XS</given-names></name><name><surname>Wang</surname><given-names>XA</given-names></name><name><surname>Wu</surname><given-names>WG</given-names></name><name><surname>Hu</surname><given-names>YP</given-names></name><name><surname>Li</surname><given-names>ML</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Weng</surname><given-names>H</given-names></name><name><surname>Shu</surname><given-names>YJ</given-names></name><name><surname>Liu</surname><given-names>TY</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><etal/></person-group><article-title>MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway</article-title><source>Cancer Biol Ther</source><year>2014</year><volume>15</volume><fpage>806</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">24658096</pub-id></element-citation></ref><ref id="B178"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>HJ</given-names></name><name><surname>Yoo</surname><given-names>BC</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>BL</given-names></name><name><surname>Kim</surname><given-names>WH</given-names></name></person-group><article-title>Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas</article-title><source>Pathol Oncol Res</source><year>2007</year><volume>13</volume><fpage>326</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">18158568</pub-id></element-citation></ref><ref id="B179"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DC</given-names></name><name><surname>Yang</surname><given-names>ZL</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name></person-group><article-title>Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma</article-title><source>Pathol Oncol Res</source><year>2011</year><volume>17</volume><fpage>859</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">21455631</pub-id></element-citation></ref><ref id="B180"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalekou</surname><given-names>H</given-names></name><name><surname>Miliaras</surname><given-names>D</given-names></name></person-group><article-title>Cytokeratin 7 and 20 expression in gallbladder carcinoma</article-title><source>Pol J Pathol</source><year>2011</year><volume>62</volume><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">21574103</pub-id></element-citation></ref><ref id="B181"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wistuba</surname><given-names>II</given-names></name><name><surname>Maitra</surname><given-names>A</given-names></name><name><surname>Carrasco</surname><given-names>R</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Troncoso</surname><given-names>P</given-names></name><name><surname>Minna</surname><given-names>JD</given-names></name><name><surname>Gazdar</surname><given-names>AF</given-names></name></person-group><article-title>High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma</article-title><source>Br J Cancer</source><year>2002</year><volume>87</volume><fpage>432</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">12177780</pub-id></element-citation></ref><ref id="B182"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholes</surname><given-names>AG</given-names></name><name><surname>Liloglou</surname><given-names>T</given-names></name><name><surname>Maloney</surname><given-names>P</given-names></name><name><surname>Hagan</surname><given-names>S</given-names></name><name><surname>Nunn</surname><given-names>J</given-names></name><name><surname>Hiscott</surname><given-names>P</given-names></name><name><surname>Damato</surname><given-names>BE</given-names></name><name><surname>Grierson</surname><given-names>I</given-names></name><name><surname>Field</surname><given-names>JK</given-names></name></person-group><article-title>Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><fpage>2472</fpage><lpage>2477</lpage><pub-id pub-id-type="pmid">11581185</pub-id></element-citation></ref><ref id="B183"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>WJ</given-names></name><name><surname>Cho</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Park</surname><given-names>GS</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>BK</given-names></name><name><surname>Park</surname><given-names>WS</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kang</surname><given-names>CS</given-names></name></person-group><article-title>Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx</article-title><source>J Korean Med Sci</source><year>2004</year><volume>19</volume><fpage>345</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">15201498</pub-id></element-citation></ref><ref id="B184"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldin</surname><given-names>RD</given-names></name><name><surname>Roa</surname><given-names>JC</given-names></name></person-group><article-title>Gallbladder cancer: a morphological and molecular update</article-title><source>Histopathology</source><year>2009</year><volume>55</volume><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">19490172</pub-id></element-citation></ref><ref id="B185"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagisawa</surname><given-names>N</given-names></name><name><surname>Mikami</surname><given-names>T</given-names></name><name><surname>Saegusa</surname><given-names>M</given-names></name><name><surname>Okayasu</surname><given-names>I</given-names></name></person-group><article-title>More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>19</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">11196159</pub-id></element-citation></ref><ref id="B186"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saetta</surname><given-names>A</given-names></name><name><surname>Koilakou</surname><given-names>SV</given-names></name><name><surname>Michalopoulos</surname><given-names>NV</given-names></name><name><surname>Davaris</surname><given-names>PS</given-names></name></person-group><article-title>Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas</article-title><source>Hepatogastroenterology</source><year>2003</year><volume>50</volume><fpage>1799</fpage><lpage>1802</lpage><pub-id pub-id-type="pmid">14696408</pub-id></element-citation></ref><ref id="B187"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagisawa</surname><given-names>N</given-names></name><name><surname>Mikami</surname><given-names>T</given-names></name><name><surname>Yamashita</surname><given-names>K</given-names></name><name><surname>Okayasu</surname><given-names>I</given-names></name></person-group><article-title>Microsatellite instability in chronic cholecystitis is indicative of an early stage in gallbladder carcinogenesis</article-title><source>Am J Clin Pathol</source><year>2003</year><volume>120</volume><fpage>413</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">14502806</pub-id></element-citation></ref><ref id="B188"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa</surname><given-names>JC</given-names></name><name><surname>Roa</surname><given-names>I</given-names></name><name><surname>Correa</surname><given-names>P</given-names></name><name><surname>Vo</surname><given-names>Q</given-names></name><name><surname>Araya</surname><given-names>JC</given-names></name><name><surname>Villaseca</surname><given-names>M</given-names></name><name><surname>Guzm&#x000e1;n</surname><given-names>P</given-names></name><name><surname>Schneider</surname><given-names>BG</given-names></name></person-group><article-title>Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder</article-title><source>J Gastroenterol</source><year>2005</year><volume>40</volume><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">15692793</pub-id></element-citation></ref><ref id="B189"><label>189</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priya</surname><given-names>TP</given-names></name><name><surname>Kapoor</surname><given-names>VK</given-names></name><name><surname>Krishnani</surname><given-names>N</given-names></name><name><surname>Agrawal</surname><given-names>V</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name></person-group><article-title>Role of E-cadherin gene in gall bladder cancer and its precursor lesions</article-title><source>Virchows Arch</source><year>2010</year><volume>456</volume><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">20376482</pub-id></element-citation></ref><ref id="B190"><label>190</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priya</surname><given-names>TP</given-names></name><name><surname>Kapoor</surname><given-names>VK</given-names></name><name><surname>Krishnani</surname><given-names>N</given-names></name><name><surname>Agrawal</surname><given-names>V</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name></person-group><article-title>Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer</article-title><source>Cancer Invest</source><year>2009</year><volume>27</volume><fpage>764</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">19452299</pub-id></element-citation></ref><ref id="B191"><label>191</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Kuroki</surname><given-names>T</given-names></name><name><surname>Kitaoka</surname><given-names>F</given-names></name><name><surname>Tajima</surname><given-names>Y</given-names></name><name><surname>Kanematsu</surname><given-names>T</given-names></name></person-group><article-title>Loss of heterozygosity of chromosome 16q in gallbladder carcinoma</article-title><source>J Surg Res</source><year>2002</year><volume>102</volume><fpage>133</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">11796009</pub-id></element-citation></ref><ref id="B192"><label>192</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>K</given-names></name><name><surname>Mohapatra</surname><given-names>T</given-names></name><name><surname>Das</surname><given-names>P</given-names></name><name><surname>Misra</surname><given-names>MC</given-names></name><name><surname>Gupta</surname><given-names>SD</given-names></name><name><surname>Ghosh</surname><given-names>M</given-names></name><name><surname>Kabra</surname><given-names>M</given-names></name><name><surname>Bansal</surname><given-names>VK</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Sreenivas</surname><given-names>V</given-names></name><etal/></person-group><article-title>Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer</article-title><source>Ann Surg</source><year>2014</year><volume>260</volume><fpage>1073</fpage><lpage>1080</lpage><pub-id pub-id-type="pmid">24827397</pub-id></element-citation></ref><ref id="B193"><label>193</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riquelme</surname><given-names>E</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Baez</surname><given-names>S</given-names></name><name><surname>Diaz</surname><given-names>A</given-names></name><name><surname>Pruyas</surname><given-names>M</given-names></name><name><surname>Wistuba</surname><given-names>II</given-names></name><name><surname>Corvalan</surname><given-names>A</given-names></name></person-group><article-title>Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma</article-title><source>Cancer Lett</source><year>2007</year><volume>250</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">17084965</pub-id></element-citation></ref><ref id="B194"><label>194</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa</surname><given-names>JC</given-names></name><name><surname>Anabal&#x000f3;n</surname><given-names>L</given-names></name><name><surname>Roa</surname><given-names>I</given-names></name><name><surname>Melo</surname><given-names>A</given-names></name><name><surname>Araya</surname><given-names>JC</given-names></name><name><surname>Tapia</surname><given-names>O</given-names></name><name><surname>de Aretxabala</surname><given-names>X</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>B</given-names></name></person-group><article-title>Promoter methylation profile in gallbladder cancer</article-title><source>J Gastroenterol</source><year>2006</year><volume>41</volume><fpage>269</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">16699861</pub-id></element-citation></ref><ref id="B195"><label>195</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>P</given-names></name><name><surname>Manterola</surname><given-names>C</given-names></name><name><surname>Araya</surname><given-names>JC</given-names></name><name><surname>Villaseca</surname><given-names>M</given-names></name><name><surname>Guzm&#x000e1;n</surname><given-names>P</given-names></name><name><surname>Sanhueza</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Alvarez</surname><given-names>H</given-names></name><name><surname>Roa</surname><given-names>JC</given-names></name></person-group><article-title>Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions</article-title><source>Mol Carcinog</source><year>2009</year><volume>48</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">18543280</pub-id></element-citation></ref><ref id="B196"><label>196</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letelier</surname><given-names>P</given-names></name><name><surname>Brebi</surname><given-names>P</given-names></name><name><surname>Tapia</surname><given-names>O</given-names></name><name><surname>Roa</surname><given-names>JC</given-names></name></person-group><article-title>DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer</article-title><source>Clin Epigenetics</source><year>2012</year><volume>4</volume><fpage>11</fpage><pub-id pub-id-type="pmid">22794276</pub-id></element-citation></ref><ref id="B197"><label>197</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tozawa</surname><given-names>T</given-names></name><name><surname>Tamura</surname><given-names>G</given-names></name><name><surname>Honda</surname><given-names>T</given-names></name><name><surname>Nawata</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>W</given-names></name><name><surname>Makino</surname><given-names>N</given-names></name><name><surname>Kawata</surname><given-names>S</given-names></name><name><surname>Sugai</surname><given-names>T</given-names></name><name><surname>Suto</surname><given-names>T</given-names></name><name><surname>Motoyama</surname><given-names>T</given-names></name></person-group><article-title>Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients</article-title><source>Cancer Sci</source><year>2004</year><volume>95</volume><fpage>736</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">15471559</pub-id></element-citation></ref><ref id="B198"><label>198</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Shivapurkar</surname><given-names>N</given-names></name><name><surname>Riquelme</surname><given-names>E</given-names></name><name><surname>Shigematsu</surname><given-names>H</given-names></name><name><surname>Reddy</surname><given-names>J</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Miyajima</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Bekele</surname><given-names>BN</given-names></name><name><surname>Gazdar</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><fpage>6126</fpage><lpage>6133</lpage><pub-id pub-id-type="pmid">15447999</pub-id></element-citation></ref><ref id="B199"><label>199</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa S</surname><given-names>JC</given-names></name><name><surname>Garc&#x000ed;a M</surname><given-names>P</given-names></name><name><surname>Melo A</surname><given-names>A</given-names></name><name><surname>Tapia E</surname><given-names>O</given-names></name><name><surname>Villaseca H</surname><given-names>M</given-names></name><name><surname>Araya O</surname><given-names>JC</given-names></name><name><surname>Guzm&#x000e1;n G</surname><given-names>P</given-names></name></person-group><article-title>[Gene methylation patterns in digestive tumors]</article-title><source>Rev Med Chil</source><year>2008</year><volume>136</volume><fpage>451</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">18769787</pub-id></element-citation></ref><ref id="B200"><label>200</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname><given-names>Y</given-names></name><name><surname>Kitajima</surname><given-names>Y</given-names></name><name><surname>Miyoshi</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Kitahara</surname><given-names>K</given-names></name><name><surname>Soejima</surname><given-names>H</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name></person-group><article-title>Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers</article-title><source>Ann Surg Oncol</source><year>2005</year><volume>12</volume><fpage>354</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">15915369</pub-id></element-citation></ref><ref id="B201"><label>201</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klump</surname><given-names>B</given-names></name><name><surname>Hsieh</surname><given-names>CJ</given-names></name><name><surname>Dette</surname><given-names>S</given-names></name><name><surname>Holzmann</surname><given-names>K</given-names></name><name><surname>Kiebetalich</surname><given-names>R</given-names></name><name><surname>Jung</surname><given-names>M</given-names></name><name><surname>Sinn</surname><given-names>U</given-names></name><name><surname>Ortner</surname><given-names>M</given-names></name><name><surname>Porschen</surname><given-names>R</given-names></name><name><surname>Gregor</surname><given-names>M</given-names></name></person-group><article-title>Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease</article-title><source>Clin Cancer Res</source><year>2003</year><volume>9</volume><fpage>1773</fpage><lpage>1778</lpage><pub-id pub-id-type="pmid">12738733</pub-id></element-citation></ref><ref id="B202"><label>202</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadokoro</surname><given-names>H</given-names></name><name><surname>Shigihara</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Takase</surname><given-names>M</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name></person-group><article-title>Two distinct pathways of p16 gene inactivation in gallbladder cancer</article-title><source>World J Gastroenterol</source><year>2007</year><volume>13</volume><fpage>6396</fpage><lpage>6403</lpage><pub-id pub-id-type="pmid">18081229</pub-id></element-citation></ref><ref id="B203"><label>203</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kee</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Jung</surname><given-names>YW</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Bae</surname><given-names>HI</given-names></name><name><surname>Hong</surname><given-names>HS</given-names></name><name><surname>Yun</surname><given-names>YK</given-names></name><etal/></person-group><article-title>Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer</article-title><source>Mol Cells</source><year>2007</year><volume>24</volume><fpage>364</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">18182852</pub-id></element-citation></ref><ref id="B204"><label>204</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Shigematsu</surname><given-names>H</given-names></name><name><surname>Shivapurkar</surname><given-names>N</given-names></name><name><surname>Echebiri</surname><given-names>C</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Stastny</surname><given-names>V</given-names></name><name><surname>Augustus</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>CW</given-names></name><name><surname>Wistuba</surname><given-names>II</given-names></name><etal/></person-group><article-title>Aberrant methylation of Reprimo in human malignancies</article-title><source>Int J Cancer</source><year>2005</year><volume>115</volume><fpage>503</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">15700311</pub-id></element-citation></ref><ref id="B205"><label>205</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>TD</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Shrivastav</surname><given-names>BR</given-names></name><name><surname>Tiwari</surname><given-names>PK</given-names></name></person-group><article-title>Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes</article-title><source>Gene</source><year>2016</year><volume>576</volume><fpage>743</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">26456195</pub-id></element-citation></ref><ref id="B206"><label>206</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishak</surname><given-names>G</given-names></name><name><surname>Leal</surname><given-names>MF</given-names></name><name><surname>Dos Santos</surname><given-names>NP</given-names></name><name><surname>Demachki</surname><given-names>S</given-names></name><name><surname>Nunes</surname><given-names>CA</given-names></name><name><surname>do Nascimento Borges</surname><given-names>B</given-names></name><name><surname>Calcagno</surname><given-names>DQ</given-names></name><name><surname>Smith</surname><given-names>MC</given-names></name><name><surname>Assump&#x000e7;&#x000e3;o</surname><given-names>PP</given-names></name><name><surname>Burbano</surname><given-names>RR</given-names></name></person-group><article-title>Deregulation of MYC and TP53 through genetic and epigenetic alterations in gallbladder carcinomas</article-title><source>Clin Exp Med</source><year>2015</year><volume>15</volume><fpage>421</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">25200035</pub-id></element-citation></ref><ref id="B207"><label>207</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagohara</surname><given-names>LT</given-names></name><name><surname>Schussel</surname><given-names>JL</given-names></name><name><surname>Subbannayya</surname><given-names>T</given-names></name><name><surname>Sahasrabuddhe</surname><given-names>N</given-names></name><name><surname>Lebron</surname><given-names>C</given-names></name><name><surname>Brait</surname><given-names>M</given-names></name><name><surname>Maldonado</surname><given-names>L</given-names></name><name><surname>Valle</surname><given-names>BL</given-names></name><name><surname>Pirini</surname><given-names>F</given-names></name><name><surname>Jahuira</surname><given-names>M</given-names></name><etal/></person-group><article-title>Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile</article-title><source>Future Oncol</source><year>2015</year><volume>11</volume><fpage>233</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">25066711</pub-id></element-citation></ref><ref id="B208"><label>208</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Bae</surname><given-names>HI</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>SG</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name></person-group><article-title>Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features</article-title><source>Cancer Sci</source><year>2006</year><volume>97</volume><fpage>1205</fpage><lpage>1210</lpage><pub-id pub-id-type="pmid">16965602</pub-id></element-citation></ref><ref id="B209"><label>209</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroki</surname><given-names>T</given-names></name><name><surname>Tajima</surname><given-names>Y</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Kanematsu</surname><given-names>T</given-names></name></person-group><article-title>Genetic alterations in gallbladder carcinoma</article-title><source>Surg Today</source><year>2005</year><volume>35</volume><fpage>101</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">15674488</pub-id></element-citation></ref><ref id="B210"><label>210</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name></person-group><article-title>Study on CCK-induced gallbladder emptying with real-time ultrasonography</article-title><source>Zhonghua Nei Ke Za Zhi</source><year>1995</year><volume>34</volume><fpage>385</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">8582185</pub-id></element-citation></ref><ref id="B211"><label>211</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammert</surname><given-names>F</given-names></name><name><surname>Carey</surname><given-names>MC</given-names></name><name><surname>Paigen</surname><given-names>B</given-names></name></person-group><article-title>Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map</article-title><source>Gastroenterology</source><year>2001</year><volume>120</volume><fpage>221</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">11208732</pub-id></element-citation></ref><ref id="B212"><label>212</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>B</given-names></name><name><surname>Mittal</surname><given-names>RD</given-names></name></person-group><article-title>Genetics of gallstone disease</article-title><source>J Postgrad Med</source><year>2002</year><volume>48</volume><fpage>149</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">12215703</pub-id></element-citation></ref><ref id="B213"><label>213</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittenburg</surname><given-names>H</given-names></name><name><surname>Lyons</surname><given-names>MA</given-names></name><name><surname>Paigen</surname><given-names>B</given-names></name><name><surname>Carey</surname><given-names>MC</given-names></name></person-group><article-title>Mapping cholesterol gallstone susceptibility (Lith) genes in inbred mice</article-title><source>Dig Liver Dis</source><year>2003</year><volume>35 Suppl 3</volume><fpage>S2</fpage><lpage>S7</lpage></element-citation></ref><ref id="B214"><label>214</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Dixit</surname><given-names>M</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility</article-title><source>Int J Gastrointest Cancer</source><year>2006</year><volume>37</volume><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">17987404</pub-id></element-citation></ref><ref id="B215"><label>215</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Nigam</surname><given-names>P</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India</article-title><source>Biomarkers</source><year>2006</year><volume>11</volume><fpage>250</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">16760134</pub-id></element-citation></ref><ref id="B216"><label>216</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Modi</surname><given-names>DR</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittall</surname><given-names>B</given-names></name></person-group><article-title>Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease</article-title><source>Cancer Biol Ther</source><year>2007</year><volume>6</volume><fpage>91</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">17224641</pub-id></element-citation></ref><ref id="B217"><label>217</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Dixit</surname><given-names>M</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Haplotype analysis of signal peptide (insertion/deletion) and XbaI polymorphisms of the APOB gene in gallbladder cancer</article-title><source>Liver Int</source><year>2007</year><volume>27</volume><fpage>1008</fpage><lpage>1015</lpage><pub-id pub-id-type="pmid">17696941</pub-id></element-citation></ref><ref id="B218"><label>218</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population</article-title><source>Eur J Cancer Prev</source><year>2008</year><volume>17</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">18287863</pub-id></element-citation></ref><ref id="B219"><label>219</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnoi</surname><given-names>M</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Choudhury</surname><given-names>G</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Modi</surname><given-names>DR</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Do TNFA -308 G/A and IL6 -174 G/C gene polymorphisms modulate risk of gallbladder cancer in the north Indian population?</article-title><source>Asian Pac J Cancer Prev</source><year>2007</year><volume>8</volume><fpage>567</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">18260730</pub-id></element-citation></ref><ref id="B220"><label>220</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnoi</surname><given-names>M</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population</article-title><source>Cancer Genet Cytogenet</source><year>2008</year><volume>186</volume><fpage>63</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">18940468</pub-id></element-citation></ref><ref id="B221"><label>221</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnoi</surname><given-names>M</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Modi</surname><given-names>DR</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Genetic susceptibility of epidermal growth factor +61A&#x00026; gt; G and transforming growth factor beta1 -509C&#x00026; gt; T gene polymorphisms with gallbladder cancer</article-title><source>Hum Immunol</source><year>2008</year><volume>69</volume><fpage>360</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">18571008</pub-id></element-citation></ref><ref id="B222"><label>222</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>WY</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Sakoda</surname><given-names>LC</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Han</surname><given-names>TQ</given-names></name><name><surname>Zhang</surname><given-names>BH</given-names></name><name><surname>Chen</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China</article-title><source>Carcinogenesis</source><year>2008</year><volume>29</volume><fpage>100</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">17984110</pub-id></element-citation></ref><ref id="B223"><label>223</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>WY</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Sakoda</surname><given-names>LC</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Chanock</surname><given-names>S</given-names></name><etal/></person-group><article-title>Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2008</year><volume>17</volume><fpage>2123</fpage><lpage>2127</lpage><pub-id pub-id-type="pmid">18708406</pub-id></element-citation></ref><ref id="B224"><label>224</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Sakoda</surname><given-names>LC</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>BE</given-names></name><name><surname>Rosenberg</surname><given-names>PS</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China</article-title><source>Carcinogenesis</source><year>2009</year><volume>30</volume><fpage>606</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">19168589</pub-id></element-citation></ref><ref id="B225"><label>225</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility</article-title><source>Scand J Immunol</source><year>2008</year><volume>67</volume><fpage>516</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">18405329</pub-id></element-citation></ref><ref id="B226"><label>226</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer</article-title><source>Mol Genet Metab</source><year>2008</year><volume>94</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">18178499</pub-id></element-citation></ref><ref id="B227"><label>227</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Dixit</surname><given-names>M</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer</article-title><source>J Gastroenterol Hepatol</source><year>2008</year><volume>23</volume><fpage>970</fpage><lpage>975</lpage><pub-id pub-id-type="pmid">17944886</pub-id></element-citation></ref><ref id="B228"><label>228</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Pandey</surname><given-names>P</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>No association of Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer</article-title><source>DNA Cell Biol</source><year>2008</year><volume>27</volume><fpage>127</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">17979520</pub-id></element-citation></ref><ref id="B229"><label>229</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Tulsyan</surname><given-names>S</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Single nucleotide polymorphism in the ABCG8 transporter gene is associated with gallbladder cancer susceptibility</article-title><source>Liver Int</source><year>2009</year><volume>29</volume><fpage>831</fpage><lpage>837</lpage><pub-id pub-id-type="pmid">19018975</pub-id></element-citation></ref><ref id="B230"><label>230</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population</article-title><source>Scand J Immunol</source><year>2009</year><volume>70</volume><fpage>614</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">19906204</pub-id></element-citation></ref><ref id="B231"><label>231</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population</article-title><source>Ann Surg Oncol</source><year>2009</year><volume>16</volume><fpage>1695</fpage><lpage>1703</lpage><pub-id pub-id-type="pmid">19266243</pub-id></element-citation></ref><ref id="B232"><label>232</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India</article-title><source>Cancer</source><year>2010</year><volume>116</volume><fpage>3160</fpage><lpage>3169</lpage><pub-id pub-id-type="pmid">20564624</pub-id></element-citation></ref><ref id="B233"><label>233</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>SN</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population</article-title><source>J Gastroenterol</source><year>2009</year><volume>44</volume><fpage>774</fpage><lpage>780</lpage><pub-id pub-id-type="pmid">19455278</pub-id></element-citation></ref><ref id="B234"><label>234</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>PC</given-names></name><name><surname>Zembutsu</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Kamatani</surname><given-names>N</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group><article-title>A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population</article-title><source>J Hum Genet</source><year>2012</year><volume>57</volume><fpage>235</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">22318345</pub-id></element-citation></ref><ref id="B235"><label>235</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Tiwari</surname><given-names>S</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: Gene-D-12-01446)</article-title><source>Gene</source><year>2013</year><volume>518</volume><fpage>303</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">23353777</pub-id></element-citation></ref><ref id="B236"><label>236</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>X</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Ala499Val (C&#x00026; gt; T) and Lys939Gln (A&#x00026; gt; C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma--a case-control study in China</article-title><source>Carcinogenesis</source><year>2011</year><volume>32</volume><fpage>496</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">21113018</pub-id></element-citation></ref><ref id="B237"><label>237</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>Y</given-names></name><name><surname>Baez</surname><given-names>S</given-names></name><name><surname>Calvo</surname><given-names>A</given-names></name><name><surname>Pruyas</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Kiyohara</surname><given-names>C</given-names></name><name><surname>Oyama</surname><given-names>M</given-names></name><name><surname>Ikegami</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women</article-title><source>Int J Biol Markers</source><year>2010</year><volume>25</volume><fpage>75</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">20544687</pub-id></element-citation></ref><ref id="B238"><label>238</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Tsuchiya</surname><given-names>Y</given-names></name><name><surname>Lang</surname><given-names>I</given-names></name><name><surname>Zoltan</surname><given-names>S</given-names></name><name><surname>Nakadaira</surname><given-names>H</given-names></name><name><surname>Ajioka</surname><given-names>Y</given-names></name><name><surname>Kiyohara</surname><given-names>C</given-names></name><name><surname>Oyama</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name></person-group><article-title>Effect of genetic predisposition on the risk of gallbladder cancer in Hungary</article-title><source>Asian Pac J Cancer Prev</source><year>2008</year><volume>9</volume><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">18990008</pub-id></element-citation></ref><ref id="B239"><label>239</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>Y</given-names></name><name><surname>Kiyohara</surname><given-names>C</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Polymorphisms of cytochrome P450 1A1, glutathione S-transferase class mu, and tumour protein p53 genes and the risk of developing gallbladder cancer in Japanese</article-title><source>Clin Biochem</source><year>2007</year><volume>40</volume><fpage>881</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">17531965</pub-id></element-citation></ref><ref id="B240"><label>240</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Variants and haplotypes in Flap endonuclease 1 and risk of gallbladder cancer and gallstones: a population-based study in China</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>18160</fpage><pub-id pub-id-type="pmid">26668074</pub-id></element-citation></ref><ref id="B241"><label>241</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>HL</given-names></name><name><surname>Hsing</surname><given-names>AW</given-names></name><name><surname>Vogtmann</surname><given-names>E</given-names></name><name><surname>Chu</surname><given-names>LW</given-names></name><name><surname>Cheng</surname><given-names>JR</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>YT</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name></person-group><article-title>Variants in CCK and CCKAR genes to susceptibility to biliary tract cancers and stones: a population-based study in Shanghai, China</article-title><source>J Gastroenterol Hepatol</source><year>2013</year><volume>28</volume><fpage>1476</fpage><lpage>1481</lpage><pub-id pub-id-type="pmid">23701593</pub-id></element-citation></ref><ref id="B242"><label>242</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Srivastava</surname><given-names>N</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e40162</fpage><pub-id pub-id-type="pmid">22808109</pub-id></element-citation></ref><ref id="B243"><label>243</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Rosenberg</surname><given-names>PS</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Olsen</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Sakoda</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China</article-title><source>Carcinogenesis</source><year>2010</year><volume>31</volume><fpage>842</fpage><lpage>846</lpage><pub-id pub-id-type="pmid">20172949</pub-id></element-citation></ref><ref id="B244"><label>244</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>TE</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>TG</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Han</surname><given-names>TQ</given-names></name><etal/></person-group><article-title>Androgen receptor CAG repeat length and risk of biliary tract cancer and stones</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2010</year><volume>19</volume><fpage>787</fpage><lpage>793</lpage><pub-id pub-id-type="pmid">20200439</pub-id></element-citation></ref><ref id="B245"><label>245</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>SC</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Han</surname><given-names>TQ</given-names></name><name><surname>Zhang</surname><given-names>BH</given-names></name><name><surname>Sakoda</surname><given-names>LC</given-names></name><name><surname>Leitzmann</surname><given-names>MF</given-names></name><etal/></person-group><article-title>Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China</article-title><source>Carcinogenesis</source><year>2008</year><volume>29</volume><fpage>944</fpage><lpage>948</lpage><pub-id pub-id-type="pmid">18375961</pub-id></element-citation></ref><ref id="B246"><label>246</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakoda</surname><given-names>LC</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Chen</surname><given-names>BE</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Rosenberg</surname><given-names>PS</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Han</surname><given-names>TQ</given-names></name><etal/></person-group><article-title>Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China</article-title><source>Carcinogenesis</source><year>2006</year><volume>27</volume><fpage>1251</fpage><lpage>1256</lpage><pub-id pub-id-type="pmid">16361272</pub-id></element-citation></ref><ref id="B247"><label>247</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsing</surname><given-names>AW</given-names></name><name><surname>Sakoda</surname><given-names>LC</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Chen</surname><given-names>BE</given-names></name><name><surname>Rosenberg</surname><given-names>PS</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China</article-title><source>Cancer Res</source><year>2008</year><volume>68</volume><fpage>6442</fpage><lpage>6452</lpage><pub-id pub-id-type="pmid">18676870</pub-id></element-citation></ref><ref id="B248"><label>248</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>FA</given-names></name><name><surname>Koshiol</surname><given-names>J</given-names></name><name><surname>Hsing</surname><given-names>AW</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Chu</surname><given-names>LW</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Han</surname><given-names>TQ</given-names></name><name><surname>Zhang</surname><given-names>BH</given-names></name><etal/></person-group><article-title>Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China</article-title><source>BMC Cancer</source><year>2012</year><volume>12</volume><fpage>468</fpage><pub-id pub-id-type="pmid">23057767</pub-id></element-citation></ref><ref id="B249"><label>249</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer</article-title><source>Liver Int</source><year>2012</year><volume>32</volume><fpage>1278</fpage><lpage>1286</lpage><pub-id pub-id-type="pmid">22621753</pub-id></element-citation></ref><ref id="B250"><label>250</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Zheng</surname><given-names>SL</given-names></name><name><surname>Sakoda</surname><given-names>LC</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>TQ</given-names></name><etal/></person-group><article-title>CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China</article-title><source>Int J Cancer</source><year>2006</year><volume>118</volume><fpage>2847</fpage><lpage>2853</lpage><pub-id pub-id-type="pmid">16381022</pub-id></element-citation></ref><ref id="B251"><label>251</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users</article-title><source>Tumour Biol</source><year>2014</year><volume>35</volume><fpage>6531</fpage><lpage>6537</lpage><pub-id pub-id-type="pmid">24687554</pub-id></element-citation></ref><ref id="B252"><label>252</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility</article-title><source>Tumour Biol</source><year>2014</year><volume>35</volume><fpage>5431</fpage><lpage>5439</lpage><pub-id pub-id-type="pmid">24535777</pub-id></element-citation></ref><ref id="B253"><label>253</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>BE</given-names></name><name><surname>Rosenberg</surname><given-names>P</given-names></name><name><surname>Sakoda</surname><given-names>LC</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2008</year><volume>17</volume><fpage>525</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">18296645</pub-id></element-citation></ref><ref id="B254"><label>254</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>HL</given-names></name><name><surname>Cheng</surname><given-names>JR</given-names></name><name><surname>Andreotti</surname><given-names>G</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Shen</surname><given-names>MC</given-names></name><name><surname>Chu</surname><given-names>LW</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Hsing</surname><given-names>AW</given-names></name></person-group><article-title>Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China</article-title><source>Carcinogenesis</source><year>2011</year><volume>32</volume><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">21062971</pub-id></element-citation></ref><ref id="B255"><label>255</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Choudhuri</surname><given-names>G</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>CYP7A1 (-204 A&#x00026; gt; C; rs3808607 and -469 T&#x00026; gt; C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population</article-title><source>Metabolism</source><year>2010</year><volume>59</volume><fpage>767</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">20005541</pub-id></element-citation></ref><ref id="B256"><label>256</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isomura</surname><given-names>Y</given-names></name><name><surname>Yamaji</surname><given-names>Y</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Seto</surname><given-names>M</given-names></name><name><surname>Asaoka</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Nakai</surname><given-names>Y</given-names></name><name><surname>Sasahira</surname><given-names>N</given-names></name><name><surname>Isayama</surname><given-names>H</given-names></name><etal/></person-group><article-title>A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer</article-title><source>J Gastroenterol</source><year>2010</year><volume>45</volume><fpage>1045</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">20549256</pub-id></element-citation></ref><ref id="B257"><label>257</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>JJ</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations</article-title><source>Int J Mol Sci</source><year>2015</year><volume>16</volume><fpage>28038</fpage><lpage>28049</lpage><pub-id pub-id-type="pmid">26602921</pub-id></element-citation></ref><ref id="B258"><label>258</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population</article-title><source>Mol Carcinog</source><year>2010</year><volume>49</volume><fpage>684</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">20564345</pub-id></element-citation></ref><ref id="B259"><label>259</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility</article-title><source>Tumour Biol</source><year>2013</year><volume>34</volume><fpage>3959</fpage><lpage>3966</lpage><pub-id pub-id-type="pmid">23838803</pub-id></element-citation></ref><ref id="B260"><label>260</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Yadav</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Tulsayan</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population</article-title><source>Tumour Biol</source><year>2014</year><volume>35</volume><fpage>2583</fpage><lpage>2589</lpage><pub-id pub-id-type="pmid">24186075</pub-id></element-citation></ref><ref id="B261"><label>261</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Rastogi</surname><given-names>N</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>1835</fpage><lpage>1844</lpage><pub-id pub-id-type="pmid">26318430</pub-id></element-citation></ref><ref id="B262"><label>262</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Chihara</surname><given-names>D</given-names></name><name><surname>Chiwaki</surname><given-names>F</given-names></name><name><surname>Yanagihara</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Sakamoto</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Saeki</surname><given-names>N</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name></person-group><article-title>Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells</article-title><source>J Carcinog</source><year>2013</year><volume>12</volume><fpage>4</fpage><pub-id pub-id-type="pmid">23599686</pub-id></element-citation></ref><ref id="B263"><label>263</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females</article-title><source>Gene</source><year>2013</year><volume>530</volume><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">23988503</pub-id></element-citation></ref><ref id="B264"><label>264</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population</article-title><source>J Hum Genet</source><year>2010</year><volume>55</volume><fpage>495</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">20520619</pub-id></element-citation></ref><ref id="B265"><label>265</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Yadav</surname><given-names>A</given-names></name><name><surname>Rastogi</surname><given-names>N</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Evaluation of miR-27a, miR-181a, and miR-570 genetic variants with gallbladder cancer susceptibility and treatment outcome in a North Indian population</article-title><source>Mol Diagn Ther</source><year>2015</year><volume>19</volume><fpage>317</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">26288960</pub-id></element-citation></ref><ref id="B266"><label>266</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Yadav</surname><given-names>S</given-names></name><name><surname>Rastogi</surname><given-names>N</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>8083</fpage><lpage>8095</lpage><pub-id pub-id-type="pmid">26715268</pub-id></element-citation></ref><ref id="B267"><label>267</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pramanik</surname><given-names>V</given-names></name><name><surname>Sarkar</surname><given-names>BN</given-names></name><name><surname>Kar</surname><given-names>M</given-names></name><name><surname>Das</surname><given-names>G</given-names></name><name><surname>Malay</surname><given-names>BK</given-names></name><name><surname>Sufia</surname><given-names>KK</given-names></name><name><surname>Lakkakula</surname><given-names>BV</given-names></name><name><surname>Vadlamudi</surname><given-names>RR</given-names></name></person-group><article-title>A novel polymorphism in codon 25 of the KRAS gene associated with gallbladder carcinoma patients of the eastern part of India</article-title><source>Genet Test Mol Biomarkers</source><year>2011</year><volume>15</volume><fpage>431</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">21375404</pub-id></element-citation></ref><ref id="B268"><label>268</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Angiotensin I-converting enzyme insertion/deletion polymorphism and increased risk of gall bladder cancer in women</article-title><source>DNA Cell Biol</source><year>2010</year><volume>29</volume><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">20438364</pub-id></element-citation></ref><ref id="B269"><label>269</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>DNMT3B -579 G&#x00026; gt; T promoter polymorphism and risk of gallbladder carcinoma in North Indian population</article-title><source>J Gastrointest Cancer</source><year>2010</year><volume>41</volume><fpage>248</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">20480259</pub-id></element-citation></ref><ref id="B270"><label>270</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Significant association between toll-like receptor gene polymorphisms and gallbladder cancer</article-title><source>Liver Int</source><year>2010</year><volume>30</volume><fpage>1067</fpage><lpage>1072</lpage><pub-id pub-id-type="pmid">20492496</pub-id></element-citation></ref><ref id="B271"><label>271</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population</article-title><source>J Cancer Res Clin Oncol</source><year>2014</year><volume>140</volume><fpage>725</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">24556804</pub-id></element-citation></ref><ref id="B272"><label>272</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>KL</given-names></name><name><surname>Umar</surname><given-names>M</given-names></name><name><surname>Pandey</surname><given-names>M</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Association of potentially functional genetic variants of PLCE1 with gallbladder cancer susceptibility in north Indian population</article-title><source>J Gastrointest Cancer</source><year>2013</year><volume>44</volume><fpage>436</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">23975622</pub-id></element-citation></ref><ref id="B273"><label>273</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>WT</given-names></name><name><surname>Ning</surname><given-names>SJ</given-names></name><name><surname>Zhang</surname><given-names>SJ</given-names></name></person-group><article-title>Vitamin D receptor genetic variants are associated with susceptibility of gallbladder adenocarcinoma in a Chinese cohort</article-title><source>Genet Mol Res</source><year>2014</year><volume>13</volume><fpage>5387</fpage><lpage>5394</lpage><pub-id pub-id-type="pmid">25078595</pub-id></element-citation></ref><ref id="B274"><label>274</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albores-Saavedra</surname><given-names>J</given-names></name><name><surname>Alc&#x000e1;ntra-Vazquez</surname><given-names>A</given-names></name><name><surname>Cruz-Ortiz</surname><given-names>H</given-names></name><name><surname>Herrera-Goepfert</surname><given-names>R</given-names></name></person-group><article-title>The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ</article-title><source>Cancer</source><year>1980</year><volume>45</volume><fpage>919</fpage><lpage>927</lpage><pub-id pub-id-type="pmid">7260842</pub-id></element-citation></ref><ref id="B275"><label>275</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roa</surname><given-names>I</given-names></name><name><surname>Araya</surname><given-names>JC</given-names></name><name><surname>Villaseca</surname><given-names>M</given-names></name><name><surname>De Aretxabala</surname><given-names>X</given-names></name><name><surname>Riedemann</surname><given-names>P</given-names></name><name><surname>Endoh</surname><given-names>K</given-names></name><name><surname>Roa</surname><given-names>J</given-names></name></person-group><article-title>Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression</article-title><source>Gastroenterology</source><year>1996</year><volume>111</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">8698204</pub-id></element-citation></ref><ref id="B276"><label>276</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaittinen</surname><given-names>E</given-names></name></person-group><article-title>Carcinoma of the gall-bladder. A study of 390 cases diagnosed in Finland 1953-1967</article-title><source>Ann Chir Gynaecol Fenn Suppl</source><year>1970</year><volume>168</volume><fpage>1</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">5268194</pub-id></element-citation></ref><ref id="B277"><label>277</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>B</given-names></name></person-group><article-title>Potential biomarkers in gallbladder cancer: present status and future directions</article-title><source>Biomarkers</source><year>2013</year><volume>18</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22931385</pub-id></element-citation></ref><ref id="B278"><label>278</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>CZ</given-names></name><name><surname>Zhang</surname><given-names>KH</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>XH</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Lv</surname><given-names>NH</given-names></name></person-group><article-title>Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer</article-title><source>BMC Gastroenterol</source><year>2013</year><volume>13</volume><fpage>87</fpage><pub-id pub-id-type="pmid">23672279</pub-id></element-citation></ref><ref id="B279"><label>279</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zur</surname><given-names>B</given-names></name><name><surname>Holdenrieder</surname><given-names>S</given-names></name><name><surname>Walgenbach-Br&#x000fc;nagel</surname><given-names>G</given-names></name><name><surname>Albers</surname><given-names>E</given-names></name><name><surname>Stoffel-Wagner</surname><given-names>B</given-names></name></person-group><article-title>Method comparison for determination of the tumor markers AFP, CEA, PSA and free PSA between Immulite 2000 XPI and Dimension Vista 1500</article-title><source>Clin Lab</source><year>2012</year><volume>58</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">22372351</pub-id></element-citation></ref><ref id="B280"><label>280</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Xiong</surname><given-names>B</given-names></name></person-group><article-title>Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population</article-title><source>Hepatogastroenterology</source><year>2013</year><volume>60</volume><fpage>1297</fpage><lpage>1301</lpage><pub-id pub-id-type="pmid">23933921</pub-id></element-citation></ref><ref id="B281"><label>281</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopmann</surname><given-names>J</given-names></name><name><surname>Thuluvath</surname><given-names>PJ</given-names></name><name><surname>Zahurak</surname><given-names>ML</given-names></name><name><surname>Kristiansen</surname><given-names>TZ</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Schulick</surname><given-names>R</given-names></name><name><surname>Argani</surname><given-names>P</given-names></name><name><surname>Hidalgo</surname><given-names>M</given-names></name><name><surname>Iacobelli</surname><given-names>S</given-names></name><name><surname>Goggins</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma</article-title><source>Cancer</source><year>2004</year><volume>101</volume><fpage>1609</fpage><lpage>1615</lpage><pub-id pub-id-type="pmid">15378479</pub-id></element-citation></ref><ref id="B282"><label>282</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Liang</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma</article-title><source>Dig Dis Sci</source><year>2015</year><volume>60</volume><fpage>1273</fpage><lpage>1283</lpage><pub-id pub-id-type="pmid">25487191</pub-id></element-citation></ref><ref id="B283"><label>283</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barreto</surname><given-names>SG</given-names></name><name><surname>Dutt</surname><given-names>A</given-names></name><name><surname>Chaudhary</surname><given-names>A</given-names></name></person-group><article-title>A genetic model for gallbladder carcinogenesis and its dissemination</article-title><source>Ann Oncol</source><year>2014</year><volume>25</volume><fpage>1086</fpage><lpage>1097</lpage><pub-id pub-id-type="pmid">24705974</pub-id></element-citation></ref></ref-list></back></article>